id	sid	tid	token	lemma	pos
aji-164	1	1	_	_	PUNCT
aji-164	2	1	_	_	PUNCT
aji-164	3	1	_	_	PUNCT
aji-164	4	1	_	_	PUNCT
aji-164	5	1	_	_	PUNCT
aji-164	6	1	_	_	PUNCT
aji-164	7	1	_	_	PUNCT
aji-164	8	1	_	_	PUNCT
aji-164	9	1	_	_	PUNCT
aji-164	10	1	_	_	PUNCT
aji-164	11	1	_	_	PUNCT
aji-164	12	1	_	_	PUNCT
aji-164	13	1	_	_	PUNCT
aji-164	14	1	_	_	PUNCT
aji-164	15	1	_	_	PUNCT
aji-164	16	1	_	_	PUNCT
aji-164	17	1	_	_	PUNCT
aji-164	18	1	_	_	PUNCT
aji-164	19	1	_	_	PUNCT
aji-164	20	1	_	_	PUNCT
aji-164	21	1	_	_	PUNCT
aji-164	22	1	_	_	PUNCT
aji-164	23	1	_	_	PUNCT
aji-164	24	1	_	_	PUNCT
aji-164	25	1	_	_	PUNCT
aji-164	26	1	_	_	PUNCT
aji-164	27	1	_	_	PUNCT
aji-164	28	1	_	_	PUNCT
aji-164	29	1	_	_	PUNCT
aji-164	30	1	_	_	PUNCT
aji-164	31	1	_	_	PUNCT
aji-164	32	1	_	_	PUNCT
aji-164	33	1	_	_	PUNCT
aji-164	34	1	_	_	PUNCT
aji-164	35	1	_	_	PUNCT
aji-164	36	1	_	_	PUNCT
aji-164	37	1	_	_	PUNCT
aji-164	38	1	_	_	PUNCT
aji-164	39	1	_	_	PUNCT
aji-164	40	1	_	_	PUNCT
aji-164	41	1	_	_	PUNCT
aji-164	42	1	_	_	PUNCT
aji-164	43	1	_	_	PUNCT
aji-164	44	1	_	_	PUNCT
aji-164	45	1	_	_	PUNCT
aji-164	46	1	_	_	PUNCT
aji-164	47	1	_	_	PUNCT
aji-164	48	1	_	_	PUNCT
aji-164	49	1	_	_	PUNCT
aji-164	50	1	_	_	PUNCT
aji-164	51	1	_	_	PUNCT
aji-164	52	1	_	_	PUNCT
aji-164	53	1	_	_	PUNCT
aji-164	54	1	_	_	PUNCT
aji-164	55	1	_	_	PUNCT
aji-164	56	1	_	_	PUNCT
aji-164	57	1	_	_	PUNCT
aji-164	58	1	_	_	PUNCT
aji-164	59	1	_	_	PUNCT
aji-164	60	1	_	_	PUNCT
aji-164	61	1	_	_	PUNCT
aji-164	62	1	_	_	PUNCT
aji-164	63	1	_	_	PUNCT
aji-164	64	1	_	_	PUNCT
aji-164	65	1	_	_	PUNCT
aji-164	66	1	_	_	PUNCT
aji-164	67	1	_	_	PUNCT
aji-164	68	1	_	_	PUNCT
aji-164	69	1	_	_	PUNCT
aji-164	70	1	_	_	PUNCT
aji-164	71	1	_	_	PUNCT
aji-164	72	1	_	_	PUNCT
aji-164	73	1	_	_	PUNCT
aji-164	74	1	_	_	PUNCT
aji-164	75	1	_	_	PUNCT
aji-164	76	1	_	_	PUNCT
aji-164	77	1	_	_	PUNCT
aji-164	78	1	_	_	PUNCT
aji-164	79	1	_	_	PUNCT
aji-164	80	1	_	_	PUNCT
aji-164	81	1	_	_	PUNCT
aji-164	82	1	_	_	PUNCT
aji-164	83	1	_	_	PUNCT
aji-164	84	1	_	_	PUNCT
aji-164	85	1	_	_	PUNCT
aji-164	86	1	_	_	PUNCT
aji-164	87	1	_	_	PUNCT
aji-164	88	1	_	_	PUNCT
aji-164	89	1	_	_	PUNCT
aji-164	90	1	_	_	PUNCT
aji-164	91	1	_	_	PUNCT
aji-164	92	1	_	_	PUNCT
aji-164	93	1	_	_	PUNCT
aji-164	94	1	_	_	PUNCT
aji-164	95	1	_	_	PUNCT
aji-164	96	1	_	_	PUNCT
aji-164	97	1	_	_	PUNCT
aji-164	98	1	_	_	PUNCT
aji-164	99	1	_	_	PUNCT
aji-164	100	1	_	_	PUNCT
aji-164	101	1	_	_	PUNCT
aji-164	102	1	*	*	PUNCT
aji-164	102	2	corresponding	correspond	VERB
aji-164	102	3	author	author	NOUN
aji-164	102	4	:	:	PUNCT
aji-164	102	5	e	e	NOUN
aji-164	102	6	-	-	NOUN
aji-164	102	7	mail	mail	NOUN
aji-164	102	8	:	:	PUNCT
aji-164	102	9	ibrahimshnawa3@gmail.com	ibrahimshnawa3@gmail.com	X
aji-164	102	10	;	;	PUNCT
aji-164	102	11	cite	cite	VERB
aji-164	102	12	as	as	ADP
aji-164	102	13	:	:	PUNCT
aji-164	102	14	shnawa	shnawa	PROPN
aji-164	102	15	,	,	PUNCT
aji-164	102	16	ibrahim	ibrahim	PROPN
aji-164	102	17	m	m	PROPN
aji-164	102	18	s.	s.	PROPN
aji-164	102	19	2025	2025	NUM
aji-164	102	20	.	.	PUNCT
aji-164	103	1	“	"	PUNCT
aji-164	103	2	an	an	DET
aji-164	103	3	alum	alum	ADJ
aji-164	103	4	loaded	load	VERB
aji-164	103	5	macrophage	macrophage	ADJ
aji-164	103	6	driven	drive	VERB
aji-164	103	7	autoimmune	autoimmune	ADJ
aji-164	103	8	myopathy	myopathy	ADJ
aji-164	103	9	”	"	PUNCT
aji-164	103	10	.	.	PUNCT
aji-164	104	1	asian	asian	ADJ
aji-164	104	2	journal	journal	NOUN
aji-164	104	3	of	of	ADP
aji-164	104	4	immunology	immunology	NOUN
aji-164	104	5	8	8	NUM
aji-164	104	6	(	(	PUNCT
aji-164	104	7	1):97	1):97	NUM
aji-164	104	8	-	-	SYM
aji-164	104	9	103	103	NUM
aji-164	104	10	.	.	PUNCT
aji-164	105	1	https://doi.org/10.9734/aji/2025/v8i1164	https://doi.org/10.9734/aji/2025/v8i1164	NOUN
aji-164	105	2	.	.	PUNCT
aji-164	106	1	asian	asian	ADJ
aji-164	106	2	journal	journal	NOUN
aji-164	106	3	of	of	ADP
aji-164	106	4	immunology	immunology	NOUN
aji-164	106	5	volume	volume	NOUN
aji-164	106	6	8	8	NUM
aji-164	106	7	,	,	PUNCT
aji-164	106	8	issue	issue	NOUN
aji-164	106	9	1	1	NUM
aji-164	106	10	,	,	PUNCT
aji-164	106	11	page	page	NOUN
aji-164	106	12	97	97	NUM
aji-164	106	13	-	-	SYM
aji-164	106	14	103	103	NUM
aji-164	106	15	,	,	PUNCT
aji-164	106	16	2025	2025	NUM
aji-164	106	17	;	;	PUNCT
aji-164	106	18	article	article	NOUN
aji-164	106	19	no.aji.134974	no.aji.134974	VERB
aji-164	106	20	an	an	DET
aji-164	106	21	alum	alum	ADJ
aji-164	106	22	loaded	load	VERB
aji-164	106	23	macrophage	macrophage	ADJ
aji-164	106	24	driven	drive	VERB
aji-164	106	25	autoimmune	autoimmune	ADJ
aji-164	106	26	myopathy	myopathy	ADJ
aji-164	106	27	ibrahim	ibrahim	PROPN
aji-164	107	1	m	m	PROPN
aji-164	107	2	s	s	VERB
aji-164	107	3	shnawa	shnawa	NOUN
aji-164	107	4	a	a	DET
aji-164	107	5	,	,	PUNCT
aji-164	107	6	b	b	X
aji-164	107	7	*	*	PUNCT
aji-164	107	8	a	a	DET
aji-164	107	9	department	department	NOUN
aji-164	107	10	of	of	ADP
aji-164	107	11	medical	medical	ADJ
aji-164	107	12	biotechnology	biotechnology	NOUN
aji-164	107	13	,	,	PUNCT
aji-164	107	14	college	college	NOUN
aji-164	107	15	of	of	ADP
aji-164	107	16	biotechnology	biotechnology	NOUN
aji-164	107	17	,	,	PUNCT
aji-164	107	18	al	al	PROPN
aji-164	107	19	-	-	PUNCT
aji-164	107	20	qasim	qasim	PROPN
aji-164	107	21	green	green	PROPN
aji-164	107	22	university	university	PROPN
aji-164	107	23	,	,	PUNCT
aji-164	107	24	qasim	qasim	PROPN
aji-164	107	25	,	,	PUNCT
aji-164	107	26	babylon	babylon	PROPN
aji-164	107	27	,	,	PUNCT
aji-164	107	28	iraq	iraq	PROPN
aji-164	107	29	.	.	PUNCT
aji-164	108	1	b	b	X
aji-164	108	2	college	college	NOUN
aji-164	108	3	of	of	ADP
aji-164	108	4	nursing	nursing	NOUN
aji-164	108	5	,	,	PUNCT
aji-164	108	6	university	university	NOUN
aji-164	108	7	of	of	ADP
aji-164	108	8	hilla	hilla	PROPN
aji-164	108	9	,	,	PUNCT
aji-164	108	10	babylon	babylon	PROPN
aji-164	108	11	,	,	PUNCT
aji-164	108	12	iraq	iraq	PROPN
aji-164	108	13	.	.	PUNCT
aji-164	109	1	author	author	PROPN
aji-164	109	2	’s	’s	PART
aji-164	109	3	contribution	contribution	NOUN
aji-164	109	4	the	the	DET
aji-164	109	5	sole	sole	ADJ
aji-164	109	6	author	author	NOUN
aji-164	109	7	designed	design	VERB
aji-164	109	8	,	,	PUNCT
aji-164	109	9	analysed	analyse	VERB
aji-164	109	10	,	,	PUNCT
aji-164	109	11	interpreted	interpret	VERB
aji-164	109	12	and	and	CCONJ
aji-164	109	13	prepared	prepare	VERB
aji-164	109	14	the	the	DET
aji-164	109	15	manuscript	manuscript	NOUN
aji-164	109	16	.	.	PUNCT
aji-164	110	1	article	article	NOUN
aji-164	110	2	information	information	PROPN
aji-164	110	3	doi	doi	PROPN
aji-164	110	4	:	:	PUNCT
aji-164	110	5	https://doi.org/10.9734/aji/2025/v8i1164	https://doi.org/10.9734/aji/2025/v8i1164	VERB
aji-164	110	6	open	open	ADJ
aji-164	110	7	peer	peer	NOUN
aji-164	110	8	review	review	NOUN
aji-164	110	9	history	history	NOUN
aji-164	110	10	:	:	PUNCT
aji-164	110	11	this	this	DET
aji-164	110	12	journal	journal	NOUN
aji-164	110	13	follows	follow	VERB
aji-164	110	14	the	the	DET
aji-164	110	15	advanced	advance	VERB
aji-164	110	16	open	open	ADJ
aji-164	110	17	peer	peer	NOUN
aji-164	110	18	review	review	NOUN
aji-164	110	19	policy	policy	NOUN
aji-164	110	20	.	.	PUNCT
aji-164	111	1	identity	identity	NOUN
aji-164	111	2	of	of	ADP
aji-164	111	3	the	the	DET
aji-164	111	4	reviewers	reviewer	NOUN
aji-164	111	5	,	,	PUNCT
aji-164	111	6	editor(s	editor(s	NOUN
aji-164	111	7	)	)	PUNCT
aji-164	111	8	and	and	CCONJ
aji-164	111	9	additional	additional	ADJ
aji-164	111	10	reviewers	reviewer	NOUN
aji-164	111	11	,	,	PUNCT
aji-164	111	12	peer	peer	NOUN
aji-164	111	13	review	review	NOUN
aji-164	111	14	comments	comment	NOUN
aji-164	111	15	,	,	PUNCT
aji-164	111	16	different	different	ADJ
aji-164	111	17	versions	version	NOUN
aji-164	111	18	of	of	ADP
aji-164	111	19	the	the	DET
aji-164	111	20	manuscript	manuscript	NOUN
aji-164	111	21	,	,	PUNCT
aji-164	111	22	comments	comment	NOUN
aji-164	111	23	of	of	ADP
aji-164	111	24	the	the	DET
aji-164	111	25	editors	editor	NOUN
aji-164	111	26	,	,	PUNCT
aji-164	111	27	etc	etc	X
aji-164	111	28	are	be	AUX
aji-164	111	29	available	available	ADJ
aji-164	111	30	here	here	ADV
aji-164	111	31	:	:	PUNCT
aji-164	111	32	https://pr.sdiarticle5.com/review-history/134974	https://pr.sdiarticle5.com/review-history/134974	PROPN
aji-164	111	33	received	receive	VERB
aji-164	111	34	:	:	PUNCT
aji-164	111	35	25/02/2025	25/02/2025	NUM
aji-164	111	36	published	publish	VERB
aji-164	111	37	:	:	PUNCT
aji-164	111	38	03/05/2025	03/05/2025	NUM
aji-164	111	39	abstract	abstract	ADJ
aji-164	111	40	immune	immune	ADJ
aji-164	111	41	mediated	mediate	VERB
aji-164	111	42	diseases	disease	NOUN
aji-164	111	43	and	and	CCONJ
aji-164	111	44	syndromes	syndrome	NOUN
aji-164	111	45	are	be	AUX
aji-164	111	46	rare	rare	ADJ
aji-164	111	47	and	and	CCONJ
aji-164	111	48	attributed	attribute	VERB
aji-164	111	49	at	at	ADP
aji-164	111	50	most	most	ADJ
aji-164	111	51	to	to	ADP
aji-164	111	52	genetic	genetic	ADJ
aji-164	111	53	and	and	CCONJ
aji-164	111	54	environmental	environmental	ADJ
aji-164	111	55	interactions	interaction	NOUN
aji-164	111	56	.	.	PUNCT
aji-164	112	1	macrophagic	macrophagic	PROPN
aji-164	112	2	myofasciitis	myofasciitis	PROPN
aji-164	112	3	mmf	mmf	NOUN
aji-164	112	4	is	be	AUX
aji-164	112	5	one	one	NUM
aji-164	112	6	of	of	ADP
aji-164	112	7	these	these	DET
aji-164	112	8	syndromes	syndrome	NOUN
aji-164	112	9	sub	sub	NOUN
aji-164	112	10	-	-	NOUN
aji-164	112	11	entities	entity	NOUN
aji-164	112	12	.	.	PUNCT
aji-164	113	1	in	in	ADP
aji-164	113	2	the	the	DET
aji-164	113	3	present	present	ADJ
aji-164	113	4	opinion	opinion	NOUN
aji-164	113	5	the	the	DET
aji-164	113	6	immunobiology	immunobiology	NOUN
aji-164	113	7	of	of	ADP
aji-164	113	8	mmf	mmf	NOUN
aji-164	113	9	was	be	AUX
aji-164	113	10	being	be	AUX
aji-164	113	11	reviewed	review	VERB
aji-164	113	12	.	.	PUNCT
aji-164	114	1	the	the	DET
aji-164	114	2	molecular	molecular	ADJ
aji-164	114	3	autoimmune	autoimmune	ADJ
aji-164	114	4	mechanisms	mechanism	NOUN
aji-164	114	5	can	can	AUX
aji-164	114	6	be	be	AUX
aji-164	114	7	as	as	SCONJ
aji-164	114	8	follows	follow	VERB
aji-164	114	9	;	;	PUNCT
aji-164	114	10	concurrent	concurrent	ADJ
aji-164	114	11	release	release	NOUN
aji-164	114	12	of	of	ADP
aji-164	114	13	alum	alum	ADJ
aji-164	114	14	nano	nano	NOUN
aji-164	114	15	-	-	PUNCT
aji-164	114	16	molecules	molecule	NOUN
aji-164	114	17	are	be	AUX
aji-164	114	18	taken	take	VERB
aji-164	114	19	up	up	ADP
aji-164	114	20	by	by	ADP
aji-164	114	21	macrophage	macrophage	ADJ
aji-164	114	22	persist	persist	NOUN
aji-164	114	23	in	in	ADV
aji-164	114	24	,	,	PUNCT
aji-164	114	25	combine	combine	VERB
aji-164	114	26	with	with	ADP
aji-164	114	27	cellular	cellular	ADJ
aji-164	114	28	proteins	protein	NOUN
aji-164	114	29	forming	form	VERB
aji-164	114	30	metalloprotein	metalloprotein	NOUN
aji-164	114	31	.	.	PUNCT
aji-164	115	1	it	it	PRON
aji-164	115	2	is	be	AUX
aji-164	115	3	now	now	ADV
aji-164	115	4	modified	modify	VERB
aji-164	115	5	cellular	cellular	ADJ
aji-164	115	6	protein	protein	NOUN
aji-164	115	7	in	in	ADP
aji-164	115	8	a	a	DET
aji-164	115	9	modified	modify	VERB
aji-164	115	10	macrophage	macrophage	NOUN
aji-164	115	11	which	which	PRON
aji-164	115	12	have	have	VERB
aji-164	115	13	dc	dc	PROPN
aji-164	115	14	marker	marker	NOUN
aji-164	115	15	,	,	PUNCT
aji-164	115	16	but	but	CCONJ
aji-164	115	17	still	still	ADV
aji-164	115	18	of	of	ADP
aji-164	115	19	macrophage	macrophage	ADJ
aji-164	115	20	morphology	morphology	NOUN
aji-164	115	21	.	.	PUNCT
aji-164	116	1	metalloprotein	metalloprotein	PROPN
aji-164	116	2	,	,	PUNCT
aji-164	116	3	when	when	SCONJ
aji-164	116	4	being	be	AUX
aji-164	116	5	extracellular	extracellular	ADJ
aji-164	116	6	on	on	ADP
aji-164	116	7	cellular	cellular	ADJ
aji-164	116	8	burst	burst	NOUN
aji-164	116	9	or	or	CCONJ
aji-164	116	10	on	on	ADP
aji-164	116	11	diffusion	diffusion	NOUN
aji-164	116	12	to	to	ADP
aji-164	116	13	extracellular	extracellular	ADJ
aji-164	116	14	space	space	NOUN
aji-164	116	15	will	will	AUX
aji-164	116	16	reach	reach	VERB
aji-164	116	17	immune	immune	ADJ
aji-164	116	18	cells	cell	NOUN
aji-164	116	19	,	,	PUNCT
aji-164	116	20	in	in	ADP
aji-164	116	21	presence	presence	NOUN
aji-164	116	22	of	of	ADP
aji-164	116	23	;	;	PUNCT
aji-164	116	24	chronic	chronic	ADJ
aji-164	116	25	induction	induction	NOUN
aji-164	116	26	,	,	PUNCT
aji-164	116	27	pathogenic	pathogenic	ADJ
aji-164	116	28	allele	allele	NOUN
aji-164	116	29	,	,	PUNCT
aji-164	116	30	the	the	DET
aji-164	116	31	hla	hla	PROPN
aji-164	116	32	dr1	dr1	PROPN
aji-164	116	33	01	01	NUM
aji-164	116	34	and	and	CCONJ
aji-164	116	35	the	the	DET
aji-164	116	36	affected	affected	ADJ
aji-164	116	37	tissue	tissue	NOUN
aji-164	116	38	microenvironment	microenvironment	NOUN
aji-164	116	39	.	.	PUNCT
aji-164	117	1	molecular	molecular	ADJ
aji-164	117	2	mimicry	mimicry	ADJ
aji-164	117	3	,	,	PUNCT
aji-164	117	4	antigen	antigen	ADJ
aji-164	117	5	bystander	bystander	NOUN
aji-164	117	6	and/or	and/or	CCONJ
aji-164	117	7	epitope	epitope	NOUN
aji-164	117	8	spreading	spread	VERB
aji-164	117	9	response	response	NOUN
aji-164	117	10	may	may	AUX
aji-164	117	11	operate	operate	VERB
aji-164	117	12	and	and	CCONJ
aji-164	117	13	autoimmune	autoimmune	ADJ
aji-164	117	14	tissue	tissue	NOUN
aji-164	117	15	changes	change	NOUN
aji-164	117	16	happened	happen	VERB
aji-164	117	17	within	within	ADP
aji-164	117	18	continuum	continuum	NOUN
aji-164	117	19	of	of	ADP
aji-164	117	20	granulomatous	granulomatous	ADJ
aji-164	117	21	lesion	lesion	NOUN
aji-164	117	22	developed	develop	VERB
aji-164	117	23	in	in	ADP
aji-164	117	24	skeletal	skeletal	ADJ
aji-164	117	25	muscle	muscle	NOUN
aji-164	117	26	at	at	ADP
aji-164	117	27	the	the	DET
aji-164	117	28	injection	injection	NOUN
aji-164	117	29	site	site	NOUN
aji-164	117	30	.	.	PUNCT
aji-164	118	1	modified	modify	VERB
aji-164	118	2	macrophage	macrophage	NOUN
aji-164	118	3	may	may	AUX
aji-164	118	4	migrate	migrate	VERB
aji-164	118	5	to	to	ADP
aji-164	118	6	regional	regional	ADJ
aji-164	118	7	lymph	lymph	NOUN
aji-164	118	8	node	node	NOUN
aji-164	118	9	and	and	CCONJ
aji-164	118	10	spleen	spleen	NOUN
aji-164	118	11	the	the	PRON
aji-164	118	12	finally	finally	ADV
aji-164	118	13	reach	reach	VERB
aji-164	118	14	the	the	DET
aji-164	118	15	brain	brain	NOUN
aji-164	118	16	.	.	PUNCT
aji-164	119	1	as	as	ADP
aji-164	119	2	a	a	DET
aji-164	119	3	result	result	NOUN
aji-164	119	4	,	,	PUNCT
aji-164	119	5	disturbance	disturbance	NOUN
aji-164	119	6	occurs	occur	VERB
aji-164	119	7	in	in	ADP
aji-164	119	8	skeletal	skeletal	ADJ
aji-164	119	9	muscle	muscle	NOUN
aji-164	119	10	functions	function	NOUN
aji-164	119	11	and	and	CCONJ
aji-164	119	12	in	in	ADP
aji-164	119	13	brain	brain	NOUN
aji-164	119	14	cognition	cognition	NOUN
aji-164	119	15	function	function	NOUN
aji-164	119	16	.	.	PUNCT
aji-164	120	1	opinion	opinion	NOUN
aji-164	120	2	article	article	NOUN
aji-164	120	3	https://doi.org/10.9734/aji/2025/v8i1164	https://doi.org/10.9734/aji/2025/v8i1164	PROPN
aji-164	120	4	https://pr.sdiarticle5.com/review-history/134974	https://pr.sdiarticle5.com/review-history/134974	PROPN
aji-164	120	5	shnawa	shnawa	NOUN
aji-164	120	6	;	;	PUNCT
aji-164	120	7	asian	asian	PROPN
aji-164	120	8	j.	j.	PROPN
aji-164	120	9	immunol	immunol	PROPN
aji-164	120	10	.	.	PROPN
aji-164	120	11	,	,	PUNCT
aji-164	120	12	vol	vol	NOUN
aji-164	120	13	.	.	PROPN
aji-164	120	14	8	8	NUM
aji-164	120	15	,	,	PUNCT
aji-164	120	16	no	no	INTJ
aji-164	120	17	.	.	NOUN
aji-164	120	18	1	1	NUM
aji-164	120	19	,	,	PUNCT
aji-164	120	20	pp	pp	ADJ
aji-164	120	21	.	.	PUNCT
aji-164	121	1	97	97	NUM
aji-164	121	2	-	-	SYM
aji-164	121	3	103	103	NUM
aji-164	121	4	,	,	PUNCT
aji-164	121	5	2025	2025	NUM
aji-164	121	6	;	;	PUNCT
aji-164	121	7	article	article	NOUN
aji-164	121	8	no.aji.134974	no.aji.134974	VERB
aji-164	121	9	98	98	NUM
aji-164	121	10	keywords	keyword	NOUN
aji-164	121	11	:	:	PUNCT
aji-164	122	1	alum	alum	ADJ
aji-164	122	2	;	;	PUNCT
aji-164	122	3	allele	allele	NOUN
aji-164	122	4	;	;	PUNCT
aji-164	123	1	autoimmune	autoimmune	ADJ
aji-164	123	2	;	;	PUNCT
aji-164	123	3	environment	environment	NOUN
aji-164	123	4	;	;	PUNCT
aji-164	123	5	genetics	genetic	NOUN
aji-164	123	6	;	;	PUNCT
aji-164	123	7	granuloma	granuloma	NOUN
aji-164	123	8	;	;	PUNCT
aji-164	123	9	hla	hla	NOUN
aji-164	123	10	;	;	PUNCT
aji-164	123	11	macrophage	macrophage	ADJ
aji-164	123	12	myopathy	myopathy	ADJ
aji-164	123	13	.	.	PUNCT
aji-164	124	1	1	1	X
aji-164	124	2	.	.	X
aji-164	124	3	introduction	introduction	NOUN
aji-164	124	4	immuno	immuno	NOUN
aji-164	124	5	-	-	PUNCT
aji-164	124	6	prophylactants	prophylactant	NOUN
aji-164	124	7	are	be	AUX
aji-164	124	8	vaccines	vaccine	NOUN
aji-164	124	9	and	and	CCONJ
aji-164	124	10	serotherpeutics	serotherpeutic	NOUN
aji-164	124	11	.	.	PUNCT
aji-164	125	1	these	these	DET
aji-164	125	2	standard	standard	ADJ
aji-164	125	3	biologics	biologic	NOUN
aji-164	125	4	are	be	AUX
aji-164	125	5	helpful	helpful	ADJ
aji-164	125	6	for	for	ADP
aji-164	125	7	prevention	prevention	NOUN
aji-164	125	8	and	and	CCONJ
aji-164	125	9	therapy	therapy	NOUN
aji-164	125	10	,	,	PUNCT
aji-164	125	11	both	both	CCONJ
aji-164	125	12	in	in	ADP
aji-164	125	13	man	man	NOUN
aji-164	125	14	and	and	CCONJ
aji-164	125	15	animals	animal	NOUN
aji-164	125	16	.	.	PUNCT
aji-164	126	1	vaccines	vaccine	NOUN
aji-164	126	2	and	and	CCONJ
aji-164	126	3	adjuvants	adjuvant	NOUN
aji-164	126	4	so	so	ADV
aji-164	126	5	far	far	ADV
aji-164	126	6	they	they	PRON
aji-164	126	7	are	be	AUX
aji-164	126	8	helpful	helpful	ADJ
aji-164	126	9	but	but	CCONJ
aji-164	126	10	they	they	PRON
aji-164	126	11	are	be	AUX
aji-164	126	12	associated	associate	VERB
aji-164	126	13	with	with	ADP
aji-164	126	14	an	an	DET
aji-164	126	15	adverse	adverse	ADJ
aji-164	126	16	effects	effect	NOUN
aji-164	126	17	.	.	PUNCT
aji-164	127	1	vaccine	vaccine	NOUN
aji-164	127	2	and	and	CCONJ
aji-164	127	3	adjuvant	adjuvant	ADJ
aji-164	127	4	adverse	adverse	ADJ
aji-164	127	5	effects	effect	NOUN
aji-164	127	6	can	can	AUX
aji-164	127	7	be	be	AUX
aji-164	127	8	ramified	ramify	VERB
aji-164	127	9	into	into	ADP
aji-164	127	10	;	;	PUNCT
aji-164	127	11	vaccine	vaccine	NOUN
aji-164	127	12	and	and	CCONJ
aji-164	127	13	adjuvant	adjuvant	ADJ
aji-164	127	14	associated	associated	ADJ
aji-164	127	15	disease	disease	NOUN
aji-164	127	16	enhancement	enhancement	NOUN
aji-164	127	17	vade	vade	NOUN
aji-164	127	18	and	and	CCONJ
aji-164	127	19	vaccine	vaccine	NOUN
aji-164	127	20	failure	failure	NOUN
aji-164	127	21	vf	vf	X
aji-164	127	22	(	(	PUNCT
aji-164	127	23	shnawa	shnawa	PROPN
aji-164	127	24	,	,	PUNCT
aji-164	127	25	2017	2017	NUM
aji-164	127	26	,	,	PUNCT
aji-164	127	27	2023	2023	NUM
aji-164	127	28	,	,	PUNCT
aji-164	127	29	shnawa	shnawa	PROPN
aji-164	127	30	&	&	CCONJ
aji-164	127	31	alkhafaji	alkhafaji	PROPN
aji-164	127	32	2023	2023	NUM
aji-164	127	33	)	)	PUNCT
aji-164	127	34	.	.	PUNCT
aji-164	128	1	one	one	NUM
aji-164	128	2	of	of	ADP
aji-164	128	3	the	the	DET
aji-164	128	4	known	know	VERB
aji-164	128	5	vade	vade	NOUN
aji-164	128	6	is	be	AUX
aji-164	128	7	shoenfeld	shoenfeld	VERB
aji-164	128	8	syndrome	syndrome	PROPN
aji-164	128	9	ss	ss	PROPN
aji-164	128	10	(	(	PUNCT
aji-164	128	11	shoenfeld	shoenfeld	VERB
aji-164	128	12	et	et	PROPN
aji-164	128	13	al	al	PROPN
aji-164	128	14	.	.	PROPN
aji-164	128	15	,	,	PUNCT
aji-164	128	16	2011	2011	NUM
aji-164	128	17	)	)	PUNCT
aji-164	128	18	.	.	PUNCT
aji-164	129	1	ss	ss	PROPN
aji-164	129	2	grouped	group	VERB
aji-164	129	3	five	five	NUM
aji-164	129	4	disease	disease	NOUN
aji-164	129	5	sub	sub	NOUN
aji-164	129	6	-	-	NOUN
aji-164	129	7	entities	entity	NOUN
aji-164	129	8	as	as	ADP
aji-164	129	9	;	;	PUNCT
aji-164	129	10	ipostvaccination	ipostvaccination	NOUN
aji-164	129	11	with	with	ADP
aji-164	129	12	adjuvanated	adjuvanate	VERB
aji-164	129	13	vaccine	vaccine	NOUN
aji-164	129	14	illness	illness	NOUN
aji-164	129	15	,	,	PUNCT
aji-164	129	16	ii	ii	ADJ
aji-164	129	17	-	-	PUNCT
aji-164	129	18	macrophagic	macrophagic	ADJ
aji-164	129	19	myofasciitis	myofasciitis	PROPN
aji-164	129	20	illness	illness	NOUN
aji-164	129	21	mmf	mmf	NOUN
aji-164	129	22	,	,	PUNCT
aji-164	129	23	iii	iii	X
aji-164	129	24	–	–	PUNCT
aji-164	129	25	sick	sick	ADJ
aji-164	129	26	building	building	NOUN
aji-164	129	27	illness	illness	NOUN
aji-164	129	28	,	,	PUNCT
aji-164	129	29	iv	iv	NUM
aji-164	129	30	-	-	PUNCT
aji-164	129	31	gulf	gulf	NOUN
aji-164	129	32	war	war	NOUN
aji-164	129	33	illness	illness	NOUN
aji-164	129	34	and	and	CCONJ
aji-164	129	35	v	v	ADP
aji-164	129	36	siliconosis	siliconosis	NOUN
aji-164	129	37	.	.	PUNCT
aji-164	130	1	this	this	DET
aji-164	130	2	syndrome	syndrome	NOUN
aji-164	130	3	sub	sub	NOUN
aji-164	130	4	-	-	NOUN
aji-164	130	5	entity	entity	NOUN
aji-164	130	6	is	be	AUX
aji-164	130	7	a	a	DET
aji-164	130	8	molecular	molecular	ADJ
aji-164	130	9	immunogenetic	immunogenetic	ADJ
aji-164	130	10	disease	disease	NOUN
aji-164	130	11	with	with	ADP
aji-164	130	12	presentation	presentation	NOUN
aji-164	130	13	of	of	ADP
aji-164	130	14	an	an	DET
aji-164	130	15	autoimmune	autoimmune	ADJ
aji-164	130	16	reactions	reaction	NOUN
aji-164	130	17	.	.	PUNCT
aji-164	131	1	it	it	PRON
aji-164	131	2	is	be	AUX
aji-164	131	3	an	an	DET
aji-164	131	4	inducive	inducive	ADJ
aji-164	131	5	chronic	chronic	ADJ
aji-164	131	6	rare	rare	ADJ
aji-164	131	7	syndrome	syndrome	NOUN
aji-164	131	8	associated	associate	VERB
aji-164	131	9	with	with	ADP
aji-164	131	10	specific	specific	ADJ
aji-164	131	11	human	human	ADJ
aji-164	131	12	leukocyte	leukocyte	NOUN
aji-164	131	13	antigen	antigen	ADJ
aji-164	131	14	haplotype	haplotype	NOUN
aji-164	131	15	(	(	PUNCT
aji-164	131	16	calarelli	calarelli	PROPN
aji-164	131	17	et	et	PROPN
aji-164	131	18	al	al	PROPN
aji-164	131	19	.	.	PROPN
aji-164	131	20	,	,	PUNCT
aji-164	131	21	2024	2024	NUM
aji-164	131	22	)	)	PUNCT
aji-164	131	23	.	.	PUNCT
aji-164	132	1	the	the	DET
aji-164	132	2	objective	objective	NOUN
aji-164	132	3	of	of	ADP
aji-164	132	4	the	the	DET
aji-164	132	5	present	present	ADJ
aji-164	132	6	opinion	opinion	NOUN
aji-164	132	7	paper	paper	NOUN
aji-164	132	8	was	be	AUX
aji-164	132	9	to	to	PART
aji-164	132	10	tackle	tackle	VERB
aji-164	132	11	the	the	DET
aji-164	132	12	immunobiology	immunobiology	NOUN
aji-164	133	1	[	[	X
aji-164	133	2	box	box	NOUN
aji-164	133	3	one	one	NUM
aji-164	133	4	]	]	PUNCT
aji-164	133	5	of	of	ADP
aji-164	133	6	mmf	mmf	NOUN
aji-164	133	7	.	.	PUNCT
aji-164	134	1	box	box	NOUN
aji-164	134	2	-	-	PUNCT
aji-164	134	3	one	one	NUM
aji-164	134	4	:	:	PUNCT
aji-164	134	5	relevant	relevant	ADJ
aji-164	134	6	terminology	terminology	NOUN
aji-164	134	7	(	(	PUNCT
aji-164	134	8	abbas	abbas	PROPN
aji-164	134	9	et	et	PROPN
aji-164	134	10	al	al	PROPN
aji-164	134	11	.	.	PROPN
aji-164	134	12	,	,	PUNCT
aji-164	134	13	2015	2015	NUM
aji-164	134	14	)	)	PUNCT
aji-164	134	15	1	1	NUM
aji-164	134	16	.	.	X
aji-164	134	17	anergy	anergy	PROPN
aji-164	134	18	:	:	PUNCT
aji-164	134	19	a	a	DET
aji-164	134	20	state	state	NOUN
aji-164	134	21	of	of	ADP
aji-164	134	22	unresponsiveness	unresponsiveness	NOUN
aji-164	134	23	to	to	ADP
aji-164	134	24	antigenic	antigenic	ADJ
aji-164	134	25	stimulation	stimulation	NOUN
aji-164	134	26	.	.	PUNCT
aji-164	135	1	lymphocyte	lymphocyte	ADJ
aji-164	135	2	anergy	anergy	NOUN
aji-164	135	3	is	be	AUX
aji-164	135	4	failure	failure	NOUN
aji-164	135	5	of	of	ADP
aji-164	135	6	t	t	PROPN
aji-164	135	7	and/or	and/or	CCONJ
aji-164	135	8	b	b	PROPN
aji-164	135	9	cell	cell	NOUN
aji-164	135	10	clones	clone	NOUN
aji-164	135	11	to	to	PART
aji-164	135	12	react	react	VERB
aji-164	135	13	antigen	antigen	ADV
aji-164	135	14	and	and	CCONJ
aji-164	135	15	is	be	AUX
aji-164	135	16	a	a	DET
aji-164	135	17	mechanism	mechanism	NOUN
aji-164	135	18	of	of	ADP
aji-164	135	19	maintaining	maintain	VERB
aji-164	135	20	immune	immune	ADJ
aji-164	135	21	tolerance	tolerance	NOUN
aji-164	135	22	to	to	ADP
aji-164	135	23	self	self	NOUN
aji-164	135	24	antigens	antigen	NOUN
aji-164	135	25	.	.	PUNCT
aji-164	136	1	2	2	X
aji-164	136	2	.	.	X
aji-164	136	3	antigen	antigen	ADJ
aji-164	136	4	bystander	bystander	NOUN
aji-164	136	5	:	:	PUNCT
aji-164	136	6	continued	continue	VERB
aji-164	136	7	immune	immune	ADJ
aji-164	136	8	responses	response	NOUN
aji-164	136	9	to	to	ADP
aji-164	136	10	infection	infection	NOUN
aji-164	136	11	modified	modify	VERB
aji-164	136	12	proteins	protein	NOUN
aji-164	136	13	,	,	PUNCT
aji-164	136	14	an	an	DET
aji-164	136	15	attendant	attendant	ADJ
aji-164	136	16	inflammation	inflammation	NOUN
aji-164	136	17	allow	allow	VERB
aji-164	136	18	exposure	exposure	NOUN
aji-164	136	19	of	of	ADP
aji-164	136	20	autoantigens	autoantigen	NOUN
aji-164	136	21	to	to	ADP
aji-164	136	22	immune	immune	ADJ
aji-164	136	23	responses	response	NOUN
aji-164	136	24	.	.	PUNCT
aji-164	137	1	theoretically	theoretically	ADV
aji-164	137	2	,	,	PUNCT
aji-164	137	3	this	this	PRON
aji-164	137	4	could	could	AUX
aji-164	137	5	operate	operate	VERB
aji-164	137	6	through	through	ADP
aji-164	137	7	t	t	PROPN
aji-164	137	8	cell	cell	NOUN
aji-164	137	9	recognition	recognition	NOUN
aji-164	137	10	resulting	result	VERB
aji-164	137	11	in	in	ADP
aji-164	137	12	help	help	NOUN
aji-164	137	13	of	of	ADP
aji-164	137	14	potentially	potentially	ADV
aji-164	137	15	,	,	PUNCT
aji-164	137	16	b	b	PROPN
aji-164	137	17	lymphocyte	lymphocyte	NOUN
aji-164	137	18	.	.	PUNCT
aji-164	138	1	3	3	X
aji-164	138	2	.	.	PUNCT
aji-164	138	3	clonal	clonal	ADJ
aji-164	138	4	ignorance	ignorance	NOUN
aji-164	138	5	:	:	PUNCT
aji-164	138	6	a	a	DET
aji-164	138	7	form	form	NOUN
aji-164	138	8	of	of	ADP
aji-164	138	9	lymphocyte	lymphocyte	ADJ
aji-164	138	10	unresponsiveness	unresponsiveness	NOUN
aji-164	138	11	in	in	ADP
aji-164	138	12	which	which	PRON
aji-164	138	13	self	self	NOUN
aji-164	138	14	antigens	antigen	NOUN
aji-164	138	15	are	be	AUX
aji-164	138	16	ignored	ignore	VERB
aji-164	138	17	by	by	ADP
aji-164	138	18	the	the	DET
aji-164	138	19	immune	immune	ADJ
aji-164	138	20	system	system	NOUN
aji-164	138	21	even	even	ADV
aji-164	138	22	though	though	SCONJ
aji-164	138	23	lymphocyte	lymphocyte	ADJ
aji-164	138	24	specific	specific	NOUN
aji-164	138	25	for	for	ADP
aji-164	138	26	their	their	PRON
aji-164	138	27	antigens	antigen	NOUN
aji-164	138	28	remain	remain	VERB
aji-164	138	29	viable	viable	ADJ
aji-164	138	30	and	and	CCONJ
aji-164	138	31	functional	functional	ADJ
aji-164	138	32	.	.	PUNCT
aji-164	139	1	4	4	X
aji-164	139	2	.	.	X
aji-164	139	3	clonal	clonal	ADJ
aji-164	139	4	deletion	deletion	NOUN
aji-164	139	5	:	:	PUNCT
aji-164	139	6	a	a	DET
aji-164	139	7	mechanism	mechanism	NOUN
aji-164	139	8	of	of	ADP
aji-164	139	9	lymphocyte	lymphocyte	ADJ
aji-164	139	10	tolerance	tolerance	NOUN
aji-164	139	11	in	in	ADP
aji-164	139	12	which	which	PRON
aji-164	139	13	an	an	DET
aji-164	139	14	immature	immature	ADJ
aji-164	139	15	t	t	NOUN
aji-164	139	16	cell	cell	NOUN
aji-164	139	17	in	in	ADP
aji-164	139	18	the	the	DET
aji-164	139	19	thymus	thymus	NOUN
aji-164	139	20	or	or	CCONJ
aji-164	139	21	immature	immature	ADJ
aji-164	139	22	b	b	NOUN
aji-164	139	23	cells	cell	NOUN
aji-164	139	24	in	in	ADP
aji-164	139	25	bone	bone	NOUN
aji-164	139	26	marrow	marrow	NOUN
aji-164	139	27	undergoes	undergo	VERB
aji-164	139	28	apoptotic	apoptotic	ADJ
aji-164	139	29	death	death	NOUN
aji-164	139	30	as	as	ADP
aji-164	139	31	a	a	DET
aji-164	139	32	consquences	consquence	NOUN
aji-164	139	33	of	of	ADP
aji-164	139	34	recognizing	recognize	VERB
aji-164	139	35	self	self	NOUN
aji-164	139	36	antigens	antigen	NOUN
aji-164	139	37	.	.	PUNCT
aji-164	140	1	5	5	X
aji-164	140	2	.	.	X
aji-164	140	3	epitope	epitope	PROPN
aji-164	140	4	spreading	spread	VERB
aji-164	140	5	:	:	PUNCT
aji-164	140	6	in	in	ADP
aji-164	140	7	autoimmunity	autoimmunity	NOUN
aji-164	140	8	it	it	PRON
aji-164	140	9	is	be	AUX
aji-164	140	10	found	find	VERB
aji-164	140	11	that	that	SCONJ
aji-164	140	12	the	the	DET
aji-164	140	13	development	development	NOUN
aji-164	140	14	of	of	ADP
aji-164	140	15	immune	immune	ADJ
aji-164	140	16	responses	response	NOUN
aji-164	140	17	to	to	ADP
aji-164	140	18	multiple	multiple	ADJ
aji-164	140	19	epitopes	epitope	NOUN
aji-164	140	20	as	as	ADP
aji-164	140	21	an	an	DET
aji-164	140	22	autoimmune	autoimmune	ADJ
aji-164	140	23	disease	disease	NOUN
aji-164	140	24	originally	originally	ADV
aji-164	140	25	target	target	VERB
aji-164	140	26	one	one	NUM
aji-164	140	27	epitope	epitope	NOUN
aji-164	140	28	progresses	progress	VERB
aji-164	140	29	,	,	PUNCT
aji-164	140	30	likely	likely	ADV
aji-164	140	31	caused	cause	VERB
aji-164	140	32	by	by	ADP
aji-164	140	33	further	further	ADJ
aji-164	140	34	breakdown	breakdown	NOUN
aji-164	140	35	in	in	ADP
aji-164	140	36	tolerance	tolerance	NOUN
aji-164	140	37	and	and	CCONJ
aji-164	140	38	release	release	NOUN
aji-164	140	39	of	of	ADP
aji-164	140	40	additional	additional	ADJ
aji-164	140	41	tissue	tissue	NOUN
aji-164	140	42	antigen	antigen	ADJ
aji-164	140	43	due	due	ADP
aji-164	140	44	to	to	ADP
aji-164	140	45	self	self	NOUN
aji-164	140	46	protein	protein	NOUN
aji-164	140	47	stimulated	stimulate	VERB
aji-164	140	48	by	by	ADP
aji-164	140	49	the	the	DET
aji-164	140	50	initial	initial	ADJ
aji-164	140	51	response	response	NOUN
aji-164	140	52	.	.	PUNCT
aji-164	141	1	6	6	X
aji-164	141	2	.	.	X
aji-164	141	3	molecular	molecular	ADJ
aji-164	141	4	mimicry	mimicry	NOUN
aji-164	141	5	:	:	PUNCT
aji-164	141	6	a	a	DET
aji-164	141	7	postulated	postulate	VERB
aji-164	141	8	mechanism	mechanism	NOUN
aji-164	141	9	of	of	ADP
aji-164	141	10	autoimmunity	autoimmunity	NOUN
aji-164	141	11	triggered	trigger	VERB
aji-164	141	12	by	by	ADP
aji-164	141	13	infection	infection	NOUN
aji-164	141	14	with	with	ADP
aji-164	141	15	a	a	DET
aji-164	141	16	microbe	microbe	NOUN
aji-164	141	17	that	that	PRON
aji-164	141	18	cross	cross	VERB
aji-164	141	19	react	react	NOUN
aji-164	141	20	with	with	ADP
aji-164	141	21	self	self	NOUN
aji-164	141	22	antigen	antigen	ADJ
aji-164	141	23	.	.	PUNCT
aji-164	142	1	immune	immune	ADJ
aji-164	142	2	response	response	NOUN
aji-164	142	3	to	to	ADP
aji-164	142	4	the	the	DET
aji-164	142	5	microbe	microbe	NOUN
aji-164	142	6	results	result	NOUN
aji-164	142	7	in	in	ADP
aji-164	142	8	reactions	reaction	NOUN
aji-164	142	9	with	with	ADP
aji-164	142	10	self	self	NOUN
aji-164	142	11	tissue	tissue	NOUN
aji-164	142	12	antigen	antigen	ADV
aji-164	142	13	.	.	PUNCT
aji-164	143	1	7	7	X
aji-164	143	2	.	.	NUM
aji-164	143	3	sequestrated	sequestrate	VERB
aji-164	143	4	antigens	antigen	NOUN
aji-164	143	5	:	:	PUNCT
aji-164	143	6	there	there	PRON
aji-164	143	7	are	be	VERB
aji-164	143	8	certain	certain	ADJ
aji-164	143	9	tissue	tissue	NOUN
aji-164	143	10	niches	niche	NOUN
aji-164	143	11	in	in	ADP
aji-164	143	12	which	which	PRON
aji-164	143	13	their	their	PRON
aji-164	143	14	specific	specific	ADJ
aji-164	143	15	antigens	antigen	NOUN
aji-164	143	16	are	be	AUX
aji-164	143	17	not	not	PART
aji-164	143	18	recognized	recognize	VERB
aji-164	143	19	to	to	ADP
aji-164	143	20	immune	immune	ADJ
aji-164	143	21	system	system	NOUN
aji-164	143	22	cells	cell	NOUN
aji-164	143	23	during	during	ADP
aji-164	143	24	the	the	DET
aji-164	143	25	ontogeny	ontogeny	NOUN
aji-164	143	26	of	of	ADP
aji-164	143	27	the	the	DET
aji-164	143	28	individuals	individual	NOUN
aji-164	143	29	.	.	PUNCT
aji-164	144	1	like	like	INTJ
aji-164	144	2	,	,	PUNCT
aji-164	144	3	eye	eye	NOUN
aji-164	144	4	vetrus	vetrus	NOUN
aji-164	144	5	fluid	fluid	NOUN
aji-164	144	6	,	,	PUNCT
aji-164	144	7	semen	semen	NOUN
aji-164	144	8	plasm	plasm	NOUN
aji-164	144	9	,	,	PUNCT
aji-164	144	10	and	and	CCONJ
aji-164	144	11	synovial	synovial	ADJ
aji-164	144	12	fluid	fluid	NOUN
aji-164	144	13	when	when	SCONJ
aji-164	144	14	exposed	expose	VERB
aji-164	144	15	to	to	ADP
aji-164	144	16	immune	immune	ADJ
aji-164	144	17	cells	cell	NOUN
aji-164	144	18	will	will	AUX
aji-164	144	19	be	be	AUX
aji-164	144	20	recognized	recognize	VERB
aji-164	144	21	as	as	ADP
aji-164	144	22	foreign	foreign	ADJ
aji-164	144	23	.	.	PUNCT
aji-164	145	1	8	8	X
aji-164	145	2	.	.	X
aji-164	146	1	tolerance	tolerance	NOUN
aji-164	146	2	:	:	PUNCT
aji-164	146	3	unresponsiveness	unresponsiveness	NOUN
aji-164	146	4	of	of	ADP
aji-164	146	5	adaptive	adaptive	ADJ
aji-164	146	6	immune	immune	ADJ
aji-164	146	7	system	system	NOUN
aji-164	146	8	to	to	ADP
aji-164	146	9	antigen	antigen	PROPN
aji-164	146	10	,	,	PUNCT
aji-164	146	11	as	as	ADP
aji-164	146	12	a	a	DET
aji-164	146	13	result	result	NOUN
aji-164	146	14	of	of	ADP
aji-164	146	15	inactivation	inactivation	NOUN
aji-164	146	16	or	or	CCONJ
aji-164	146	17	death	death	NOUN
aji-164	146	18	of	of	ADP
aji-164	146	19	the	the	DET
aji-164	146	20	antigen	antigen	ADJ
aji-164	146	21	specific	specific	ADJ
aji-164	146	22	lymphocyte	lymphocyte	NOUN
aji-164	146	23	induced	induce	VERB
aji-164	146	24	by	by	ADP
aji-164	146	25	the	the	DET
aji-164	146	26	exposure	exposure	NOUN
aji-164	146	27	to	to	ADP
aji-164	146	28	antigen	antigen	PROPN
aji-164	146	29	.	.	PUNCT
aji-164	147	1	2	2	X
aji-164	147	2	.	.	X
aji-164	147	3	macrophagic	macrophagic	PROPN
aji-164	147	4	myofasciitis	myofasciitis	PROPN
aji-164	147	5	mmf	mmf	NOUN
aji-164	147	6	concept	concept	NOUN
aji-164	147	7	mmf	mmf	NOUN
aji-164	147	8	is	be	AUX
aji-164	147	9	an	an	DET
aji-164	147	10	uncommon	uncommon	ADJ
aji-164	147	11	immune	immune	ADJ
aji-164	147	12	mediated	mediate	VERB
aji-164	147	13	inflammatory	inflammatory	ADJ
aji-164	147	14	disorder	disorder	NOUN
aji-164	147	15	of	of	ADP
aji-164	147	16	muscle	muscle	NOUN
aji-164	147	17	and	and	CCONJ
aji-164	147	18	is	be	AUX
aji-164	147	19	believed	believe	VERB
aji-164	147	20	to	to	PART
aji-164	147	21	be	be	AUX
aji-164	147	22	due	due	ADJ
aji-164	147	23	to	to	ADP
aji-164	147	24	an	an	DET
aji-164	147	25	alum	alum	NOUN
aji-164	147	26	in	in	ADP
aji-164	147	27	a	a	DET
aji-164	147	28	vaccine	vaccine	NOUN
aji-164	147	29	combination	combination	NOUN
aji-164	147	30	exhibited	exhibit	VERB
aji-164	147	31	persistence	persistence	NOUN
aji-164	147	32	at	at	ADP
aji-164	147	33	the	the	DET
aji-164	147	34	site	site	NOUN
aji-164	147	35	of	of	ADP
aji-164	147	36	injection	injection	NOUN
aji-164	147	37	.	.	PUNCT
aji-164	148	1	the	the	DET
aji-164	148	2	conditions	condition	NOUN
aji-164	148	3	characterized	characterize	VERB
aji-164	148	4	by	by	ADP
aji-164	148	5	diffuse	diffuse	PROPN
aji-164	148	6	myalgia	myalgia	NOUN
aji-164	148	7	,	,	PUNCT
aji-164	148	8	arthralgia	arthralgia	NOUN
aji-164	148	9	and	and	CCONJ
aji-164	148	10	fatigue	fatigue	NOUN
aji-164	148	11	(	(	PUNCT
aji-164	148	12	ravindran	ravindran	NOUN
aji-164	148	13	2024	2024	NUM
aji-164	148	14	,	,	PUNCT
aji-164	148	15	dittmann	dittmann	NOUN
aji-164	148	16	2000	2000	NUM
aji-164	148	17	,	,	PUNCT
aji-164	148	18	ieraeli	ieraeli	NOUN
aji-164	148	19	et	et	NOUN
aji-164	148	20	al	al	PROPN
aji-164	148	21	2011	2011	NUM
aji-164	148	22	)	)	PUNCT
aji-164	148	23	.	.	PUNCT
aji-164	149	1	it	it	PRON
aji-164	149	2	is	be	AUX
aji-164	149	3	a	a	DET
aji-164	149	4	rare	rare	ADJ
aji-164	149	5	inflammatory	inflammatory	ADJ
aji-164	149	6	condition	condition	NOUN
aji-164	149	7	that	that	PRON
aji-164	149	8	affect	affect	VERB
aji-164	149	9	skeletal	skeletal	ADJ
aji-164	149	10	muscle	muscle	NOUN
aji-164	149	11	and	and	CCONJ
aji-164	149	12	connective	connective	ADJ
aji-164	149	13	tissue	tissue	NOUN
aji-164	149	14	characterized	characterize	VERB
aji-164	149	15	by	by	ADP
aji-164	149	16	infiltration	infiltration	NOUN
aji-164	149	17	of	of	ADP
aji-164	149	18	macrophages	macrophage	NOUN
aji-164	149	19	into	into	ADP
aji-164	149	20	muscle	muscle	NOUN
aji-164	149	21	tissue	tissue	NOUN
aji-164	149	22	,	,	PUNCT
aji-164	149	23	in	in	ADP
aji-164	149	24	which	which	PRON
aji-164	149	25	the	the	DET
aji-164	149	26	affected	affected	ADJ
aji-164	149	27	subject	subject	NOUN
aji-164	149	28	presents	present	NOUN
aji-164	149	29	local	local	ADJ
aji-164	149	30	or	or	CCONJ
aji-164	149	31	systemic	systemic	ADJ
aji-164	149	32	manifestation	manifestation	NOUN
aji-164	149	33	.	.	PUNCT
aji-164	150	1	the	the	DET
aji-164	150	2	local	local	ADJ
aji-164	150	3	manifestation	manifestation	NOUN
aji-164	150	4	can	can	AUX
aji-164	150	5	be	be	AUX
aji-164	150	6	an	an	DET
aji-164	150	7	immune	immune	ADJ
aji-164	150	8	active	active	ADJ
aji-164	150	9	lesion	lesion	NOUN
aji-164	150	10	of	of	ADP
aji-164	150	11	granuloma	granuloma	NOUN
aji-164	150	12	,	,	PUNCT
aji-164	150	13	in	in	ADP
aji-164	150	14	a	a	DET
aji-164	150	15	rare	rare	ADJ
aji-164	150	16	muscle	muscle	NOUN
aji-164	150	17	disease	disease	NOUN
aji-164	150	18	characterized	characterize	VERB
aji-164	150	19	by	by	ADP
aji-164	150	20	;	;	PUNCT
aji-164	150	21	microscopic	microscopic	ADJ
aji-164	150	22	lesions	lesion	NOUN
aji-164	150	23	found	find	VERB
aji-164	150	24	in	in	ADP
aji-164	150	25	muscle	muscle	NOUN
aji-164	150	26	biopsies	biopsy	NOUN
aji-164	150	27	that	that	PRON
aji-164	150	28	showed	show	VERB
aji-164	150	29	infiltration	infiltration	NOUN
aji-164	150	30	of	of	ADP
aji-164	150	31	the	the	DET
aji-164	150	32	muscle	muscle	NOUN
aji-164	150	33	tissue	tissue	NOUN
aji-164	150	34	by	by	ADP
aji-164	150	35	pas	pa	NOUN
aji-164	150	36	positive	positive	ADJ
aji-164	150	37	macrophages	macrophage	NOUN
aji-164	150	38	in	in	ADP
aji-164	150	39	light	light	ADJ
aji-164	150	40	microscope	microscope	NOUN
aji-164	150	41	and	and	CCONJ
aji-164	150	42	alum	alum	NOUN
aji-164	150	43	crystal	crystal	NOUN
aji-164	150	44	inclusion	inclusion	NOUN
aji-164	150	45	in	in	ADP
aji-164	150	46	electron	electron	NOUN
aji-164	150	47	microscopic	microscopic	ADJ
aji-164	150	48	studies	study	NOUN
aji-164	150	49	and	and	CCONJ
aji-164	150	50	they	they	PRON
aji-164	150	51	are	be	AUX
aji-164	150	52	traced	trace	VERB
aji-164	150	53	in	in	ADP
aji-164	150	54	epimysium	epimysium	NOUN
aji-164	150	55	,	,	PUNCT
aji-164	150	56	perimysium	perimysium	ADJ
aji-164	150	57	,	,	PUNCT
aji-164	150	58	prefascular	prefascular	ADJ
aji-164	150	59	endomysium	endomysium	NOUN
aji-164	150	60	with	with	ADP
aji-164	150	61	crystal	crystal	NOUN
aji-164	150	62	lesion	lesion	NOUN
aji-164	150	63	composed	compose	VERB
aji-164	150	64	of	of	ADP
aji-164	150	65	aluminum	aluminum	NOUN
aji-164	150	66	salt	salt	NOUN
aji-164	150	67	(	(	PUNCT
aji-164	150	68	tervaert	tervaert	PROPN
aji-164	150	69	et	et	PROPN
aji-164	150	70	al	al	PROPN
aji-164	150	71	,	,	PUNCT
aji-164	150	72	2023	2023	NUM
aji-164	150	73	,	,	PUNCT
aji-164	150	74	gibson	gibson	PROPN
aji-164	150	75	,	,	PUNCT
aji-164	150	76	2024	2024	NUM
aji-164	150	77	)	)	PUNCT
aji-164	150	78	.	.	PUNCT
aji-164	151	1	hence	hence	ADV
aji-164	151	2	,	,	PUNCT
aji-164	151	3	aluminum	aluminum	NOUN
aji-164	151	4	containing	contain	VERB
aji-164	151	5	vaccines	vaccine	NOUN
aji-164	151	6	have	have	AUX
aji-164	151	7	been	be	AUX
aji-164	151	8	implicated	implicate	VERB
aji-164	151	9	.	.	PUNCT
aji-164	152	1	mmf	mmf	NOUN
aji-164	152	2	lesions	lesion	NOUN
aji-164	152	3	result	result	VERB
aji-164	152	4	from	from	ADP
aji-164	152	5	aluminum	aluminum	NOUN
aji-164	152	6	hydroxide	hydroxide	NOUN
aji-164	152	7	adjuvant	adjuvant	NOUN
aji-164	152	8	hidden	hide	VERB
aji-164	152	9	within	within	ADP
aji-164	152	10	the	the	DET
aji-164	152	11	tissue	tissue	NOUN
aji-164	152	12	with	with	ADP
aji-164	152	13	frequent	frequent	ADJ
aji-164	152	14	steady	steady	ADJ
aji-164	152	15	state	state	NOUN
aji-164	152	16	release	release	NOUN
aji-164	152	17	of	of	ADP
aji-164	152	18	alum	alum	ADJ
aji-164	152	19	causing	cause	VERB
aji-164	152	20	immune	immune	ADJ
aji-164	152	21	reactions	reaction	NOUN
aji-164	152	22	(	(	PUNCT
aji-164	152	23	watad	watad	NOUN
aji-164	152	24	et	et	PROPN
aji-164	152	25	al	al	PROPN
aji-164	152	26	.	.	PROPN
aji-164	152	27	,	,	PUNCT
aji-164	152	28	2017	2017	NUM
aji-164	152	29	,	,	PUNCT
aji-164	152	30	santos	santos	PROPN
aji-164	152	31	et	et	PROPN
aji-164	152	32	al	al	PROPN
aji-164	152	33	2018	2018	NUM
aji-164	152	34	,	,	PUNCT
aji-164	152	35	caldarelli	caldarelli	NOUN
aji-164	152	36	et	et	PROPN
aji-164	152	37	al	al	PROPN
aji-164	152	38	.	.	PROPN
aji-164	152	39	,	,	PUNCT
aji-164	152	40	2024	2024	NUM
aji-164	152	41	)	)	PUNCT
aji-164	152	42	.	.	PUNCT
aji-164	153	1	shnawa	shnawa	PROPN
aji-164	153	2	;	;	PUNCT
aji-164	153	3	asian	asian	PROPN
aji-164	153	4	j.	j.	PROPN
aji-164	153	5	immunol	immunol	PROPN
aji-164	153	6	.	.	PROPN
aji-164	153	7	,	,	PUNCT
aji-164	153	8	vol	vol	NOUN
aji-164	153	9	.	.	PROPN
aji-164	153	10	8	8	NUM
aji-164	153	11	,	,	PUNCT
aji-164	153	12	no	no	INTJ
aji-164	153	13	.	.	NOUN
aji-164	153	14	1	1	NUM
aji-164	153	15	,	,	PUNCT
aji-164	153	16	pp	pp	ADJ
aji-164	153	17	.	.	PUNCT
aji-164	154	1	97	97	NUM
aji-164	154	2	-	-	SYM
aji-164	154	3	103	103	NUM
aji-164	154	4	,	,	PUNCT
aji-164	154	5	2025	2025	NUM
aji-164	154	6	;	;	PUNCT
aji-164	154	7	article	article	NOUN
aji-164	154	8	no.aji.134974	no.aji.134974	VERB
aji-164	154	9	99	99	NUM
aji-164	154	10	3	3	NUM
aji-164	154	11	.	.	PUNCT
aji-164	154	12	timeline	timeline	NOUN
aji-164	154	13	knowing	know	VERB
aji-164	154	14	the	the	DET
aji-164	154	15	past	past	NOUN
aji-164	154	16	will	will	AUX
aji-164	154	17	in	in	ADP
aji-164	154	18	light	light	VERB
aji-164	154	19	the	the	DET
aji-164	154	20	present	present	NOUN
aji-164	154	21	and	and	CCONJ
aji-164	154	22	pin	pin	NOUN
aji-164	154	23	point	point	VERB
aji-164	154	24	directions	direction	NOUN
aji-164	154	25	to	to	ADP
aji-164	154	26	the	the	DET
aji-164	154	27	future	future	NOUN
aji-164	154	28	.	.	PUNCT
aji-164	155	1	so	so	ADV
aji-164	155	2	,	,	PUNCT
aji-164	155	3	the	the	DET
aji-164	155	4	mmf	mmf	NOUN
aji-164	155	5	timeline	timeline	NOUN
aji-164	155	6	made	make	VERB
aji-164	155	7	in	in	ADP
aji-164	155	8	table	table	NOUN
aji-164	155	9	1	1	NUM
aji-164	155	10	.	.	PUNCT
aji-164	155	11	table	table	NOUN
aji-164	155	12	1	1	NUM
aji-164	155	13	.	.	X
aji-164	155	14	macrophagic	macrophagic	PROPN
aji-164	155	15	myofasciitis	myofasciitis	PROPN
aji-164	155	16	timeline	timeline	PROPN
aji-164	155	17	achievement	achievement	NOUN
aji-164	155	18	date	date	PROPN
aji-164	155	19	reference	reference	NOUN
aji-164	155	20	mmf	mmf	NOUN
aji-164	155	21	was	be	AUX
aji-164	155	22	initially	initially	ADV
aji-164	155	23	described	describe	VERB
aji-164	155	24	as	as	ADP
aji-164	155	25	an	an	DET
aji-164	155	26	emergency	emergency	NOUN
aji-164	155	27	entity	entity	NOUN
aji-164	155	28	by	by	ADP
aji-164	155	29	franch	franch	ADJ
aji-164	155	30	myo	myo	NOUN
aji-164	155	31	-	-	PUNCT
aji-164	155	32	pathologist	pathologist	NOUN
aji-164	155	33	.	.	PUNCT
aji-164	156	1	the	the	DET
aji-164	156	2	reported	report	VERB
aji-164	156	3	in	in	ADP
aji-164	156	4	lancet	lancet	PROPN
aji-164	156	5	1993,1998	1993,1998	NUM
aji-164	156	6	shivane	shivane	NOUN
aji-164	156	7	et	et	PROPN
aji-164	156	8	al	al	PROPN
aji-164	156	9	.	.	PROPN
aji-164	156	10	,	,	PUNCT
aji-164	156	11	2012	2012	NUM
aji-164	156	12	amoura	amoura	NOUN
aji-164	156	13	et	et	PROPN
aji-164	156	14	al	al	PROPN
aji-164	156	15	.	.	PROPN
aji-164	156	16	,	,	PUNCT
aji-164	156	17	2000	2000	NUM
aji-164	156	18	between	between	ADP
aji-164	156	19	1993	1993	NUM
aji-164	156	20	and	and	CCONJ
aji-164	156	21	1999	1999	NUM
aji-164	156	22	more	more	ADJ
aji-164	156	23	than	than	ADP
aji-164	156	24	50	50	NUM
aji-164	156	25	cases	case	NOUN
aji-164	156	26	of	of	ADP
aji-164	156	27	mmf	mmf	NOUN
aji-164	156	28	have	have	AUX
aji-164	156	29	been	be	AUX
aji-164	156	30	described	describe	VERB
aji-164	156	31	in	in	ADP
aji-164	156	32	france	france	PROPN
aji-164	156	33	1999	1999	NUM
aji-164	156	34	amoura	amoura	NOUN
aji-164	156	35	et	et	PROPN
aji-164	156	36	al	al	PROPN
aji-164	156	37	.	.	PROPN
aji-164	156	38	,	,	PUNCT
aji-164	156	39	2000	2000	NUM
aji-164	156	40	mmf	mmf	NOUN
aji-164	156	41	patient	patient	NOUN
aji-164	156	42	presents	present	VERB
aji-164	156	43	central	central	ADJ
aji-164	156	44	nervous	nervous	ADJ
aji-164	156	45	system	system	NOUN
aji-164	156	46	disease	disease	NOUN
aji-164	156	47	2001	2001	NUM
aji-164	156	48	authier	authier	NOUN
aji-164	156	49	2001	2001	NUM
aji-164	156	50	long	long	ADJ
aji-164	156	51	term	term	NOUN
aji-164	156	52	persistence	persistence	NOUN
aji-164	156	53	of	of	ADP
aji-164	156	54	vaccine	vaccine	NOUN
aji-164	156	55	driven	drive	VERB
aji-164	156	56	alum	alum	NOUN
aji-164	156	57	in	in	ADP
aji-164	156	58	muscle	muscle	NOUN
aji-164	156	59	2001	2001	NUM
aji-164	156	60	gherardi	gherardi	NOUN
aji-164	156	61	et	et	NOUN
aji-164	156	62	al	al	PROPN
aji-164	156	63	.	.	PROPN
aji-164	156	64	,	,	PUNCT
aji-164	156	65	2011	2011	NUM
aji-164	156	66	mmf	mmf	NOUN
aji-164	156	67	present	present	ADJ
aji-164	156	68	local	local	ADJ
aji-164	156	69	and	and	CCONJ
aji-164	156	70	systemic	systemic	ADJ
aji-164	156	71	forms	form	NOUN
aji-164	156	72	2003	2003	NUM
aji-164	156	73	papo	papo	PROPN
aji-164	156	74	2003	2003	NUM
aji-164	156	75	electron	electron	NOUN
aji-164	156	76	microscopic	microscopic	ADJ
aji-164	156	77	study	study	NOUN
aji-164	156	78	of	of	ADP
aji-164	156	79	mmf	mmf	NOUN
aji-164	156	80	lesion	lesion	NOUN
aji-164	156	81	description	description	NOUN
aji-164	156	82	2003	2003	NUM
aji-164	156	83	-	-	SYM
aji-164	156	84	2005	2005	NUM
aji-164	156	85	shmgdi	shmgdi	NOUN
aji-164	156	86	et	et	NOUN
aji-164	156	87	al	al	PROPN
aji-164	156	88	.	.	PROPN
aji-164	156	89	,	,	PUNCT
aji-164	156	90	2005	2005	NUM
aji-164	156	91	reporting	reporting	NOUN
aji-164	156	92	mmf	mmf	NOUN
aji-164	156	93	unrelated	unrelated	ADJ
aji-164	156	94	to	to	ADP
aji-164	156	95	vaccination	vaccination	NOUN
aji-164	156	96	2005	2005	NUM
aji-164	156	97	park	park	NOUN
aji-164	156	98	et	et	PROPN
aji-164	156	99	al	al	PROPN
aji-164	156	100	.	.	PROPN
aji-164	156	101	,	,	PUNCT
aji-164	156	102	2005	2005	NUM
aji-164	156	103	experimental	experimental	ADJ
aji-164	156	104	induction	induction	NOUN
aji-164	156	105	of	of	ADP
aji-164	156	106	mmf	mmf	NOUN
aji-164	156	107	in	in	ADP
aji-164	156	108	rats.th1	rats.th1	PROPN
aji-164	156	109	bias	bias	NOUN
aji-164	156	110	response	response	NOUN
aji-164	156	111	,	,	PUNCT
aji-164	156	112	th1	th1	PROPN
aji-164	156	113	/	/	SYM
aji-164	156	114	th2	th2	PROPN
aji-164	156	115	balance	balance	NOUN
aji-164	156	116	unchanged	unchanged	ADJ
aji-164	156	117	in	in	ADP
aji-164	156	118	norma	norma	PROPN
aji-164	156	119	lesion	lesion	NOUN
aji-164	156	120	size	size	NOUN
aji-164	156	121	2006	2006	NUM
aji-164	156	122	authier	authier	NOUN
aji-164	156	123	et	et	PROPN
aji-164	156	124	al	al	PROPN
aji-164	156	125	.	.	PROPN
aji-164	156	126	,	,	PUNCT
aji-164	156	127	2006	2006	NUM
aji-164	156	128	mmf	mmf	NOUN
aji-164	156	129	being	being	AUX
aji-164	156	130	prove	prove	NOUN
aji-164	156	131	of	of	ADP
aji-164	156	132	vaccine	vaccine	NOUN
aji-164	156	133	autoimmune	autoimmune	ADV
aji-164	156	134	related	relate	VERB
aji-164	156	135	disease	disease	NOUN
aji-164	156	136	2011	2011	NUM
aji-164	157	1	israeli	israeli	PROPN
aji-164	157	2	et	et	PROPN
aji-164	157	3	al	al	PROPN
aji-164	157	4	.	.	PROPN
aji-164	157	5	,	,	PUNCT
aji-164	157	6	2011	2011	NUM
aji-164	157	7	macrophage	macrophage	NOUN
aji-164	157	8	take	take	VERB
aji-164	157	9	up	up	ADP
aji-164	157	10	alum	alum	ADJ
aji-164	157	11	in	in	ADP
aji-164	157	12	tendon	tendon	NOUN
aji-164	157	13	through	through	ADP
aji-164	157	14	fluerescent	fluerescent	PROPN
aji-164	157	15	alum	alum	PROPN
aji-164	157	16	translocate	translocate	VERB
aji-164	157	17	to	to	PART
aji-164	157	18	drainage	drainage	VERB
aji-164	157	19	lymph	lymph	NOUN
aji-164	157	20	node	node	NOUN
aji-164	157	21	then	then	ADV
aji-164	157	22	to	to	ADP
aji-164	157	23	blood	blood	NOUN
aji-164	157	24	,	,	PUNCT
aji-164	157	25	spleen	spleen	NOUN
aji-164	157	26	and	and	CCONJ
aji-164	157	27	brain	brain	NOUN
aji-164	157	28	2012	2012	NUM
aji-164	157	29	gherardi	gherardi	PROPN
aji-164	157	30	&	&	CCONJ
aji-164	157	31	authier	authier	NOUN
aji-164	157	32	2012	2012	NUM
aji-164	157	33	mmf	mmf	NOUN
aji-164	157	34	several	several	ADJ
aji-164	157	35	reports	report	NOUN
aji-164	157	36	in	in	ADP
aji-164	157	37	uk	uk	PROPN
aji-164	157	38	2012	2012	NUM
aji-164	157	39	shivahe	shivahe	VERB
aji-164	157	40	et	et	PROPN
aji-164	157	41	al	al	PROPN
aji-164	157	42	.	.	PROPN
aji-164	157	43	,	,	PUNCT
aji-164	157	44	2012	2012	NUM
aji-164	157	45	a	a	DET
aji-164	157	46	report	report	NOUN
aji-164	157	47	of	of	ADP
aji-164	157	48	an	an	DET
aji-164	157	49	atypical	atypical	ADJ
aji-164	157	50	presentation	presentation	NOUN
aji-164	157	51	of	of	ADP
aji-164	157	52	mmf	mmf	NOUN
aji-164	157	53	2020	2020	NUM
aji-164	157	54	dias	dias	PROPN
aji-164	157	55	et	et	PROPN
aji-164	157	56	al	al	PROPN
aji-164	157	57	.	.	PROPN
aji-164	157	58	,	,	PUNCT
aji-164	157	59	2020	2020	NUM
aji-164	157	60	al	al	PROPN
aji-164	157	61	(	(	PUNCT
aji-164	157	62	oh)3	oh)3	ADJ
aji-164	157	63	vaccine	vaccine	NOUN
aji-164	157	64	associated	associate	VERB
aji-164	157	65	with	with	ADP
aji-164	157	66	mmf	mmf	NOUN
aji-164	157	67	pseudo	pseudo	NOUN
aji-164	157	68	-	-	NOUN
aji-164	157	69	lymph	lymph	NOUN
aji-164	157	70	node	node	NOUN
aji-164	157	71	and	and	CCONJ
aji-164	157	72	causing	cause	VERB
aji-164	157	73	hypersensitivity	hypersensitivity	NOUN
aji-164	157	74	2020	2020	NUM
aji-164	157	75	kim	kim	PROPN
aji-164	157	76	et	et	PROPN
aji-164	157	77	al	al	PROPN
aji-164	157	78	.	.	PROPN
aji-164	157	79	,	,	PUNCT
aji-164	157	80	2020	2020	NUM
aji-164	157	81	4	4	NUM
aji-164	157	82	.	.	PUNCT
aji-164	157	83	immunobiology	immunobiology	NOUN
aji-164	157	84	relatively	relatively	ADV
aji-164	157	85	,	,	PUNCT
aji-164	157	86	immune	immune	ADJ
aji-164	157	87	cells	cell	NOUN
aji-164	157	88	both	both	CCONJ
aji-164	157	89	naïve	naïve	ADJ
aji-164	157	90	and	and	CCONJ
aji-164	157	91	active	active	ADJ
aji-164	157	92	forms	form	NOUN
aji-164	157	93	could	could	AUX
aji-164	157	94	be	be	AUX
aji-164	157	95	involved	involve	VERB
aji-164	157	96	in	in	ADP
aji-164	157	97	immunobiology	immunobiology	NOUN
aji-164	157	98	of	of	ADP
aji-164	157	99	mmf	mmf	NOUN
aji-164	157	100	.	.	PUNCT
aji-164	158	1	though	though	SCONJ
aji-164	158	2	the	the	DET
aji-164	158	3	main	main	ADJ
aji-164	158	4	player	player	NOUN
aji-164	158	5	cells	cell	NOUN
aji-164	158	6	is	be	AUX
aji-164	158	7	the	the	DET
aji-164	158	8	naïve	naïve	ADJ
aji-164	158	9	and	and	CCONJ
aji-164	158	10	active	active	ADJ
aji-164	158	11	macrophage	macrophage	NOUN
aji-164	158	12	.	.	PUNCT
aji-164	159	1	autoreactive	autoreactive	ADJ
aji-164	159	2	b	b	PROPN
aji-164	159	3	cells	cell	NOUN
aji-164	159	4	are	be	AUX
aji-164	159	5	evidently	evidently	ADV
aji-164	159	6	involved	involve	VERB
aji-164	159	7	,	,	PUNCT
aji-164	159	8	autoreactive	autoreactive	ADJ
aji-164	159	9	t	t	PROPN
aji-164	159	10	cells	cell	NOUN
aji-164	159	11	are	be	AUX
aji-164	159	12	of	of	ADP
aji-164	159	13	unclear	unclear	ADJ
aji-164	159	14	role	role	NOUN
aji-164	159	15	.	.	PUNCT
aji-164	160	1	modified	modify	VERB
aji-164	160	2	macrophages	macrophage	NOUN
aji-164	160	3	of	of	ADP
aji-164	160	4	dc	dc	PROPN
aji-164	160	5	surface	surface	NOUN
aji-164	160	6	markers	marker	NOUN
aji-164	160	7	,	,	PUNCT
aji-164	160	8	modified	modify	VERB
aji-164	160	9	morphology	morphology	NOUN
aji-164	160	10	and	and	CCONJ
aji-164	160	11	modified	modify	VERB
aji-164	160	12	function	function	NOUN
aji-164	160	13	but	but	CCONJ
aji-164	160	14	still	still	ADV
aji-164	160	15	of	of	ADP
aji-164	160	16	macrophage	macrophage	ADJ
aji-164	160	17	morphotype	morphotype	NOUN
aji-164	160	18	are	be	AUX
aji-164	160	19	noted	note	VERB
aji-164	160	20	.th1	.th1	PUNCT
aji-164	160	21	/	/	SYM
aji-164	160	22	th2	th2	PROPN
aji-164	160	23	are	be	AUX
aji-164	160	24	note	note	ADV
aji-164	160	25	changed	change	VERB
aji-164	160	26	and	and	CCONJ
aji-164	160	27	th1	th1	NOUN
aji-164	160	28	biased	biased	ADJ
aji-164	160	29	responses	response	NOUN
aji-164	160	30	.	.	PUNCT
aji-164	161	1	these	these	PRON
aji-164	161	2	are	be	AUX
aji-164	161	3	the	the	DET
aji-164	161	4	main	main	ADJ
aji-164	161	5	immune	immune	ADJ
aji-164	161	6	-	-	PUNCT
aji-164	161	7	biological	biological	ADJ
aji-164	161	8	features	feature	NOUN
aji-164	161	9	of	of	ADP
aji-164	161	10	mmf	mmf	NOUN
aji-164	161	11	as	as	SCONJ
aji-164	161	12	presented	present	VERB
aji-164	161	13	in	in	ADP
aji-164	161	14	the	the	DET
aji-164	161	15	following	follow	VERB
aji-164	161	16	paragraphs	paragraph	NOUN
aji-164	161	17	.	.	PUNCT
aji-164	162	1	alum	alum	ADJ
aji-164	162	2	nano	nano	NOUN
aji-164	162	3	-	-	PUNCT
aji-164	162	4	molecules	molecule	NOUN
aji-164	162	5	may	may	AUX
aji-164	162	6	reach	reach	VERB
aji-164	162	7	distant	distant	ADJ
aji-164	162	8	organs	organ	NOUN
aji-164	162	9	of	of	ADP
aji-164	162	10	the	the	DET
aji-164	162	11	body	body	NOUN
aji-164	162	12	including	include	VERB
aji-164	162	13	brain	brain	NOUN
aji-164	162	14	through	through	ADP
aji-164	162	15	the	the	DET
aji-164	162	16	migration	migration	NOUN
aji-164	162	17	of	of	ADP
aji-164	162	18	the	the	DET
aji-164	162	19	an	an	DET
aji-164	162	20	alum	alum	ADV
aji-164	162	21	loaded	load	VERB
aji-164	162	22	macrophage	macrophage	NOUN
aji-164	162	23	or	or	CCONJ
aji-164	162	24	though	though	SCONJ
aji-164	162	25	out	out	ADP
aji-164	162	26	diffusion	diffusion	NOUN
aji-164	162	27	process	process	NOUN
aji-164	162	28	across	across	ADP
aji-164	162	29	the	the	DET
aji-164	162	30	semipermeable	semipermeable	NOUN
aji-164	162	31	membranes	membrane	NOUN
aji-164	162	32	.	.	PUNCT
aji-164	163	1	this	this	PRON
aji-164	163	2	accompanied	accompany	VERB
aji-164	163	3	by	by	ADP
aji-164	163	4	an	an	DET
aji-164	163	5	active	active	ADJ
aji-164	163	6	liver	liver	NOUN
aji-164	163	7	detoxification	detoxification	NOUN
aji-164	163	8	of	of	ADP
aji-164	163	9	this	this	DET
aji-164	163	10	chemical	chemical	ADJ
aji-164	163	11	insult	insult	NOUN
aji-164	163	12	.	.	PUNCT
aji-164	164	1	clearance	clearance	NOUN
aji-164	164	2	of	of	ADP
aji-164	164	3	alum	alum	NOUN
aji-164	164	4	from	from	ADP
aji-164	164	5	the	the	DET
aji-164	164	6	body	body	NOUN
aji-164	164	7	have	have	AUX
aji-164	164	8	been	be	AUX
aji-164	164	9	found	find	VERB
aji-164	164	10	a	a	DET
aji-164	164	11	species	specie	NOUN
aji-164	164	12	dependent	dependent	ADJ
aji-164	164	13	process	process	NOUN
aji-164	164	14	(	(	PUNCT
aji-164	164	15	gherardi	gherardi	NOUN
aji-164	164	16	et	et	NOUN
aji-164	164	17	al	al	PROPN
aji-164	164	18	.	.	PROPN
aji-164	164	19	,	,	PUNCT
aji-164	164	20	2019	2019	NUM
aji-164	164	21	)	)	PUNCT
aji-164	164	22	.	.	PUNCT
aji-164	165	1	alum	alum	ADJ
aji-164	165	2	adjuvant	adjuvant	NOUN
aji-164	165	3	induces	induce	VERB
aji-164	165	4	humoral	humoral	ADJ
aji-164	165	5	immune	immune	ADJ
aji-164	165	6	th2	th2	PROPN
aji-164	165	7	responses	response	NOUN
aji-164	165	8	via	via	ADP
aji-164	165	9	primary	primary	ADJ
aji-164	165	10	and	and	CCONJ
aji-164	165	11	secondary	secondary	ADJ
aji-164	165	12	response	response	NOUN
aji-164	165	13	events	event	NOUN
aji-164	165	14	in	in	ADP
aji-164	165	15	mice	mouse	NOUN
aji-164	165	16	and	and	CCONJ
aji-164	165	17	mixed	mixed	ADJ
aji-164	165	18	humoral	humoral	ADJ
aji-164	165	19	and	and	CCONJ
aji-164	165	20	cellular	cellular	ADJ
aji-164	165	21	responses	response	NOUN
aji-164	165	22	in	in	ADP
aji-164	165	23	human	human	ADJ
aji-164	165	24	being	be	AUX
aji-164	165	25	whereby	whereby	SCONJ
aji-164	165	26	vaccine	vaccine	NOUN
aji-164	165	27	adjuvant	adjuvant	ADJ
aji-164	165	28	supports	support	VERB
aji-164	165	29	the	the	DET
aji-164	165	30	activation	activation	NOUN
aji-164	165	31	of	of	ADP
aji-164	165	32	cd8	cd8	PROPN
aji-164	165	33	t	t	PROPN
aji-164	165	34	cells	cell	NOUN
aji-164	165	35	but	but	CCONJ
aji-164	165	36	these	these	DET
aji-164	165	37	cells	cell	NOUN
aji-164	165	38	does	do	AUX
aji-164	165	39	not	not	PART
aji-164	165	40	differentiated	differentiate	VERB
aji-164	165	41	to	to	ADP
aji-164	165	42	cytotoxic	cytotoxic	ADJ
aji-164	165	43	t	t	NOUN
aji-164	165	44	cells	cell	NOUN
aji-164	165	45	(	(	PUNCT
aji-164	165	46	hogen	hogen	NOUN
aji-164	165	47	-	-	PUNCT
aji-164	165	48	esch	esch	PROPN
aji-164	165	49	2013	2013	NUM
aji-164	165	50	)	)	PUNCT
aji-164	165	51	.	.	PUNCT
aji-164	166	1	in	in	ADP
aji-164	166	2	an	an	DET
aji-164	166	3	in	in	ADP
aji-164	166	4	-	-	PUNCT
aji-164	166	5	vitro	vitro	X
aji-164	166	6	culture	culture	NOUN
aji-164	166	7	system	system	NOUN
aji-164	166	8	al(oh)2	al(oh)2	NOUN
aji-164	166	9	stimulate	stimulate	VERB
aji-164	166	10	isolated	isolated	ADJ
aji-164	166	11	macrophages	macrophage	NOUN
aji-164	166	12	that	that	PRON
aji-164	166	13	contains	contain	VERB
aji-164	166	14	large	large	ADJ
aji-164	166	15	and	and	CCONJ
aji-164	166	16	persistent	persistent	ADJ
aji-164	166	17	intracellular	intracellular	ADJ
aji-164	166	18	crystalline	crystalline	NOUN
aji-164	166	19	inclusion	inclusion	NOUN
aji-164	166	20	,	,	PUNCT
aji-164	166	21	the	the	DET
aji-164	166	22	“	"	PUNCT
aji-164	166	23	alum	alum	ADJ
aji-164	166	24	loaded	load	VERB
aji-164	166	25	macrophage	macrophage	NOUN
aji-164	166	26	”	"	PUNCT
aji-164	166	27	alm.alm	alm.alm	PROPN
aji-164	166	28	exhibit	exhibit	VERB
aji-164	166	29	phenotypical	phenotypical	ADJ
aji-164	166	30	and	and	CCONJ
aji-164	166	31	functional	functional	ADJ
aji-164	166	32	modifications	modification	NOUN
aji-164	166	33	as	as	SCONJ
aji-164	166	34	they	they	PRON
aji-164	166	35	showed	show	VERB
aji-164	166	36	myeloid	myeloid	ADJ
aji-164	166	37	dendritic	dendritic	ADJ
aji-164	166	38	cell	cell	NOUN
aji-164	166	39	surface	surface	NOUN
aji-164	166	40	markers[hladr	markers[hladr	PUNCT
aji-164	167	1	high,/cd1a-/cd14-	high,/cd1a-/cd14-	PROPN
aji-164	167	2	]	]	PUNCT
aji-164	167	3	and	and	CCONJ
aji-164	167	4	displayed	display	VERB
aji-164	167	5	potent	potent	ADJ
aji-164	167	6	ability	ability	NOUN
aji-164	167	7	to	to	PART
aji-164	167	8	induce	induce	VERB
aji-164	167	9	mhc	mhc	NOUN
aji-164	167	10	restricted	restrict	VERB
aji-164	167	11	antigen	antigen	ADJ
aji-164	167	12	specific	specific	ADJ
aji-164	167	13	memory	memory	NOUN
aji-164	167	14	response	response	NOUN
aji-164	167	15	but	but	CCONJ
aji-164	167	16	kept	keep	VERB
aji-164	167	17	macrophage	macrophage	ADJ
aji-164	167	18	morphology	morphology	NOUN
aji-164	167	19	.	.	PUNCT
aji-164	168	1	this	this	PRON
aji-164	168	2	suggest	suggest	VERB
aji-164	168	3	a	a	DET
aji-164	168	4	key	key	ADJ
aji-164	168	5	role	role	NOUN
aji-164	168	6	of	of	ADP
aji-164	168	7	alm	alm	NOUN
aji-164	168	8	in	in	ADP
aji-164	168	9	relation	relation	NOUN
aji-164	168	10	to	to	ADP
aji-164	168	11	the	the	DET
aji-164	168	12	alum	alum	ADJ
aji-164	168	13	-	-	PUNCT
aji-164	168	14	vaccine	vaccine	NOUN
aji-164	168	15	and	and	CCONJ
aji-164	168	16	important	important	ADJ
aji-164	168	17	role	role	NOUN
aji-164	168	18	in	in	ADP
aji-164	168	19	this	this	DET
aji-164	168	20	memory	memory	NOUN
aji-164	168	21	response	response	NOUN
aji-164	168	22	(	(	PUNCT
aji-164	168	23	ann	ann	PROPN
aji-164	168	24	-	-	PUNCT
aji-164	168	25	ceclle	ceclle	PROPN
aji-164	168	26	et	et	PROPN
aji-164	168	27	al	al	PROPN
aji-164	168	28	.	.	PROPN
aji-164	168	29	,	,	PUNCT
aji-164	168	30	2004	2004	NUM
aji-164	168	31	)	)	PUNCT
aji-164	168	32	.	.	PUNCT
aji-164	169	1	the	the	DET
aji-164	169	2	vaccine	vaccine	NOUN
aji-164	169	3	alum	alum	VERB
aji-164	169	4	adjuvant	adjuvant	ADJ
aji-164	169	5	formulation	formulation	NOUN
aji-164	169	6	when	when	SCONJ
aji-164	169	7	applied	apply	VERB
aji-164	169	8	into	into	ADP
aji-164	169	9	the	the	DET
aji-164	169	10	muscle	muscle	NOUN
aji-164	169	11	,	,	PUNCT
aji-164	169	12	months	month	NOUN
aji-164	169	13	to	to	ADP
aji-164	169	14	years	year	NOUN
aji-164	169	15	later	later	ADV
aji-164	169	16	,	,	PUNCT
aji-164	169	17	the	the	DET
aji-164	169	18	alum	alum	ADJ
aji-164	169	19	persists	persist	NOUN
aji-164	169	20	hidden	hide	VERB
aji-164	169	21	in	in	ADP
aji-164	169	22	the	the	DET
aji-164	169	23	inoculation	inoculation	NOUN
aji-164	169	24	site	site	NOUN
aji-164	169	25	.	.	PUNCT
aji-164	170	1	then	then	ADV
aji-164	170	2	released	release	VERB
aji-164	170	3	frequently	frequently	ADV
aji-164	170	4	in	in	ADP
aji-164	170	5	a	a	DET
aji-164	170	6	steady	steady	ADJ
aji-164	170	7	state	state	NOUN
aji-164	170	8	manner	manner	NOUN
aji-164	170	9	leading	lead	VERB
aji-164	170	10	to	to	ADP
aji-164	170	11	chronic	chronic	ADJ
aji-164	170	12	induction	induction	NOUN
aji-164	170	13	of	of	ADP
aji-164	170	14	immune	immune	ADJ
aji-164	170	15	reaction	reaction	NOUN
aji-164	170	16	in	in	ADP
aji-164	170	17	the	the	DET
aji-164	170	18	application	application	NOUN
aji-164	170	19	site	site	NOUN
aji-164	170	20	macrophages	macrophage	NOUN
aji-164	170	21	and	and	CCONJ
aji-164	170	22	to	to	ADP
aji-164	170	23	lesser	less	ADJ
aji-164	170	24	extent	extent	NOUN
aji-164	170	25	lymphocytes	lymphocyte	NOUN
aji-164	170	26	accumulate	accumulate	VERB
aji-164	170	27	in	in	ADP
aji-164	170	28	the	the	DET
aji-164	170	29	injection	injection	NOUN
aji-164	170	30	site	site	NOUN
aji-164	170	31	took	take	VERB
aji-164	170	32	up	up	ADP
aji-164	170	33	alum	alum	ADJ
aji-164	170	34	nano	nano	NOUN
aji-164	170	35	-	-	PUNCT
aji-164	170	36	molecules	molecule	NOUN
aji-164	170	37	may	may	AUX
aji-164	170	38	be	be	AUX
aji-164	170	39	through	through	ADP
aji-164	170	40	pinocytosis	pinocytosis	NOUN
aji-164	170	41	.	.	PUNCT
aji-164	171	1	local	local	ADJ
aji-164	171	2	granulomatous	granulomatous	ADJ
aji-164	171	3	response	response	NOUN
aji-164	171	4	is	be	AUX
aji-164	171	5	initiated	initiate	VERB
aji-164	171	6	and	and	CCONJ
aji-164	171	7	developed	develop	VERB
aji-164	171	8	.	.	PUNCT
aji-164	172	1	in	in	ADP
aji-164	172	2	continuum	continuum	ADJ
aji-164	172	3	with	with	ADP
aji-164	172	4	this	this	DET
aji-164	172	5	local	local	ADJ
aji-164	172	6	reaction	reaction	NOUN
aji-164	172	7	alum	alum	NOUN
aji-164	172	8	may	may	AUX
aji-164	172	9	combined	combine	VERB
aji-164	172	10	with	with	ADP
aji-164	172	11	self	self	NOUN
aji-164	172	12	cellular	cellular	ADJ
aji-164	172	13	protein	protein	NOUN
aji-164	172	14	from	from	ADP
aji-164	172	15	metalloprotein	metalloprotein	NOUN
aji-164	172	16	.	.	PUNCT
aji-164	173	1	a	a	DET
aji-164	173	2	modified	modify	VERB
aji-164	173	3	self	self	NOUN
aji-164	173	4	protein	protein	NOUN
aji-164	173	5	such	such	ADJ
aji-164	173	6	as	as	ADP
aji-164	173	7	a	a	DET
aji-164	173	8	metalloprotein	metalloprotein	NOUN
aji-164	173	9	of	of	ADP
aji-164	173	10	mmp	mmp	PROPN
aji-164	173	11	initiated	initiate	VERB
aji-164	173	12	specific	specific	ADJ
aji-164	173	13	immune	immune	ADJ
aji-164	173	14	and	and	CCONJ
aji-164	173	15	autoimmune	autoimmune	ADJ
aji-164	173	16	responses	response	NOUN
aji-164	173	17	in	in	ADP
aji-164	173	18	presence	presence	NOUN
aji-164	173	19	of	of	ADP
aji-164	173	20	the	the	DET
aji-164	173	21	pathogenic	pathogenic	ADJ
aji-164	173	22	allele	allele	NOUN
aji-164	173	23	hladr	hladr	NOUN
aji-164	173	24	1	1	NUM
aji-164	173	25	01	01	NUM
aji-164	173	26	and	and	CCONJ
aji-164	173	27	the	the	DET
aji-164	173	28	activated	activated	ADJ
aji-164	173	29	shnawa	shnawa	NOUN
aji-164	173	30	;	;	PUNCT
aji-164	173	31	asian	asian	PROPN
aji-164	173	32	j.	j.	PROPN
aji-164	173	33	immunol	immunol	PROPN
aji-164	173	34	.	.	PROPN
aji-164	173	35	,	,	PUNCT
aji-164	173	36	vol	vol	NOUN
aji-164	173	37	.	.	PROPN
aji-164	173	38	8	8	NUM
aji-164	173	39	,	,	PUNCT
aji-164	173	40	no	no	INTJ
aji-164	173	41	.	.	NOUN
aji-164	173	42	1	1	NUM
aji-164	173	43	,	,	PUNCT
aji-164	173	44	pp	pp	ADJ
aji-164	173	45	.	.	PUNCT
aji-164	174	1	97	97	NUM
aji-164	174	2	-	-	SYM
aji-164	174	3	103	103	NUM
aji-164	174	4	,	,	PUNCT
aji-164	174	5	2025	2025	NUM
aji-164	174	6	;	;	PUNCT
aji-164	174	7	article	article	NOUN
aji-164	174	8	no.aji.134974	no.aji.134974	VERB
aji-164	174	9	100	100	NUM
aji-164	174	10	tissue	tissue	NOUN
aji-164	174	11	microenvironment	microenvironment	NOUN
aji-164	174	12	as	as	ADP
aji-164	174	13	a	a	DET
aji-164	174	14	pathology	pathology	NOUN
aji-164	174	15	system	system	NOUN
aji-164	174	16	.	.	PUNCT
aji-164	175	1	the	the	DET
aji-164	175	2	net	net	ADJ
aji-164	175	3	result	result	NOUN
aji-164	175	4	of	of	ADP
aji-164	175	5	such	such	ADJ
aji-164	175	6	reactions	reaction	NOUN
aji-164	175	7	is	be	AUX
aji-164	175	8	the	the	DET
aji-164	175	9	production	production	NOUN
aji-164	175	10	of	of	ADP
aji-164	175	11	myo	myo	NOUN
aji-164	175	12	-	-	PUNCT
aji-164	175	13	specific	specific	ADJ
aji-164	175	14	autoantibody	autoantibody	NOUN
aji-164	175	15	and	and	CCONJ
aji-164	175	16	cd8+t	cd8+t	NOUN
aji-164	175	17	cell	cell	NOUN
aji-164	175	18	predominantly	predominantly	ADV
aji-164	175	19	existed	exist	VERB
aji-164	175	20	along	along	ADV
aji-164	175	21	with	with	ADP
aji-164	175	22	modified	modify	VERB
aji-164	175	23	macrophages	macrophage	NOUN
aji-164	175	24	in	in	ADP
aji-164	175	25	the	the	DET
aji-164	175	26	lesions	lesion	NOUN
aji-164	175	27	(	(	PUNCT
aji-164	175	28	shnawa	shnawa	PROPN
aji-164	175	29	2023	2023	NUM
aji-164	175	30	)	)	PUNCT
aji-164	175	31	.	.	PUNCT
aji-164	176	1	this	this	DET
aji-164	176	2	alum	alum	ADV
aji-164	176	3	loaded	load	VERB
aji-164	176	4	modified	modified	ADJ
aji-164	176	5	macrophages	macrophage	NOUN
aji-164	176	6	my	my	PRON
aji-164	176	7	migrate	migrate	NOUN
aji-164	176	8	through	through	ADP
aji-164	176	9	out	out	ADP
aji-164	176	10	blood	blood	NOUN
aji-164	176	11	stream	stream	NOUN
aji-164	176	12	to	to	ADP
aji-164	176	13	lymph	lymph	NOUN
aji-164	176	14	nodes	node	NOUN
aji-164	176	15	,	,	PUNCT
aji-164	176	16	spleen	spleen	NOUN
aji-164	176	17	and	and	CCONJ
aji-164	176	18	brain	brain	NOUN
aji-164	176	19	by	by	ADP
aji-164	176	20	this	this	PRON
aji-164	176	21	they	they	PRON
aji-164	176	22	may	may	AUX
aji-164	176	23	lead	lead	VERB
aji-164	176	24	to	to	ADP
aji-164	176	25	skeletal	skeletal	ADJ
aji-164	176	26	muscle	muscle	NOUN
aji-164	176	27	and	and	CCONJ
aji-164	176	28	cognitive	cognitive	ADJ
aji-164	176	29	disorders	disorder	NOUN
aji-164	176	30	(	(	PUNCT
aji-164	176	31	gherardi	gherardi	NOUN
aji-164	176	32	et	et	NOUN
aji-164	176	33	al	al	PROPN
aji-164	176	34	2021	2021	NUM
aji-164	176	35	)	)	PUNCT
aji-164	176	36	.	.	PUNCT
aji-164	177	1	mmf	mmf	NOUN
aji-164	177	2	has	have	AUX
aji-164	177	3	been	be	AUX
aji-164	177	4	reported	report	VERB
aji-164	177	5	after	after	ADP
aji-164	177	6	contact	contact	NOUN
aji-164	177	7	with	with	ADP
aji-164	177	8	metals	metal	NOUN
aji-164	177	9	and	and	CCONJ
aji-164	177	10	/or	/or	PUNCT
aji-164	177	11	vaccines.it	vaccines.it	PRON
aji-164	177	12	is	be	AUX
aji-164	177	13	typically	typically	ADV
aji-164	177	14	occurs	occur	VERB
aji-164	177	15	in	in	ADP
aji-164	177	16	individuals	individual	NOUN
aji-164	177	17	with	with	ADP
aji-164	177	18	genetic	genetic	ADJ
aji-164	177	19	predisposition	predisposition	NOUN
aji-164	177	20	like	like	ADP
aji-164	177	21	hladrb1	hladrb1	NOUN
aji-164	177	22	andptpn22.such	andptpn22.such	PROPN
aji-164	177	23	contact	contact	NOUN
aji-164	177	24	may	may	AUX
aji-164	177	25	initiate	initiate	VERB
aji-164	177	26	over	over	ADP
aji-164	177	27	-	-	PUNCT
aji-164	177	28	immune	immune	ADJ
aji-164	177	29	reaction	reaction	NOUN
aji-164	177	30	of	of	ADP
aji-164	177	31	the	the	DET
aji-164	177	32	immune	immune	ADJ
aji-164	177	33	system	system	NOUN
aji-164	177	34	that	that	PRON
aji-164	177	35	propriates	propriate	NOUN
aji-164	177	36	to	to	ADP
aji-164	177	37	production	production	NOUN
aji-164	177	38	of	of	ADP
aji-164	177	39	autoantibodies	autoantibody	NOUN
aji-164	177	40	and	and	CCONJ
aji-164	177	41	fully	fully	ADV
aji-164	177	42	cause	cause	VERB
aji-164	177	43	autoimmune	autoimmune	ADJ
aji-164	177	44	disorder	disorder	NOUN
aji-164	177	45	.	.	PUNCT
aji-164	178	1	mmf	mmf	NOUN
aji-164	178	2	is	be	AUX
aji-164	178	3	a	a	DET
aji-164	178	4	subentity	subentity	NOUN
aji-164	178	5	of	of	ADP
aji-164	178	6	asia	asia	PROPN
aji-164	178	7	syndrome	syndrome	PROPN
aji-164	178	8	results	result	NOUN
aji-164	178	9	from	from	ADP
aji-164	178	10	interaction	interaction	NOUN
aji-164	178	11	between	between	ADP
aji-164	178	12	genetic	genetic	ADJ
aji-164	178	13	and	and	CCONJ
aji-164	178	14	environmental	environmental	ADJ
aji-164	178	15	factors	factor	NOUN
aji-164	178	16	with	with	ADP
aji-164	178	17	adjuvant	adjuvant	NOUN
aji-164	178	18	through	through	ADP
aji-164	178	19	modulation	modulation	NOUN
aji-164	178	20	receptors	receptor	NOUN
aji-164	178	21	such	such	ADJ
aji-164	178	22	as	as	ADP
aji-164	178	23	tlr	tlr	PROPN
aji-164	178	24	,	,	PUNCT
aji-164	178	25	nlr	nlr	PROPN
aji-164	178	26	and	and	CCONJ
aji-164	178	27	clr	clr	VERB
aji-164	178	28	triggering	trigger	VERB
aji-164	178	29	aberrant	aberrant	ADJ
aji-164	178	30	immune	immune	ADJ
aji-164	178	31	response	response	NOUN
aji-164	178	32	prompting	prompt	VERB
aji-164	178	33	development	development	NOUN
aji-164	178	34	of	of	ADP
aji-164	178	35	an	an	DET
aji-164	178	36	autoimmune	autoimmune	ADJ
aji-164	178	37	disorder	disorder	NOUN
aji-164	178	38	(	(	PUNCT
aji-164	178	39	caldarelli	caldarelli	NOUN
aji-164	178	40	et	et	PROPN
aji-164	178	41	al	al	PROPN
aji-164	178	42	.	.	PROPN
aji-164	178	43	,	,	PUNCT
aji-164	178	44	2024	2024	NUM
aji-164	178	45	)	)	PUNCT
aji-164	178	46	.	.	PUNCT
aji-164	179	1	aluminum	aluminum	NOUN
aji-164	179	2	adjuvant	adjuvant	NOUN
aji-164	179	3	is	be	AUX
aji-164	179	4	well	well	ADV
aji-164	179	5	known	know	VERB
aji-164	179	6	enhancer	enhancer	NOUN
aji-164	179	7	of	of	ADP
aji-164	179	8	th2	th2	PROPN
aji-164	179	9	responses	response	NOUN
aji-164	179	10	.	.	PUNCT
aji-164	180	1	however	however	ADV
aji-164	180	2	,	,	PUNCT
aji-164	180	3	it	it	PRON
aji-164	180	4	has	have	AUX
aji-164	180	5	been	be	AUX
aji-164	180	6	suggested	suggest	VERB
aji-164	180	7	that	that	SCONJ
aji-164	180	8	aluminum	aluminum	NOUN
aji-164	180	9	induces	induce	VERB
aji-164	180	10	th1	th1	NOUN
aji-164	180	11	response	response	NOUN
aji-164	180	12	in	in	ADP
aji-164	180	13	presence	presence	NOUN
aji-164	180	14	of	of	ADP
aji-164	180	15	other	other	ADJ
aji-164	180	16	th1	th1	NOUN
aji-164	180	17	inducing	induce	VERB
aji-164	180	18	compounds	compound	NOUN
aji-164	180	19	such	such	ADJ
aji-164	180	20	as	as	ADP
aji-164	180	21	lps	lps	PROPN
aji-164	180	22	or	or	CCONJ
aji-164	180	23	rec	rec	NOUN
aji-164	181	1	.	.	PUNCT
aji-164	181	2	influenza	influenza	NOUN
aji-164	181	3	antigen	antigen	PROPN
aji-164	181	4	,	,	PUNCT
aji-164	181	5	a	a	DET
aji-164	181	6	bystander	bystander	NOUN
aji-164	181	7	effect	effect	NOUN
aji-164	181	8	through	through	ADP
aji-164	181	9	which	which	PRON
aji-164	181	10	alum	alum	ADJ
aji-164	181	11	adjuvant	adjuvant	ADJ
aji-164	181	12	trigger	trigger	NOUN
aji-164	181	13	autoimmunity	autoimmunity	NOUN
aji-164	181	14	via	via	ADP
aji-164	181	15	activation	activation	NOUN
aji-164	181	16	of	of	ADP
aji-164	181	17	dormant	dormant	ADJ
aji-164	181	18	autoreactive	autoreactive	PROPN
aji-164	181	19	t	t	PROPN
aji-164	181	20	lymphocyte	lymphocyte	NOUN
aji-164	181	21	in	in	ADP
aji-164	181	22	some	some	DET
aji-164	181	23	individuals	individual	NOUN
aji-164	181	24	(	(	PUNCT
aji-164	181	25	fan	fan	NOUN
aji-164	181	26	et	et	PROPN
aji-164	181	27	al	al	PROPN
aji-164	181	28	.	.	PROPN
aji-164	181	29	,	,	PUNCT
aji-164	181	30	2022	2022	NUM
aji-164	181	31	)	)	PUNCT
aji-164	181	32	.	.	PUNCT
aji-164	182	1	5	5	X
aji-164	182	2	.	.	NOUN
aji-164	182	3	mmf	mmf	NOUN
aji-164	182	4	autoimmune	autoimmune	NOUN
aji-164	182	5	mechanisms	mechanism	NOUN
aji-164	182	6	in	in	ADP
aji-164	182	7	general	general	ADJ
aji-164	182	8	autoimmune	autoimmune	ADJ
aji-164	182	9	mechanisms	mechanism	NOUN
aji-164	182	10	are	be	AUX
aji-164	182	11	of	of	ADP
aji-164	182	12	classical	classical	ADJ
aji-164	182	13	and	and	CCONJ
aji-164	182	14	recent	recent	ADJ
aji-164	182	15	mosaic	mosaic	ADJ
aji-164	182	16	nature	nature	NOUN
aji-164	182	17	(	(	PUNCT
aji-164	182	18	shnawa	shnawa	PROPN
aji-164	182	19	2023	2023	NUM
aji-164	182	20	)	)	PUNCT
aji-164	182	21	.	.	PUNCT
aji-164	183	1	mmf	mmf	NOUN
aji-164	183	2	autoimmune	autoimmune	NOUN
aji-164	183	3	mechanisms	mechanism	NOUN
aji-164	183	4	composed	compose	VERB
aji-164	183	5	of	of	ADP
aji-164	183	6	a	a	DET
aji-164	183	7	paradigm	paradigm	NOUN
aji-164	183	8	of	of	ADP
aji-164	183	9	three	three	NUM
aji-164	183	10	heritability	heritability	NOUN
aji-164	183	11	features	feature	NOUN
aji-164	183	12	and	and	CCONJ
aji-164	183	13	four	four	NUM
aji-164	183	14	govering	govering	NOUN
aji-164	183	15	etiology	etiology	NOUN
aji-164	183	16	roles	role	NOUN
aji-164	183	17	(	(	PUNCT
aji-164	183	18	li	li	PROPN
aji-164	183	19	et	et	PROPN
aji-164	183	20	al	al	PROPN
aji-164	183	21	.	.	PROPN
aji-164	183	22	,	,	PUNCT
aji-164	183	23	2015	2015	NUM
aji-164	183	24	)	)	PUNCT
aji-164	183	25	.	.	PUNCT
aji-164	184	1	as	as	SCONJ
aji-164	184	2	mentioned	mention	VERB
aji-164	184	3	in	in	ADP
aji-164	184	4	the	the	DET
aji-164	184	5	following	follow	VERB
aji-164	184	6	paragraphs	paragraph	NOUN
aji-164	184	7	;	;	PUNCT
aji-164	184	8	three	three	NUM
aji-164	184	9	main	main	ADJ
aji-164	184	10	molecular	molecular	ADJ
aji-164	184	11	mechanisms	mechanism	NOUN
aji-164	184	12	valid	valid	ADJ
aji-164	184	13	for	for	ADP
aji-164	184	14	explaining	explain	VERB
aji-164	184	15	autoimmunity	autoimmunity	NOUN
aji-164	184	16	as	as	ADP
aji-164	184	17	;	;	PUNCT
aji-164	184	18	tolerance	tolerance	NOUN
aji-164	184	19	,	,	PUNCT
aji-164	184	20	molecular	molecular	ADJ
aji-164	184	21	mimicry	mimicry	NOUN
aji-164	184	22	and	and	CCONJ
aji-164	184	23	epitope	epitope	NOUN
aji-164	184	24	spreading	spread	VERB
aji-164	184	25	.	.	PUNCT
aji-164	185	1	tolerance	tolerance	NOUN
aji-164	185	2	can	can	AUX
aji-164	185	3	be	be	AUX
aji-164	185	4	established	establish	VERB
aji-164	185	5	through	through	ADP
aji-164	185	6	clonal	clonal	ADJ
aji-164	185	7	deletion	deletion	NOUN
aji-164	185	8	,	,	PUNCT
aji-164	185	9	anergy	anergy	NOUN
aji-164	185	10	,	,	PUNCT
aji-164	185	11	clonal	clonal	ADJ
aji-164	185	12	ignorance	ignorance	NOUN
aji-164	185	13	and	and	CCONJ
aji-164	185	14	regulatory	regulatory	ADJ
aji-164	185	15	t	t	NOUN
aji-164	185	16	cell	cell	NOUN
aji-164	185	17	function	function	NOUN
aji-164	185	18	(	(	PUNCT
aji-164	185	19	perricon	perricon	NOUN
aji-164	185	20	et	et	NOUN
aji-164	185	21	al	al	PROPN
aji-164	185	22	.	.	PROPN
aji-164	185	23	,	,	PUNCT
aji-164	185	24	2019	2019	NUM
aji-164	185	25	)	)	PUNCT
aji-164	185	26	.	.	PUNCT
aji-164	186	1	the	the	DET
aji-164	186	2	heritability	heritability	NOUN
aji-164	186	3	of	of	ADP
aji-164	186	4	mmf	mmf	NOUN
aji-164	186	5	has	have	AUX
aji-164	186	6	been	be	AUX
aji-164	186	7	well	well	ADV
aji-164	186	8	documented	document	VERB
aji-164	186	9	,	,	PUNCT
aji-164	186	10	quantified	quantify	VERB
aji-164	186	11	and	and	CCONJ
aji-164	186	12	exhibit	exhibit	VERB
aji-164	186	13	three	three	NUM
aji-164	186	14	important	important	ADJ
aji-164	186	15	features	feature	NOUN
aji-164	186	16	;	;	PUNCT
aji-164	186	17	i	i	PRON
aji-164	186	18	–	–	PUNCT
aji-164	186	19	all	all	DET
aji-164	186	20	genetic	genetic	ADJ
aji-164	186	21	diseases	disease	NOUN
aji-164	186	22	have	have	VERB
aji-164	186	23	strong	strong	ADJ
aji-164	186	24	genetic	genetic	ADJ
aji-164	186	25	components	component	NOUN
aji-164	186	26	,	,	PUNCT
aji-164	186	27	ii	ii	NUM
aji-164	186	28	relatively	relatively	ADV
aji-164	186	29	large	large	ADJ
aji-164	186	30	numbers	number	NOUN
aji-164	186	31	of	of	ADP
aji-164	186	32	risk	risk	NOUN
aji-164	186	33	alleles	allele	NOUN
aji-164	186	34	are	be	AUX
aji-164	186	35	shared	share	VERB
aji-164	186	36	between	between	ADP
aji-164	186	37	multiple	multiple	ADJ
aji-164	186	38	autoimmune	autoimmune	ADJ
aji-164	186	39	diseases	disease	NOUN
aji-164	186	40	and	and	CCONJ
aji-164	186	41	iii	iii	NUM
aji-164	186	42	the	the	DET
aji-164	186	43	product	product	NOUN
aji-164	186	44	of	of	ADP
aji-164	186	45	most	most	ADJ
aji-164	186	46	of	of	ADP
aji-164	186	47	the	the	DET
aji-164	186	48	autoimmune	autoimmune	ADJ
aji-164	186	49	associated	associate	VERB
aji-164	186	50	genes	gene	NOUN
aji-164	186	51	are	be	AUX
aji-164	186	52	parts	part	NOUN
aji-164	186	53	of	of	ADP
aji-164	186	54	immunological	immunological	ADJ
aji-164	186	55	pathways	pathway	NOUN
aji-164	186	56	in	in	ADP
aji-164	186	57	particular	particular	ADJ
aji-164	186	58	t	t	NOUN
aji-164	186	59	cell	cell	NOUN
aji-164	186	60	signaling	signal	VERB
aji-164	186	61	,	,	PUNCT
aji-164	186	62	tnf	tnf	PROPN
aji-164	186	63	signaling	signaling	ADJ
aji-164	186	64	and	and	CCONJ
aji-164	186	65	innate	innate	ADJ
aji-164	186	66	immunity	immunity	NOUN
aji-164	186	67	(	(	PUNCT
aji-164	186	68	zherankova	zherankova	X
aji-164	186	69	et	et	NOUN
aji-164	186	70	al	al	PROPN
aji-164	186	71	.	.	PROPN
aji-164	186	72	,	,	PUNCT
aji-164	186	73	2009	2009	NUM
aji-164	186	74	)	)	PUNCT
aji-164	186	75	.	.	PUNCT
aji-164	187	1	the	the	DET
aji-164	187	2	reaction	reaction	NOUN
aji-164	187	3	of	of	ADP
aji-164	187	4	the	the	DET
aji-164	187	5	immune	immune	ADJ
aji-164	187	6	system	system	NOUN
aji-164	187	7	to	to	ADP
aji-164	187	8	an	an	DET
aji-164	187	9	environmental	environmental	ADJ
aji-164	187	10	stimuli	stimulus	NOUN
aji-164	187	11	,	,	PUNCT
aji-164	187	12	produce	produce	VERB
aji-164	187	13	autoimmune	autoimmune	ADJ
aji-164	187	14	disease	disease	NOUN
aji-164	187	15	should	should	AUX
aji-164	187	16	pass	pass	VERB
aji-164	187	17	four	four	NUM
aji-164	187	18	governing	governing	NOUN
aji-164	187	19	roles	role	NOUN
aji-164	187	20	in	in	ADP
aji-164	187	21	a	a	DET
aji-164	187	22	stepwise	stepwise	ADJ
aji-164	187	23	manner	manner	NOUN
aji-164	187	24	and	and	CCONJ
aji-164	187	25	start	start	VERB
aji-164	187	26	with	with	ADP
aji-164	187	27	;	;	PUNCT
aji-164	187	28	i	i	PROPN
aji-164	187	29	-	-	PUNCT
aji-164	187	30	foundation	foundation	NOUN
aji-164	187	31	of	of	ADP
aji-164	187	32	predisposing	predispose	VERB
aji-164	187	33	genetic	genetic	ADJ
aji-164	187	34	architecture	architecture	NOUN
aji-164	187	35	representing	represent	VERB
aji-164	187	36	autoimmunity	autoimmunity	NOUN
aji-164	187	37	,	,	PUNCT
aji-164	187	38	iichronic	iichronic	NOUN
aji-164	187	39	repeated	repeat	VERB
aji-164	187	40	skewed	skewed	ADJ
aji-164	187	41	and	and	CCONJ
aji-164	187	42	biased	biased	ADJ
aji-164	187	43	responses	response	NOUN
aji-164	187	44	over	over	ADP
aji-164	187	45	years	year	NOUN
aji-164	187	46	yield	yield	VERB
aji-164	187	47	pathological	pathological	ADJ
aji-164	187	48	system	system	NOUN
aji-164	187	49	,	,	PUNCT
aji-164	187	50	iiithe	iiithe	DET
aji-164	187	51	pathological	pathological	ADJ
aji-164	187	52	system	system	NOUN
aji-164	187	53	induces	induce	VERB
aji-164	187	54	loss	loss	NOUN
aji-164	187	55	of	of	ADP
aji-164	187	56	immune	immune	ADJ
aji-164	187	57	tolerance	tolerance	NOUN
aji-164	187	58	and	and	CCONJ
aji-164	187	59	ivadopting	ivadopte	VERB
aji-164	187	60	nocuous	nocuous	ADJ
aji-164	187	61	potentials	potential	NOUN
aji-164	187	62	(	(	PUNCT
aji-164	187	63	li	li	PROPN
aji-164	187	64	et	et	PROPN
aji-164	187	65	al	al	PROPN
aji-164	187	66	.	.	PROPN
aji-164	187	67	,	,	PUNCT
aji-164	187	68	2015	2015	NUM
aji-164	187	69	,	,	PUNCT
aji-164	187	70	zherankova	zherankova	X
aji-164	187	71	et	et	NOUN
aji-164	187	72	al	al	PROPN
aji-164	187	73	.	.	PROPN
aji-164	187	74	,	,	PUNCT
aji-164	187	75	2009	2009	NUM
aji-164	187	76	,	,	PUNCT
aji-164	187	77	shnawa	shnawa	NOUN
aji-164	187	78	2023	2023	NUM
aji-164	187	79	)	)	PUNCT
aji-164	187	80	.	.	PUNCT
aji-164	188	1	hence	hence	ADV
aji-164	188	2	,	,	PUNCT
aji-164	188	3	the	the	DET
aji-164	188	4	proposed	propose	VERB
aji-164	188	5	autoimmune	autoimmune	ADJ
aji-164	188	6	mechanisms	mechanism	NOUN
aji-164	188	7	of	of	ADP
aji-164	188	8	the	the	DET
aji-164	188	9	mmf	mmf	NOUN
aji-164	188	10	are	be	AUX
aji-164	188	11	as	as	SCONJ
aji-164	188	12	follows	follow	VERB
aji-164	188	13	;	;	PUNCT
aji-164	188	14	the	the	DET
aji-164	188	15	genome	genome	NOUN
aji-164	188	16	of	of	ADP
aji-164	188	17	mmf	mmf	NOUN
aji-164	188	18	patients	patient	NOUN
aji-164	188	19	has	have	VERB
aji-164	188	20	strong	strong	ADJ
aji-164	188	21	genetic	genetic	ADJ
aji-164	188	22	component	component	NOUN
aji-164	188	23	which	which	PRON
aji-164	188	24	is	be	AUX
aji-164	188	25	the	the	DET
aji-164	188	26	autoimmune	autoimmune	ADJ
aji-164	188	27	associated	associate	VERB
aji-164	188	28	genes	gene	NOUN
aji-164	188	29	that	that	PRON
aji-164	188	30	contains	contain	VERB
aji-164	188	31	large	large	ADJ
aji-164	188	32	numbers	number	NOUN
aji-164	188	33	of	of	ADP
aji-164	188	34	risk	risk	NOUN
aji-164	188	35	alleles	allele	NOUN
aji-164	188	36	.	.	PUNCT
aji-164	189	1	the	the	DET
aji-164	189	2	gene	gene	NOUN
aji-164	189	3	expression	expression	NOUN
aji-164	189	4	products	product	NOUN
aji-164	189	5	of	of	ADP
aji-164	189	6	these	these	DET
aji-164	189	7	risk	risk	NOUN
aji-164	189	8	alleles	allele	NOUN
aji-164	189	9	are	be	AUX
aji-164	189	10	parts	part	NOUN
aji-164	189	11	of	of	ADP
aji-164	189	12	the	the	DET
aji-164	189	13	immunological	immunological	ADJ
aji-164	189	14	pathway	pathway	NOUN
aji-164	189	15	.	.	PUNCT
aji-164	190	1	alum	alum	ADJ
aji-164	190	2	chronic	chronic	ADJ
aji-164	190	3	repetitive	repetitive	ADJ
aji-164	190	4	induction	induction	NOUN
aji-164	190	5	over	over	ADP
aji-164	190	6	years	year	NOUN
aji-164	190	7	face	face	VERB
aji-164	190	8	the	the	DET
aji-164	190	9	genome	genome	NOUN
aji-164	190	10	of	of	ADP
aji-164	190	11	the	the	DET
aji-164	190	12	patient	patient	NOUN
aji-164	190	13	leading	lead	VERB
aji-164	190	14	to	to	ADP
aji-164	190	15	a	a	DET
aji-164	190	16	pathological	pathological	ADJ
aji-164	190	17	system	system	NOUN
aji-164	190	18	.	.	PUNCT
aji-164	191	1	such	such	ADJ
aji-164	191	2	pathological	pathological	ADJ
aji-164	191	3	system	system	NOUN
aji-164	191	4	induces	induce	VERB
aji-164	191	5	loss	loss	NOUN
aji-164	191	6	of	of	ADP
aji-164	191	7	tolerance	tolerance	NOUN
aji-164	191	8	.	.	PUNCT
aji-164	192	1	then	then	ADV
aji-164	192	2	affected	affect	VERB
aji-164	192	3	immune	immune	ADJ
aji-164	192	4	system	system	NOUN
aji-164	192	5	adopt	adopt	VERB
aji-164	192	6	nocuous	nocuous	ADJ
aji-164	192	7	potentials	potential	NOUN
aji-164	193	1	[	[	X
aji-164	193	2	molecular	molecular	ADJ
aji-164	193	3	mimicry	mimicry	ADJ
aji-164	193	4	,	,	PUNCT
aji-164	193	5	antigen	antigen	ADJ
aji-164	193	6	bystander	bystander	NOUN
aji-164	193	7	and/or	and/or	CCONJ
aji-164	193	8	epitope	epitope	NOUN
aji-164	193	9	spreading	spread	VERB
aji-164	193	10	]	]	PUNCT
aji-164	193	11	the	the	DET
aji-164	193	12	autoimmune	autoimmune	ADJ
aji-164	193	13	condition	condition	NOUN
aji-164	193	14	.	.	PUNCT
aji-164	194	1	6	6	NUM
aji-164	194	2	.	.	NOUN
aji-164	194	3	mmf	mmf	NOUN
aji-164	194	4	immune	immune	NOUN
aji-164	194	5	features	feature	NOUN
aji-164	194	6	(	(	PUNCT
aji-164	194	7	li	li	PROPN
aji-164	194	8	et	et	PROPN
aji-164	194	9	al	al	PROPN
aji-164	194	10	.	.	PROPN
aji-164	194	11	,	,	PUNCT
aji-164	194	12	2015	2015	NUM
aji-164	194	13	,	,	PUNCT
aji-164	194	14	zherankova	zherankova	X
aji-164	194	15	et	et	NOUN
aji-164	194	16	al	al	PROPN
aji-164	194	17	.	.	PROPN
aji-164	194	18	,	,	PUNCT
aji-164	194	19	2009	2009	NUM
aji-164	194	20	,	,	PUNCT
aji-164	194	21	shnawa	shnawa	NOUN
aji-164	194	22	2023	2023	NUM
aji-164	194	23	)	)	PUNCT
aji-164	194	24	the	the	DET
aji-164	194	25	major	major	ADJ
aji-164	194	26	immune	immune	ADJ
aji-164	194	27	features	feature	NOUN
aji-164	194	28	of	of	ADP
aji-164	194	29	mmf	mmf	NOUN
aji-164	194	30	can	can	AUX
aji-164	194	31	be	be	AUX
aji-164	194	32	pointed	point	VERB
aji-164	194	33	out	out	ADP
aji-164	194	34	in	in	ADP
aji-164	194	35	the	the	DET
aji-164	194	36	followings	following	NOUN
aji-164	194	37	;	;	PUNCT
aji-164	194	38	i	i	PRON
aji-164	194	39	-rare	-rare	VERB
aji-164	194	40	immune	immune	ADJ
aji-164	194	41	mediated	mediate	VERB
aji-164	194	42	disease	disease	NOUN
aji-164	194	43	ii	ii	NOUN
aji-164	194	44	–	–	PUNCT
aji-164	194	45	it	it	PRON
aji-164	194	46	is	be	AUX
aji-164	194	47	of	of	ADP
aji-164	194	48	an	an	DET
aji-164	194	49	inducive	inducive	ADJ
aji-164	194	50	and	and	CCONJ
aji-164	194	51	constitutive	constitutive	ADJ
aji-164	194	52	nature	nature	NOUN
aji-164	194	53	.	.	PUNCT
aji-164	195	1	iii	iii	X
aji-164	195	2	–	–	PUNCT
aji-164	195	3	adjuvant	adjuvant	NOUN
aji-164	195	4	-	-	PUNCT
aji-164	195	5	alum	alum	NOUN
aji-164	195	6	driven	drive	VERB
aji-164	195	7	.	.	PUNCT
aji-164	196	1	iv	iv	X
aji-164	196	2	-	-	PUNCT
aji-164	196	3	alum	alum	ADJ
aji-164	196	4	form	form	NOUN
aji-164	196	5	metalloprotein	metalloprotein	VERB
aji-164	196	6	a	a	DET
aji-164	196	7	modified	modified	ADJ
aji-164	196	8	self	self	NOUN
aji-164	196	9	protein	protein	NOUN
aji-164	196	10	.	.	PUNCT
aji-164	197	1	v	v	X
aji-164	197	2	-	-	PUNCT
aji-164	197	3	mmf	mmf	NOUN
aji-164	197	4	macrophage	macrophage	NOUN
aji-164	197	5	appeared	appear	VERB
aji-164	197	6	to	to	ADP
aji-164	197	7	uselc3	uselc3	ADJ
aji-164	197	8	associated	associated	ADJ
aji-164	197	9	phagocytosis	phagocytosis	NOUN
aji-164	197	10	to	to	ADP
aji-164	197	11	alum	alum	ADJ
aji-164	197	12	vaccine	vaccine	NOUN
aji-164	197	13	,	,	PUNCT
aji-164	197	14	and	and	CCONJ
aji-164	197	15	secret	secret	ADJ
aji-164	197	16	pain	pain	NOUN
aji-164	197	17	inducing	induce	VERB
aji-164	197	18	molecules	molecule	NOUN
aji-164	197	19	(	(	PUNCT
aji-164	197	20	masson	masson	PROPN
aji-164	197	21	et	et	PROPN
aji-164	197	22	al	al	PROPN
aji-164	197	23	.	.	PROPN
aji-164	197	24	,	,	PUNCT
aji-164	197	25	2024	2024	NUM
aji-164	197	26	)	)	PUNCT
aji-164	197	27	.	.	PUNCT
aji-164	198	1	vimodified	vimodifie	VERB
aji-164	198	2	self	self	NOUN
aji-164	198	3	protein	protein	NOUN
aji-164	198	4	,	,	PUNCT
aji-164	198	5	antigen	antigen	ADJ
aji-164	198	6	bystander	bystander	NOUN
aji-164	198	7	and/or	and/or	CCONJ
aji-164	198	8	molecular	molecular	ADJ
aji-164	198	9	mimicry	mimicry	NOUN
aji-164	198	10	in	in	ADP
aji-164	198	11	presence	presence	NOUN
aji-164	198	12	of	of	ADP
aji-164	198	13	hladr	hladr	PROPN
aji-164	198	14	1a	1a	PROPN
aji-164	198	15	01	01	NUM
aji-164	198	16	haplotype	haplotype	NOUN
aji-164	198	17	induce	induce	VERB
aji-164	198	18	autoimmune	autoimmune	ADJ
aji-164	198	19	response	response	NOUN
aji-164	198	20	.	.	PUNCT
aji-164	199	1	vii	vii	PROPN
aji-164	199	2	-	-	PUNCT
aji-164	199	3	the	the	DET
aji-164	199	4	nature	nature	NOUN
aji-164	199	5	of	of	ADP
aji-164	199	6	the	the	DET
aji-164	199	7	autoimmune	autoimmune	ADJ
aji-164	199	8	response	response	NOUN
aji-164	199	9	in	in	ADP
aji-164	199	10	mice	mice	NOUN
aji-164	199	11	is	be	AUX
aji-164	199	12	humoral	humoral	ADJ
aji-164	199	13	while	while	SCONJ
aji-164	199	14	in	in	ADP
aji-164	199	15	man	man	NOUN
aji-164	199	16	is	be	AUX
aji-164	199	17	mixed	mix	VERB
aji-164	199	18	humoral	humoral	ADJ
aji-164	199	19	and	and	CCONJ
aji-164	199	20	cellular	cellular	ADJ
aji-164	199	21	.	.	PUNCT
aji-164	200	1	shnawa	shnawa	PROPN
aji-164	200	2	;	;	PUNCT
aji-164	200	3	asian	asian	PROPN
aji-164	200	4	j.	j.	PROPN
aji-164	200	5	immunol	immunol	PROPN
aji-164	200	6	.	.	PROPN
aji-164	200	7	,	,	PUNCT
aji-164	200	8	vol	vol	NOUN
aji-164	200	9	.	.	PROPN
aji-164	200	10	8	8	NUM
aji-164	200	11	,	,	PUNCT
aji-164	200	12	no	no	INTJ
aji-164	200	13	.	.	NOUN
aji-164	200	14	1	1	NUM
aji-164	200	15	,	,	PUNCT
aji-164	200	16	pp	pp	ADJ
aji-164	200	17	.	.	PUNCT
aji-164	201	1	97	97	NUM
aji-164	201	2	-	-	SYM
aji-164	201	3	103	103	NUM
aji-164	201	4	,	,	PUNCT
aji-164	201	5	2025	2025	NUM
aji-164	201	6	;	;	PUNCT
aji-164	201	7	article	article	NOUN
aji-164	201	8	no.aji.134974	no.aji.134974	VERB
aji-164	201	9	101	101	NUM
aji-164	201	10	viii	viii	NOUN
aji-164	201	11	-	-	PUNCT
aji-164	201	12	alum	alum	ADJ
aji-164	201	13	modified	modify	VERB
aji-164	201	14	macrophage	macrophage	NOUN
aji-164	201	15	adopt	adopt	VERB
aji-164	201	16	new	new	ADJ
aji-164	201	17	surface	surface	NOUN
aji-164	201	18	marker	marker	NOUN
aji-164	201	19	dc	dc	PROPN
aji-164	201	20	cells	cell	NOUN
aji-164	202	1	but	but	CCONJ
aji-164	202	2	they	they	PRON
aji-164	202	3	still	still	ADV
aji-164	202	4	of	of	ADP
aji-164	202	5	macrophage	macrophage	ADJ
aji-164	202	6	morphology	morphology	NOUN
aji-164	202	7	.	.	PUNCT
aji-164	203	1	such	such	ADJ
aji-164	203	2	macrophage	macrophage	NOUN
aji-164	203	3	is	be	AUX
aji-164	203	4	believed	believe	VERB
aji-164	203	5	to	to	PART
aji-164	203	6	have	have	VERB
aji-164	203	7	a	a	DET
aji-164	203	8	role	role	NOUN
aji-164	203	9	in	in	ADP
aji-164	203	10	memory	memory	NOUN
aji-164	203	11	response	response	NOUN
aji-164	203	12	.	.	PUNCT
aji-164	204	1	ix	ix	PROPN
aji-164	204	2	-	-	PUNCT
aji-164	204	3	th1	th1	PROPN
aji-164	204	4	/	/	SYM
aji-164	204	5	th2	th2	PROPN
aji-164	204	6	balance	balance	NOUN
aji-164	204	7	found	find	VERB
aji-164	204	8	stable	stable	ADJ
aji-164	204	9	,	,	PUNCT
aji-164	204	10	but	but	CCONJ
aji-164	204	11	with	with	ADP
aji-164	204	12	bias	bias	NOUN
aji-164	204	13	th1	th1	NOUN
aji-164	204	14	response	response	NOUN
aji-164	204	15	.	.	PUNCT
aji-164	205	1	x	x	X
aji-164	205	2	-	-	ADJ
aji-164	205	3	local	local	ADJ
aji-164	205	4	muscle	muscle	NOUN
aji-164	205	5	lesion	lesion	NOUN
aji-164	205	6	nature	nature	NOUN
aji-164	205	7	is	be	AUX
aji-164	205	8	granulomatous	granulomatous	ADJ
aji-164	205	9	.	.	PUNCT
aji-164	206	1	xi	xi	NOUN
aji-164	206	2	-	-	PUNCT
aji-164	206	3	the	the	DET
aji-164	206	4	immune	immune	ADJ
aji-164	206	5	whole	whole	ADJ
aji-164	206	6	mark	mark	NOUN
aji-164	206	7	of	of	ADP
aji-164	206	8	ongoing	ongoing	ADJ
aji-164	206	9	reactions	reaction	NOUN
aji-164	206	10	leads	lead	VERB
aji-164	206	11	to	to	ADP
aji-164	206	12	functional	functional	ADJ
aji-164	206	13	problems	problem	NOUN
aji-164	206	14	in	in	ADP
aji-164	206	15	skeletal	skeletal	ADJ
aji-164	206	16	muscles	muscle	NOUN
aji-164	206	17	and	and	CCONJ
aji-164	206	18	in	in	ADP
aji-164	206	19	cognition	cognition	NOUN
aji-164	206	20	.	.	PUNCT
aji-164	207	1	7	7	X
aji-164	207	2	.	.	X
aji-164	207	3	disease	disease	NOUN
aji-164	207	4	entity	entity	NOUN
aji-164	207	5	the	the	DET
aji-164	207	6	mmf	mmf	NOUN
aji-164	207	7	is	be	AUX
aji-164	207	8	a	a	DET
aji-164	207	9	rare	rare	ADJ
aji-164	207	10	macrophage	macrophage	NOUN
aji-164	207	11	driven	drive	VERB
aji-164	207	12	myopathy	myopathy	ADJ
aji-164	207	13	.	.	PUNCT
aji-164	208	1	it	it	PRON
aji-164	208	2	stands	stand	VERB
aji-164	208	3	as	as	ADP
aji-164	208	4	a	a	DET
aji-164	208	5	molecular	molecular	ADJ
aji-164	208	6	immunogenetic	immunogenetic	ADJ
aji-164	208	7	condition	condition	NOUN
aji-164	208	8	with	with	ADP
aji-164	208	9	an	an	DET
aji-164	208	10	autoimmune	autoimmune	ADJ
aji-164	208	11	presentation	presentation	NOUN
aji-164	208	12	linked	link	VERB
aji-164	208	13	to	to	ADP
aji-164	208	14	hladr	hladr	PROPN
aji-164	208	15	1a	1a	PROPN
aji-164	208	16	01	01	NUM
aji-164	208	17	susceptibility	susceptibility	NOUN
aji-164	208	18	haplotype	haplotype	NOUN
aji-164	208	19	.	.	PUNCT
aji-164	209	1	mmf	mmf	NOUN
aji-164	209	2	is	be	AUX
aji-164	209	3	grouped	group	VERB
aji-164	209	4	within	within	ADP
aji-164	209	5	the	the	DET
aji-164	209	6	shoenfeld	shoenfeld	NOUN
aji-164	209	7	’s	’s	PART
aji-164	209	8	syndrome	syndrome	NOUN
aji-164	209	9	(	(	PUNCT
aji-164	209	10	shoenfeld	shoenfeld	VERB
aji-164	209	11	et	et	PROPN
aji-164	209	12	al	al	PROPN
aji-164	209	13	.	.	PROPN
aji-164	209	14	,	,	PUNCT
aji-164	209	15	2011	2011	NUM
aji-164	209	16	)	)	PUNCT
aji-164	209	17	.	.	PUNCT
aji-164	210	1	8	8	X
aji-164	210	2	.	.	X
aji-164	210	3	laboratory	laboratory	NOUN
aji-164	210	4	immunology	immunology	NOUN
aji-164	210	5	patient	patient	NOUN
aji-164	210	6	’s	’s	PART
aji-164	210	7	blood	blood	NOUN
aji-164	210	8	samples	sample	NOUN
aji-164	210	9	collect	collect	VERB
aji-164	210	10	for	for	ADP
aji-164	210	11	the	the	DET
aji-164	210	12	systemic	systemic	ADJ
aji-164	210	13	humoral	humoral	ADJ
aji-164	210	14	and	and	CCONJ
aji-164	210	15	cellular	cellular	ADJ
aji-164	210	16	investigation	investigation	NOUN
aji-164	210	17	.	.	PUNCT
aji-164	211	1	the	the	DET
aji-164	211	2	humoral	humoral	ADJ
aji-164	211	3	for	for	ADP
aji-164	211	4	check	check	NOUN
aji-164	211	5	of	of	ADP
aji-164	211	6	myo	myo	NOUN
aji-164	211	7	-	-	PUNCT
aji-164	211	8	specific	specific	ADJ
aji-164	211	9	autoantibodies	autoantibody	NOUN
aji-164	211	10	and	and	CCONJ
aji-164	211	11	for	for	ADP
aji-164	211	12	macrophage	macrophage	NOUN
aji-164	211	13	and	and	CCONJ
aji-164	211	14	t	t	NOUN
aji-164	211	15	cell	cell	NOUN
aji-164	211	16	subsets	subset	NOUN
aji-164	211	17	.	.	PUNCT
aji-164	212	1	biopsy	biopsy	NOUN
aji-164	212	2	sample	sample	NOUN
aji-164	212	3	for	for	ADP
aji-164	212	4	detection	detection	NOUN
aji-164	212	5	of	of	ADP
aji-164	212	6	the	the	DET
aji-164	212	7	local	local	ADJ
aji-164	212	8	cellularity	cellularity	NOUN
aji-164	212	9	nature	nature	NOUN
aji-164	212	10	of	of	ADP
aji-164	212	11	the	the	DET
aji-164	212	12	granulomatous	granulomatous	ADJ
aji-164	212	13	tissue	tissue	NOUN
aji-164	212	14	reactions	reaction	NOUN
aji-164	212	15	.	.	PUNCT
aji-164	213	1	electron	electron	NOUN
aji-164	213	2	microscopic	microscopic	ADJ
aji-164	213	3	preparation	preparation	NOUN
aji-164	213	4	from	from	ADP
aji-164	213	5	the	the	DET
aji-164	213	6	lesion	lesion	NOUN
aji-164	213	7	to	to	PART
aji-164	213	8	elucidate	elucidate	VERB
aji-164	213	9	the	the	DET
aji-164	213	10	alum	alum	ADJ
aji-164	213	11	crystallization	crystallization	NOUN
aji-164	213	12	in	in	ADP
aji-164	213	13	cells	cell	NOUN
aji-164	213	14	.	.	PUNCT
aji-164	214	1	immune	immune	ADJ
aji-164	214	2	laboratory	laboratory	NOUN
aji-164	214	3	animal	animal	NOUN
aji-164	214	4	model	model	NOUN
aji-164	214	5	can	can	AUX
aji-164	214	6	be	be	AUX
aji-164	214	7	prepared	prepared	ADJ
aji-164	214	8	to	to	PART
aji-164	214	9	recheck	recheck	VERB
aji-164	214	10	the	the	DET
aji-164	214	11	founding	founding	NOUN
aji-164	214	12	in	in	ADP
aji-164	214	13	man	man	NOUN
aji-164	214	14	.	.	PUNCT
aji-164	215	1	9	9	X
aji-164	215	2	.	.	X
aji-164	215	3	laboratory	laboratory	NOUN
aji-164	215	4	animal	animal	NOUN
aji-164	215	5	immune	immune	ADJ
aji-164	215	6	models	model	NOUN
aji-164	215	7	several	several	ADJ
aji-164	215	8	number	number	NOUN
aji-164	215	9	of	of	ADP
aji-164	215	10	laboratory	laboratory	NOUN
aji-164	215	11	animal	animal	NOUN
aji-164	215	12	models	model	NOUN
aji-164	215	13	have	have	AUX
aji-164	215	14	been	be	AUX
aji-164	215	15	tempted	tempt	VERB
aji-164	215	16	by	by	ADP
aji-164	215	17	specialist	specialist	ADJ
aji-164	215	18	workers	worker	NOUN
aji-164	215	19	in	in	ADP
aji-164	215	20	this	this	DET
aji-164	215	21	field	field	NOUN
aji-164	215	22	(	(	PUNCT
aji-164	215	23	ruiz	ruiz	NOUN
aji-164	215	24	et	et	PROPN
aji-164	215	25	al	al	PROPN
aji-164	215	26	.	.	PROPN
aji-164	215	27	,	,	PUNCT
aji-164	215	28	2017	2017	NUM
aji-164	215	29	,	,	PUNCT
aji-164	215	30	colafrancesco	colafrancesco	PROPN
aji-164	215	31	et	et	PROPN
aji-164	215	32	al	al	PROPN
aji-164	215	33	.	.	PROPN
aji-164	215	34	,	,	PUNCT
aji-164	215	35	2013	2013	NUM
aji-164	215	36	)	)	PUNCT
aji-164	215	37	.	.	PUNCT
aji-164	216	1	mmf	mmf	NOUN
aji-164	216	2	lesions	lesion	NOUN
aji-164	216	3	have	have	AUX
aji-164	216	4	been	be	AUX
aji-164	216	5	reproduced	reproduce	VERB
aji-164	216	6	in	in	ADP
aji-164	216	7	;	;	PUNCT
aji-164	216	8	mice	mouse	NOUN
aji-164	216	9	,	,	PUNCT
aji-164	216	10	rat	rat	NOUN
aji-164	216	11	,	,	PUNCT
aji-164	216	12	rabbit	rabbit	NOUN
aji-164	216	13	,	,	PUNCT
aji-164	216	14	monkeys	monkey	NOUN
aji-164	216	15	and	and	CCONJ
aji-164	216	16	sheep	sheep	NOUN
aji-164	216	17	by	by	ADP
aji-164	216	18	iv	iv	ADP
aji-164	217	1	and	and	CCONJ
aji-164	217	2	i	i	PRON
aji-164	217	3	m	m	PROPN
aji-164	217	4	routes	route	NOUN
aji-164	217	5	.	.	PUNCT
aji-164	218	1	iv	iv	PRON
aji-164	218	2	associated	associate	VERB
aji-164	218	3	with	with	ADP
aji-164	218	4	rapid	rapid	ADJ
aji-164	218	5	elimination	elimination	NOUN
aji-164	218	6	.	.	PUNCT
aji-164	219	1	while	while	SCONJ
aji-164	219	2	,	,	PUNCT
aji-164	219	3	rabbit	rabbit	NOUN
aji-164	219	4	i	i	NOUN
aji-164	219	5	m	m	VERB
aji-164	219	6	injection	injection	NOUN
aji-164	219	7	elimination	elimination	NOUN
aji-164	219	8	lasts	last	VERB
aji-164	219	9	four	four	NUM
aji-164	219	10	weeks	week	NOUN
aji-164	219	11	post	post	NOUN
aji-164	219	12	injection	injection	NOUN
aji-164	219	13	(	(	PUNCT
aji-164	219	14	gherardi	gherardi	NOUN
aji-164	219	15	et	et	NOUN
aji-164	219	16	al	al	PROPN
aji-164	219	17	.	.	PROPN
aji-164	219	18	,	,	PUNCT
aji-164	219	19	2019	2019	NUM
aji-164	219	20	)	)	PUNCT
aji-164	219	21	.	.	PUNCT
aji-164	220	1	in	in	ADP
aji-164	220	2	an	an	DET
aji-164	220	3	experimental	experimental	ADJ
aji-164	220	4	animal	animal	NOUN
aji-164	220	5	setting	setting	NOUN
aji-164	220	6	,	,	PUNCT
aji-164	220	7	fluorescent	fluorescent	NOUN
aji-164	220	8	nanotagged	nanotagge	VERB
aji-164	220	9	alum	alum	NOUN
aji-164	220	10	within	within	ADP
aji-164	220	11	the	the	DET
aji-164	220	12	phagocyte	phagocyte	NOUN
aji-164	220	13	have	have	AUX
aji-164	220	14	shown	show	VERB
aji-164	220	15	translocation	translocation	NOUN
aji-164	220	16	of	of	ADP
aji-164	220	17	alum	alum	NOUN
aji-164	220	18	from	from	ADP
aji-164	220	19	the	the	DET
aji-164	220	20	site	site	NOUN
aji-164	220	21	of	of	ADP
aji-164	220	22	injection	injection	NOUN
aji-164	220	23	through	through	ADP
aji-164	220	24	blood	blood	NOUN
aji-164	220	25	circulation	circulation	NOUN
aji-164	220	26	to	to	ADP
aji-164	220	27	the	the	DET
aji-164	220	28	regional	regional	ADJ
aji-164	220	29	lymph	lymph	NOUN
aji-164	220	30	nodes	node	NOUN
aji-164	220	31	,	,	PUNCT
aji-164	220	32	spleen	spleen	NOUN
aji-164	220	33	then	then	ADV
aji-164	220	34	to	to	ADP
aji-164	220	35	brain	brain	NOUN
aji-164	220	36	(	(	PUNCT
aji-164	220	37	gherardi	gherardi	PROPN
aji-164	220	38	&	&	CCONJ
aji-164	220	39	authier	authier	NOUN
aji-164	220	40	2012	2012	NUM
aji-164	220	41	)	)	PUNCT
aji-164	220	42	.	.	PUNCT
aji-164	221	1	spurg	spurg	PROPN
aji-164	221	2	-	-	PUNCT
aji-164	221	3	dully	dully	ADV
aji-164	221	4	and	and	CCONJ
aji-164	221	5	lewis	lewis	PROPN
aji-164	221	6	rat	rat	NOUN
aji-164	221	7	injected	inject	VERB
aji-164	221	8	with	with	ADP
aji-164	221	9	10ul	10ul	NOUN
aji-164	221	10	of	of	ADP
aji-164	221	11	ai(oh)3	ai(oh)3	NOUN
aji-164	221	12	adjuvant	adjuvant	ADJ
aji-164	221	13	vaccine	vaccine	NOUN
aji-164	221	14	and	and	CCONJ
aji-164	221	15	watched	watch	VERB
aji-164	221	16	over	over	ADP
aji-164	221	17	one	one	NUM
aji-164	221	18	year	year	NOUN
aji-164	221	19	for	for	ADP
aji-164	221	20	the	the	DET
aji-164	221	21	appearance	appearance	NOUN
aji-164	221	22	of	of	ADP
aji-164	221	23	the	the	DET
aji-164	221	24	lesions	lesion	NOUN
aji-164	221	25	and	and	CCONJ
aji-164	221	26	the	the	DET
aji-164	221	27	possible	possible	ADJ
aji-164	221	28	reduction	reduction	NOUN
aji-164	221	29	of	of	ADP
aji-164	221	30	their	their	PRON
aji-164	221	31	sizes	size	NOUN
aji-164	221	32	per	per	ADP
aji-164	221	33	time	time	NOUN
aji-164	221	34	elapse	elapse	NOUN
aji-164	221	35	.	.	PUNCT
aji-164	222	1	shrinkage	shrinkage	NOUN
aji-164	222	2	of	of	ADP
aji-164	222	3	the	the	DET
aji-164	222	4	lesion	lesion	NOUN
aji-164	222	5	size	size	NOUN
aji-164	222	6	happened	happen	VERB
aji-164	222	7	over	over	ADP
aji-164	222	8	time	time	NOUN
aji-164	222	9	.	.	PUNCT
aji-164	223	1	humoral	humoral	ADJ
aji-164	223	2	th2	th2	PROPN
aji-164	223	3	and	and	CCONJ
aji-164	223	4	b	b	PROPN
aji-164	223	5	cell	cell	NOUN
aji-164	223	6	immune	immune	ADJ
aji-164	223	7	responses	response	NOUN
aji-164	223	8	mounted.th1	mounted.th1	PROPN
aji-164	223	9	/	/	SYM
aji-164	223	10	th2	th2	PROPN
aji-164	223	11	balance	balance	NOUN
aji-164	223	12	.	.	PUNCT
aji-164	224	1	the	the	DET
aji-164	224	2	function	function	NOUN
aji-164	224	3	of	of	ADP
aji-164	224	4	cytotoxic	cytotoxic	ADJ
aji-164	224	5	t	t	NOUN
aji-164	224	6	cell	cell	NOUN
aji-164	224	7	interferes	interfere	VERB
aji-164	224	8	with	with	ADP
aji-164	224	9	alum	alum	ADJ
aji-164	224	10	clearance	clearance	NOUN
aji-164	224	11	process	process	NOUN
aji-164	224	12	(	(	PUNCT
aji-164	224	13	authier	authier	NOUN
aji-164	224	14	et	et	PROPN
aji-164	224	15	al	al	PROPN
aji-164	224	16	.	.	PROPN
aji-164	224	17	,	,	PUNCT
aji-164	224	18	2006	2006	NUM
aji-164	224	19	)	)	PUNCT
aji-164	224	20	.	.	PUNCT
aji-164	225	1	10	10	X
aji-164	225	2	.	.	X
aji-164	225	3	animal	animal	NOUN
aji-164	225	4	immune	immune	ADJ
aji-164	225	5	model	model	NOUN
aji-164	225	6	suggestion	suggestion	NOUN
aji-164	225	7	a	a	DET
aji-164	225	8	group	group	NOUN
aji-164	225	9	of	of	ADP
aji-164	225	10	18	18	NUM
aji-164	225	11	spurg	spurg	NOUN
aji-164	225	12	-	-	PUNCT
aji-164	225	13	dully	dully	ADV
aji-164	225	14	rats	rat	NOUN
aji-164	225	15	will	will	AUX
aji-164	225	16	be	be	AUX
aji-164	225	17	elected	elect	VERB
aji-164	225	18	and	and	CCONJ
aji-164	225	19	grouped	group	VERB
aji-164	225	20	into	into	ADP
aji-164	225	21	three	three	NUM
aji-164	225	22	groups	group	NOUN
aji-164	225	23	each	each	PRON
aji-164	225	24	of	of	ADP
aji-164	225	25	six	six	NUM
aji-164	225	26	.	.	PUNCT
aji-164	226	1	one	one	NUM
aji-164	226	2	sham	sham	ADJ
aji-164	226	3	saline	saline	NOUN
aji-164	226	4	control	control	NOUN
aji-164	226	5	,	,	PUNCT
aji-164	226	6	one	one	NUM
aji-164	226	7	for	for	ADP
aji-164	226	8	alum	alum	ADJ
aji-164	226	9	solution	solution	NOUN
aji-164	226	10	a	a	DET
aji-164	226	11	lone	lone	NOUN
aji-164	226	12	and	and	CCONJ
aji-164	226	13	one	one	NUM
aji-164	226	14	with	with	ADP
aji-164	226	15	vaccine	vaccine	NOUN
aji-164	226	16	-alum	-alum	NOUN
aji-164	226	17	adjuvant	adjuvant	ADJ
aji-164	226	18	.	.	PUNCT
aji-164	227	1	rats	rat	NOUN
aji-164	227	2	of	of	ADP
aji-164	227	3	the	the	DET
aji-164	227	4	three	three	NUM
aji-164	227	5	groups	group	NOUN
aji-164	227	6	i	i	PRON
aji-164	227	7	m	m	AUX
aji-164	227	8	injected	inject	VERB
aji-164	227	9	,	,	PUNCT
aji-164	227	10	and	and	CCONJ
aji-164	227	11	will	will	AUX
aji-164	227	12	follow	follow	VERB
aji-164	227	13	up	up	ADP
aji-164	227	14	to	to	PART
aji-164	227	15	score	score	VERB
aji-164	227	16	the	the	DET
aji-164	227	17	lesions	lesion	NOUN
aji-164	227	18	and	and	CCONJ
aji-164	227	19	possible	possible	ADJ
aji-164	227	20	reduction	reduction	NOUN
aji-164	227	21	over	over	ADP
aji-164	227	22	time	time	NOUN
aji-164	227	23	elapse	elapse	NOUN
aji-164	227	24	.	.	PUNCT
aji-164	228	1	the	the	DET
aji-164	228	2	formed	form	VERB
aji-164	228	3	lesions	lesion	NOUN
aji-164	228	4	will	will	AUX
aji-164	228	5	be	be	AUX
aji-164	228	6	subjected	subject	VERB
aji-164	228	7	to	to	ADP
aji-164	228	8	histopathological	histopathological	ADJ
aji-164	228	9	evaluations	evaluation	NOUN
aji-164	228	10	in	in	ADP
aji-164	228	11	month	month	NOUN
aji-164	228	12	wise	wise	ADJ
aji-164	228	13	manner	manner	NOUN
aji-164	228	14	for	for	ADP
aji-164	228	15	six	six	NUM
aji-164	228	16	months	month	NOUN
aji-164	228	17	.	.	PUNCT
aji-164	229	1	11	11	NUM
aji-164	229	2	.	.	X
aji-164	230	1	fact	fact	NOUN
aji-164	230	2	sheet	sheet	NOUN
aji-164	230	3	(	(	PUNCT
aji-164	230	4	park	park	NOUN
aji-164	230	5	et	et	PROPN
aji-164	230	6	al	al	PROPN
aji-164	230	7	.	.	PROPN
aji-164	230	8	,	,	PUNCT
aji-164	230	9	2019	2019	NUM
aji-164	230	10	,	,	PUNCT
aji-164	230	11	israeli	israeli	ADJ
aji-164	230	12	et	et	PROPN
aji-164	230	13	al	al	PROPN
aji-164	230	14	.	.	PROPN
aji-164	230	15	,	,	PUNCT
aji-164	230	16	2011	2011	NUM
aji-164	230	17	,	,	PUNCT
aji-164	230	18	cruz	cruz	NOUN
aji-164	230	19	-	-	PUNCT
aji-164	230	20	tapias	tapias	NOUN
aji-164	230	21	et	et	NOUN
aji-164	230	22	al	al	PROPN
aji-164	230	23	2013	2013	NUM
aji-164	230	24	)	)	PUNCT
aji-164	230	25	terminology	terminology	NOUN
aji-164	230	26	:	:	PUNCT
aji-164	230	27	macrophagic	macrophagic	PROPN
aji-164	230	28	myofasciitis	myofasciitis	PROPN
aji-164	230	29	.	.	PUNCT
aji-164	231	1	disease	disease	NOUN
aji-164	231	2	nature	nature	NOUN
aji-164	231	3	:	:	PUNCT
aji-164	231	4	rare	rare	ADJ
aji-164	231	5	immune	immune	ADJ
aji-164	231	6	mediated	mediate	VERB
aji-164	231	7	liked	like	VERB
aji-164	231	8	to	to	ADP
aji-164	231	9	haladr1	haladr1	NOUN
aji-164	231	10	*	*	SYM
aji-164	231	11	01	01	NUM
aji-164	231	12	susceptibility	susceptibility	NOUN
aji-164	231	13	haplotype	haplotype	NOUN
aji-164	231	14	.	.	PUNCT
aji-164	232	1	onset	onset	PROPN
aji-164	232	2	duration:3	duration:3	PROPN
aji-164	232	3	months	month	NOUN
aji-164	232	4	to	to	ADP
aji-164	232	5	eight	eight	NUM
aji-164	232	6	years	year	NOUN
aji-164	232	7	.	.	PUNCT
aji-164	233	1	inducer	inducer	NOUN
aji-164	233	2	:	:	PUNCT
aji-164	233	3	vaccine	vaccine	NOUN
aji-164	233	4	-	-	PUNCT
aji-164	233	5	alum	alum	ADJ
aji-164	233	6	formulation	formulation	NOUN
aji-164	233	7	,	,	PUNCT
aji-164	233	8	or	or	CCONJ
aji-164	233	9	unknown	unknown	ADJ
aji-164	233	10	tissue	tissue	NOUN
aji-164	233	11	lesion	lesion	NOUN
aji-164	233	12	nature	nature	NOUN
aji-164	233	13	:	:	PUNCT
aji-164	233	14	local	local	ADJ
aji-164	233	15	sterio	sterio	NOUN
aji-164	233	16	-	-	PUNCT
aji-164	233	17	typed	type	VERB
aji-164	233	18	immunologically	immunologically	ADV
aji-164	233	19	active	active	ADJ
aji-164	233	20	lesion	lesion	NOUN
aji-164	233	21	.	.	PUNCT
aji-164	234	1	histology	histology	NOUN
aji-164	234	2	:	:	PUNCT
aji-164	234	3	tissue	tissue	NOUN
aji-164	234	4	sections	section	NOUN
aji-164	234	5	from	from	ADP
aji-164	234	6	biopsy	biopsy	NOUN
aji-164	234	7	made	make	VERB
aji-164	234	8	,	,	PUNCT
aji-164	234	9	stained	stain	VERB
aji-164	234	10	with	with	ADP
aji-164	234	11	pas	pa	NOUN
aji-164	234	12	searching	search	VERB
aji-164	234	13	for	for	ADP
aji-164	234	14	cellularity	cellularity	NOUN
aji-164	234	15	.	.	PUNCT
aji-164	235	1	immunology	immunology	NOUN
aji-164	235	2	:	:	PUNCT
aji-164	235	3	determination	determination	NOUN
aji-164	235	4	of	of	ADP
aji-164	235	5	myo	myo	NOUN
aji-164	235	6	-	-	PUNCT
aji-164	235	7	specific	specific	ADJ
aji-164	235	8	autoantibodies	autoantibody	NOUN
aji-164	235	9	in	in	ADP
aji-164	235	10	patients	patient	NOUN
aji-164	235	11	sera	sera	NOUN
aji-164	235	12	.	.	PUNCT
aji-164	236	1	lesion	lesion	NOUN
aji-164	236	2	description	description	NOUN
aji-164	236	3	:	:	PUNCT
aji-164	236	4	infiltration	infiltration	NOUN
aji-164	236	5	of	of	ADP
aji-164	236	6	epimysium	epimysium	NOUN
aji-164	236	7	,	,	PUNCT
aji-164	236	8	perimysium	perimysium	NOUN
aji-164	236	9	,	,	PUNCT
aji-164	236	10	and	and	CCONJ
aji-164	236	11	perivascular	perivascular	ADJ
aji-164	236	12	endomysium	endomysium	NOUN
aji-164	236	13	with	with	ADP
aji-164	236	14	alum	alum	ADJ
aji-164	236	15	loaded	load	VERB
aji-164	236	16	pas	pas	NOUN
aji-164	236	17	positive	positive	ADJ
aji-164	236	18	macrophage	macrophage	ADJ
aji-164	236	19	accumulation	accumulation	NOUN
aji-164	236	20	at	at	ADP
aji-164	236	21	the	the	DET
aji-164	236	22	site	site	NOUN
aji-164	236	23	of	of	ADP
aji-164	236	24	injection	injection	NOUN
aji-164	236	25	.	.	PUNCT
aji-164	237	1	muscle	muscle	NOUN
aji-164	237	2	necrosis	necrosis	NOUN
aji-164	237	3	is	be	AUX
aji-164	237	4	typically	typically	ADV
aji-164	237	5	absent	absent	ADJ
aji-164	237	6	,	,	PUNCT
aji-164	237	7	spars	spar	VERB
aji-164	237	8	cd8	cd8	PROPN
aji-164	237	9	t	t	PROPN
aji-164	237	10	cells	cell	NOUN
aji-164	237	11	and	and	CCONJ
aji-164	237	12	minimal	minimal	ADJ
aji-164	237	13	myofiber	myofiber	ADJ
aji-164	237	14	damage	damage	NOUN
aji-164	237	15	the	the	DET
aji-164	237	16	lesion	lesion	NOUN
aji-164	237	17	is	be	AUX
aji-164	237	18	of	of	ADP
aji-164	237	19	granulomatous	granulomatous	ADJ
aji-164	237	20	nature	nature	NOUN
aji-164	237	21	(	(	PUNCT
aji-164	237	22	gherhardi	gherhardi	NOUN
aji-164	237	23	,	,	PUNCT
aji-164	237	24	authier	authier	NOUN
aji-164	237	25	2003	2003	NUM
aji-164	237	26	)	)	PUNCT
aji-164	237	27	.	.	PUNCT
aji-164	238	1	chemical	chemical	ADJ
aji-164	238	2	analysis	analysis	NOUN
aji-164	238	3	:	:	PUNCT
aji-164	238	4	chemical	chemical	NOUN
aji-164	238	5	microanalysis	microanalysis	NOUN
aji-164	238	6	and	and	CCONJ
aji-164	238	7	atomic	atomic	ADJ
aji-164	238	8	laser	laser	NOUN
aji-164	238	9	spectrophotometery	spectrophotometery	PROPN
aji-164	238	10	reveals	reveal	VERB
aji-164	238	11	alum	alum	ADJ
aji-164	238	12	crystals	crystal	NOUN
aji-164	238	13	within	within	ADP
aji-164	238	14	the	the	DET
aji-164	238	15	macrophage	macrophage	NOUN
aji-164	238	16	.	.	PUNCT
aji-164	239	1	systemic	systemic	ADJ
aji-164	239	2	reactions	reaction	NOUN
aji-164	239	3	:	:	PUNCT
aji-164	239	4	skeletal	skeletal	ADJ
aji-164	239	5	muscle	muscle	NOUN
aji-164	239	6	and	and	CCONJ
aji-164	239	7	cognitive	cognitive	ADJ
aji-164	239	8	disorders	disorder	NOUN
aji-164	239	9	(	(	PUNCT
aji-164	239	10	israeli	israeli	PROPN
aji-164	239	11	et	et	PROPN
aji-164	239	12	al	al	PROPN
aji-164	239	13	.	.	PROPN
aji-164	239	14	,	,	PUNCT
aji-164	239	15	2011	2011	NUM
aji-164	239	16	,	,	PUNCT
aji-164	239	17	park	park	NOUN
aji-164	239	18	et	et	PROPN
aji-164	239	19	al	al	PROPN
aji-164	239	20	.	.	PROPN
aji-164	239	21	,	,	PUNCT
aji-164	239	22	2019	2019	NUM
aji-164	239	23	)	)	PUNCT
aji-164	239	24	.	.	PUNCT
aji-164	240	1	age	age	NOUN
aji-164	240	2	prevalence	prevalence	NOUN
aji-164	240	3	:	:	PUNCT
aji-164	240	4	all	all	DET
aji-164	240	5	ages	age	NOUN
aji-164	240	6	.	.	PUNCT
aji-164	241	1	shnawa	shnawa	PROPN
aji-164	241	2	;	;	PUNCT
aji-164	241	3	asian	asian	PROPN
aji-164	241	4	j.	j.	PROPN
aji-164	241	5	immunol	immunol	PROPN
aji-164	241	6	.	.	PROPN
aji-164	241	7	,	,	PUNCT
aji-164	241	8	vol	vol	NOUN
aji-164	241	9	.	.	PROPN
aji-164	241	10	8	8	NUM
aji-164	241	11	,	,	PUNCT
aji-164	241	12	no	no	INTJ
aji-164	241	13	.	.	NOUN
aji-164	241	14	1	1	NUM
aji-164	241	15	,	,	PUNCT
aji-164	241	16	pp	pp	ADJ
aji-164	241	17	.	.	PUNCT
aji-164	242	1	97	97	NUM
aji-164	242	2	-	-	SYM
aji-164	242	3	103	103	NUM
aji-164	242	4	,	,	PUNCT
aji-164	242	5	2025	2025	NUM
aji-164	242	6	;	;	PUNCT
aji-164	242	7	article	article	NOUN
aji-164	242	8	no.aji.134974	no.aji.134974	VERB
aji-164	242	9	102	102	NUM
aji-164	242	10	12	12	NUM
aji-164	242	11	.	.	PUNCT
aji-164	243	1	conclusion	conclusion	NOUN
aji-164	243	2	mmf	mmf	NOUN
aji-164	243	3	is	be	AUX
aji-164	243	4	an	an	DET
aji-164	243	5	alum	alum	ADJ
aji-164	243	6	loaded	load	VERB
aji-164	243	7	macrophage	macrophage	ADJ
aji-164	243	8	driven	drive	VERB
aji-164	243	9	autoimmune	autoimmune	ADJ
aji-164	243	10	myopathy	myopathy	ADJ
aji-164	243	11	a	a	DET
aji-164	243	12	syndrome	syndrome	NOUN
aji-164	243	13	sub	sub	NOUN
aji-164	243	14	-	-	NOUN
aji-164	243	15	entity	entity	NOUN
aji-164	243	16	.	.	PUNCT
aji-164	244	1	it	it	PRON
aji-164	244	2	is	be	AUX
aji-164	244	3	linked	link	VERB
aji-164	244	4	with	with	ADP
aji-164	244	5	specific	specific	ADJ
aji-164	244	6	hla	hla	NOUN
aji-164	244	7	haplotype	haplotype	NOUN
aji-164	244	8	susceptibility	susceptibility	NOUN
aji-164	244	9	and	and	CCONJ
aji-164	244	10	grouped	group	VERB
aji-164	244	11	within	within	ADP
aji-164	244	12	shoenfeld	shoenfeld	ADJ
aji-164	244	13	syndrome	syndrome	NOUN
aji-164	244	14	.	.	PUNCT
aji-164	245	1	mmf	mmf	NOUN
aji-164	245	2	immunobiology	immunobiology	NOUN
aji-164	245	3	and	and	CCONJ
aji-164	245	4	autoimmune	autoimmune	ADJ
aji-164	245	5	mechanisms	mechanism	NOUN
aji-164	245	6	,	,	PUNCT
aji-164	245	7	immune	immune	ADJ
aji-164	245	8	features	feature	NOUN
aji-164	245	9	and	and	CCONJ
aji-164	245	10	factsheet	factsheet	NOUN
aji-164	245	11	were	be	AUX
aji-164	245	12	issued	issue	VERB
aji-164	245	13	.	.	PUNCT
aji-164	246	1	consent	consent	NOUN
aji-164	246	2	it	it	PRON
aji-164	246	3	is	be	AUX
aji-164	246	4	not	not	PART
aji-164	246	5	applicable	applicable	ADJ
aji-164	246	6	.	.	PUNCT
aji-164	247	1	ethical	ethical	ADJ
aji-164	247	2	approval	approval	NOUN
aji-164	247	3	it	it	PRON
aji-164	247	4	is	be	AUX
aji-164	247	5	not	not	PART
aji-164	247	6	applicable	applicable	ADJ
aji-164	247	7	.	.	PUNCT
aji-164	248	1	disclaimer	disclaimer	NOUN
aji-164	248	2	(	(	PUNCT
aji-164	248	3	artificial	artificial	ADJ
aji-164	248	4	intelligence	intelligence	NOUN
aji-164	248	5	)	)	PUNCT
aji-164	248	6	author(s	author(s	NOUN
aji-164	248	7	)	)	PUNCT
aji-164	248	8	hereby	hereby	ADV
aji-164	248	9	declare	declare	VERB
aji-164	248	10	that	that	SCONJ
aji-164	248	11	no	no	DET
aji-164	248	12	generative	generative	NOUN
aji-164	248	13	ai	ai	VERB
aji-164	248	14	technologies	technology	NOUN
aji-164	248	15	such	such	ADJ
aji-164	248	16	as	as	ADP
aji-164	248	17	large	large	ADJ
aji-164	248	18	language	language	NOUN
aji-164	248	19	models	model	NOUN
aji-164	248	20	(	(	PUNCT
aji-164	248	21	chatgpt	chatgpt	NOUN
aji-164	248	22	,	,	PUNCT
aji-164	248	23	copilot	copilot	NOUN
aji-164	248	24	,	,	PUNCT
aji-164	248	25	etc	etc	X
aji-164	248	26	)	)	PUNCT
aji-164	248	27	and	and	CCONJ
aji-164	248	28	text	text	NOUN
aji-164	248	29	-	-	PUNCT
aji-164	248	30	to	to	ADP
aji-164	248	31	-	-	PUNCT
aji-164	248	32	image	image	NOUN
aji-164	248	33	generators	generator	NOUN
aji-164	248	34	have	have	AUX
aji-164	248	35	been	be	AUX
aji-164	248	36	used	use	VERB
aji-164	248	37	during	during	ADP
aji-164	248	38	writing	writing	NOUN
aji-164	248	39	or	or	CCONJ
aji-164	248	40	editing	editing	NOUN
aji-164	248	41	of	of	ADP
aji-164	248	42	this	this	DET
aji-164	248	43	manuscript	manuscript	NOUN
aji-164	248	44	.	.	PUNCT
aji-164	249	1	competing	compete	VERB
aji-164	249	2	interests	interest	NOUN
aji-164	249	3	author	author	NOUN
aji-164	249	4	has	have	AUX
aji-164	249	5	declared	declare	VERB
aji-164	249	6	that	that	SCONJ
aji-164	249	7	no	no	DET
aji-164	249	8	competing	compete	VERB
aji-164	249	9	interests	interest	NOUN
aji-164	249	10	exist	exist	VERB
aji-164	249	11	.	.	PUNCT
aji-164	250	1	references	reference	NOUN
aji-164	250	2	abbas	abbas	PROPN
aji-164	250	3	,	,	PUNCT
aji-164	250	4	a.	a.	PROPN
aji-164	250	5	k.	k.	PROPN
aji-164	250	6	,	,	PUNCT
aji-164	250	7	lichtman	lichtman	NOUN
aji-164	250	8	,	,	PUNCT
aji-164	250	9	a.	a.	PROPN
aji-164	250	10	h.	h.	PROPN
aji-164	250	11	,	,	PUNCT
aji-164	250	12	&	&	CCONJ
aji-164	250	13	pillai	pillai	PROPN
aji-164	250	14	,	,	PUNCT
aji-164	250	15	s.	s.	PROPN
aji-164	250	16	(	(	PUNCT
aji-164	250	17	2015	2015	NUM
aji-164	250	18	)	)	PUNCT
aji-164	250	19	.	.	PUNCT
aji-164	251	1	cellular	cellular	ADJ
aji-164	251	2	and	and	CCONJ
aji-164	251	3	molecular	molecular	ADJ
aji-164	251	4	immunology	immunology	NOUN
aji-164	251	5	(	(	PUNCT
aji-164	251	6	8th	8th	ADJ
aji-164	251	7	ed	ed	NOUN
aji-164	251	8	.	.	PUNCT
aji-164	251	9	)	)	PUNCT
aji-164	251	10	.	.	PUNCT
aji-164	252	1	elsevier	elsevier	PROPN
aji-164	252	2	saunders	saunders	PROPN
aji-164	252	3	,	,	PUNCT
aji-164	252	4	canada	canada	PROPN
aji-164	252	5	,	,	PUNCT
aji-164	252	6	465	465	NUM
aji-164	252	7	–	–	PUNCT
aji-164	252	8	492	492	NUM
aji-164	252	9	.	.	PUNCT
aji-164	252	10	amoura	amoura	PROPN
aji-164	252	11	,	,	PUNCT
aji-164	252	12	z.	z.	PROPN
aji-164	252	13	,	,	PUNCT
aji-164	252	14	costedoat	costedoat	PROPN
aji-164	252	15	,	,	PUNCT
aji-164	252	16	n.	n.	NOUN
aji-164	252	17	,	,	PUNCT
aji-164	252	18	maisonobe	maisonobe	PROPN
aji-164	252	19	,	,	PUNCT
aji-164	252	20	t.	t.	PROPN
aji-164	252	21	,	,	PUNCT
aji-164	252	22	et	et	PROPN
aji-164	252	23	al	al	PROPN
aji-164	252	24	.	.	PUNCT
aji-164	252	25	(	(	PUNCT
aji-164	252	26	2000	2000	NUM
aji-164	252	27	)	)	PUNCT
aji-164	252	28	.	.	PUNCT
aji-164	253	1	familial	familial	ADJ
aji-164	253	2	macrophagic	macrophagic	ADJ
aji-164	253	3	myofasciitis	myofasciitis	NOUN
aji-164	253	4	.	.	PUNCT
aji-164	254	1	ann	ann	PROPN
aji-164	254	2	.	.	PUNCT
aji-164	254	3	rheumatic	rheumatic	ADJ
aji-164	254	4	disease	disease	NOUN
aji-164	254	5	,	,	PUNCT
aji-164	254	6	59(11	59(11	NUM
aji-164	254	7	)	)	PUNCT
aji-164	254	8	,	,	PUNCT
aji-164	254	9	926	926	NUM
aji-164	254	10	.	.	PUNCT
aji-164	255	1	anne	anne	PROPN
aji-164	255	2	-	-	PUNCT
aji-164	255	3	ceclle	ceclle	PROPN
aji-164	255	4	,	,	PUNCT
aji-164	255	5	et	et	PROPN
aji-164	255	6	al	al	PROPN
aji-164	255	7	.	.	PUNCT
aji-164	255	8	(	(	PUNCT
aji-164	255	9	2004	2004	NUM
aji-164	255	10	)	)	PUNCT
aji-164	255	11	.	.	PUNCT
aji-164	256	1	aluminum	aluminum	NOUN
aji-164	256	2	hydroxide	hydroxide	NOUN
aji-164	256	3	adjuvant	adjuvant	NOUN
aji-164	256	4	induces	induce	VERB
aji-164	256	5	macrophage	macrophage	ADJ
aji-164	256	6	differentiation	differentiation	NOUN
aji-164	256	7	toward	toward	ADP
aji-164	256	8	specialized	specialized	ADJ
aji-164	256	9	antigen	antigen	ADJ
aji-164	256	10	presenting	present	VERB
aji-164	256	11	cell	cell	NOUN
aji-164	256	12	type	type	NOUN
aji-164	256	13	.	.	PUNCT
aji-164	257	1	vaccines	vaccine	NOUN
aji-164	257	2	,	,	PUNCT
aji-164	257	3	22(23–24	22(23–24	NUM
aji-164	257	4	)	)	PUNCT
aji-164	257	5	,	,	PUNCT
aji-164	257	6	3127–3155	3127–3155	NUM
aji-164	257	7	.	.	PUNCT
aji-164	257	8	authier	authier	NOUN
aji-164	257	9	,	,	PUNCT
aji-164	257	10	f.-j	f.-j	PROPN
aji-164	257	11	.	.	PUNCT
aji-164	258	1	(	(	PUNCT
aji-164	258	2	2001	2001	NUM
aji-164	258	3	)	)	PUNCT
aji-164	258	4	.	.	PUNCT
aji-164	259	1	central	central	ADJ
aji-164	259	2	nervous	nervous	ADJ
aji-164	259	3	system	system	NOUN
aji-164	259	4	disease	disease	NOUN
aji-164	259	5	in	in	ADP
aji-164	259	6	patients	patient	NOUN
aji-164	259	7	with	with	ADP
aji-164	259	8	macrophagic	macrophagic	PROPN
aji-164	259	9	myofasciitis	myofasciitis	PROPN
aji-164	259	10	.	.	PUNCT
aji-164	260	1	brain	brain	PROPN
aji-164	260	2	,	,	PUNCT
aji-164	260	3	124(5	124(5	NUM
aji-164	260	4	)	)	PUNCT
aji-164	260	5	,	,	PUNCT
aji-164	260	6	974–983	974–983	NUM
aji-164	260	7	.	.	PUNCT
aji-164	261	1	authier	authier	NOUN
aji-164	261	2	,	,	PUNCT
aji-164	261	3	f.-j	f.-j	PROPN
aji-164	261	4	.	.	PROPN
aji-164	261	5	,	,	PUNCT
aji-164	261	6	sauvates	sauvate	NOUN
aji-164	261	7	,	,	PUNCT
aji-164	261	8	s.	s.	PROPN
aji-164	261	9	,	,	PUNCT
aji-164	261	10	chrisolv	chrisolv	PROPN
aji-164	261	11	,	,	PUNCT
aji-164	261	12	c.	c.	PROPN
aji-164	261	13	,	,	PUNCT
aji-164	261	14	et	et	PROPN
aji-164	261	15	al	al	PROPN
aji-164	261	16	.	.	PUNCT
aji-164	261	17	(	(	PUNCT
aji-164	261	18	2006	2006	NUM
aji-164	261	19	)	)	PUNCT
aji-164	261	20	.	.	PUNCT
aji-164	262	1	al(oh)₃-adjuvant	al(oh)₃-adjuvant	PROPN
aji-164	262	2	vaccine	vaccine	NOUN
aji-164	262	3	induce	induce	VERB
aji-164	262	4	macrophagic	macrophagic	ADJ
aji-164	262	5	myofasciitis	myofasciitis	NOUN
aji-164	262	6	in	in	ADP
aji-164	262	7	rat	rat	NOUN
aji-164	262	8	it	it	PRON
aji-164	262	9	influences	influence	VERB
aji-164	262	10	by	by	ADP
aji-164	262	11	the	the	DET
aji-164	262	12	genetic	genetic	ADJ
aji-164	262	13	background	background	NOUN
aji-164	262	14	.	.	PUNCT
aji-164	263	1	journal	journal	NOUN
aji-164	263	2	of	of	ADP
aji-164	263	3	neuromolecular	neuromolecular	ADJ
aji-164	263	4	disorder	disorder	NOUN
aji-164	263	5	,	,	PUNCT
aji-164	263	6	16(5	16(5	NUM
aji-164	263	7	)	)	PUNCT
aji-164	263	8	,	,	PUNCT
aji-164	264	1	547–557	547–557	NUM
aji-164	264	2	.	.	PUNCT
aji-164	264	3	caldarelli	caldarelli	PROPN
aji-164	264	4	,	,	PUNCT
aji-164	264	5	m.	m.	NOUN
aji-164	264	6	,	,	PUNCT
aji-164	264	7	rio	rio	PROPN
aji-164	264	8	,	,	PUNCT
aji-164	264	9	f.	f.	PROPN
aji-164	264	10	,	,	PUNCT
aji-164	264	11	giambra	giambra	NOUN
aji-164	264	12	,	,	PUNCT
aji-164	264	13	v.	v.	ADV
aji-164	264	14	,	,	PUNCT
aji-164	264	15	et	et	PROPN
aji-164	264	16	al	al	PROPN
aji-164	264	17	.	.	PUNCT
aji-164	265	1	(	(	PUNCT
aji-164	265	2	2024	2024	NUM
aji-164	265	3	)	)	PUNCT
aji-164	265	4	.	.	PUNCT
aji-164	266	1	asai	asai	PROPN
aji-164	266	2	syndrome	syndrome	PROPN
aji-164	266	3	:	:	PUNCT
aji-164	266	4	state	state	NOUN
aji-164	266	5	of	of	ADP
aji-164	266	6	art	art	NOUN
aji-164	266	7	and	and	CCONJ
aji-164	266	8	future	future	ADJ
aji-164	266	9	prespectives	prespective	NOUN
aji-164	266	10	.	.	PUNCT
aji-164	267	1	vaccines	vaccine	NOUN
aji-164	267	2	,	,	PUNCT
aji-164	267	3	12	12	NUM
aji-164	267	4	,	,	PUNCT
aji-164	267	5	1183	1183	NUM
aji-164	267	6	.	.	PUNCT
aji-164	268	1	https://doi.org/10.3390/vaccines12101183	https://doi.org/10.3390/vaccines12101183	NOUN
aji-164	268	2	colafrancesco	colafrancesco	PROPN
aji-164	268	3	,	,	PUNCT
aji-164	268	4	s.	s.	PROPN
aji-164	268	5	,	,	PUNCT
aji-164	268	6	agmon	agmon	PROPN
aji-164	268	7	-	-	PUNCT
aji-164	268	8	levin	levin	PROPN
aji-164	268	9	,	,	PUNCT
aji-164	268	10	n.	n.	PROPN
aji-164	268	11	,	,	PUNCT
aji-164	268	12	perricone	perricone	PROPN
aji-164	268	13	,	,	PUNCT
aji-164	268	14	n	n	CCONJ
aji-164	268	15	,	,	PUNCT
aji-164	268	16	shoenfeld	shoenfeld	VERB
aji-164	268	17	,	,	PUNCT
aji-164	268	18	y.	y.	PROPN
aji-164	268	19	(	(	PUNCT
aji-164	268	20	2013	2013	NUM
aji-164	268	21	)	)	PUNCT
aji-164	268	22	.	.	PUNCT
aji-164	269	1	unraveling	unravel	VERB
aji-164	269	2	the	the	DET
aji-164	269	3	soul	soul	NOUN
aji-164	269	4	of	of	ADP
aji-164	269	5	autoimmune	autoimmune	ADJ
aji-164	269	6	disease	disease	NOUN
aji-164	269	7	:	:	PUNCT
aji-164	269	8	pathogenesis	pathogenesis	NOUN
aji-164	269	9	,	,	PUNCT
aji-164	269	10	diagnosis	diagnosis	NOUN
aji-164	269	11	and	and	CCONJ
aji-164	269	12	treatment	treatment	NOUN
aji-164	269	13	adding	add	VERB
aji-164	269	14	dowels	dowel	NOUN
aji-164	269	15	to	to	ADP
aji-164	269	16	the	the	DET
aji-164	269	17	puzzle.immunologic	puzzle.immunologic	PROPN
aji-164	269	18	research,56,200205	research,56,200205	NOUN
aji-164	269	19	cruz	cruz	NOUN
aji-164	269	20	-	-	PUNCT
aji-164	269	21	tapias	tapias	PROPN
aji-164	269	22	,	,	PUNCT
aji-164	269	23	p.	p.	PROPN
aji-164	269	24	,	,	PUNCT
aji-164	269	25	agmon	agmon	PROPN
aji-164	269	26	-	-	PUNCT
aji-164	269	27	levin	levin	PROPN
aji-164	269	28	,	,	PUNCT
aji-164	269	29	n.	n.	PROPN
aji-164	269	30	,	,	PUNCT
aji-164	269	31	israeli	israeli	PROPN
aji-164	269	32	,	,	PUNCT
aji-164	269	33	e.	e.	PROPN
aji-164	269	34	,	,	PUNCT
aji-164	269	35	et	et	PROPN
aji-164	269	36	al	al	PROPN
aji-164	269	37	.	.	PROPN
aji-164	270	1	(	(	PUNCT
aji-164	270	2	2013	2013	NUM
aji-164	270	3	)	)	PUNCT
aji-164	270	4	.	.	PUNCT
aji-164	271	1	autoimmune	autoimmune	ADJ
aji-164	271	2	-	-	PUNCT
aji-164	271	3	inflammatory	inflammatory	ADJ
aji-164	271	4	syndrome	syndrome	NOUN
aji-164	271	5	induced	induce	VERB
aji-164	271	6	by	by	ADP
aji-164	271	7	adjuvant	adjuvant	ADJ
aji-164	271	8	asiaanimal	asiaanimal	ADJ
aji-164	271	9	model	model	NOUN
aji-164	271	10	a	a	DET
aji-164	271	11	proof	proof	NOUN
aji-164	271	12	of	of	ADP
aji-164	271	13	concept	concept	NOUN
aji-164	271	14	.	.	PUNCT
aji-164	272	1	current	current	ADJ
aji-164	272	2	medical	medical	ADJ
aji-164	272	3	chemistry	chemistry	NOUN
aji-164	272	4	,	,	PUNCT
aji-164	272	5	20(32	20(32	NUM
aji-164	272	6	)	)	PUNCT
aji-164	272	7	,	,	PUNCT
aji-164	272	8	4030–4036	4030–4036	NOUN
aji-164	272	9	.	.	PUNCT
aji-164	273	1	https://doi.org/10.2174/0929867311320990	https://doi.org/10.2174/0929867311320990	NOUN
aji-164	273	2	253	253	NUM
aji-164	273	3	dias	dia	NOUN
aji-164	273	4	,	,	PUNCT
aji-164	273	5	r	r	NOUN
aji-164	273	6	,	,	PUNCT
aji-164	273	7	raquel	raquel	PROPN
aji-164	273	8	,	,	PUNCT
aji-164	273	9	f.	f.	PROPN
aji-164	273	10	,diogo	,diogo	PROPN
aji-164	273	11	,	,	PUNCT
aji-164	273	12	r,,,,cartlas	r,,,,cartlas	PROPN
aji-164	273	13	,	,	PUNCT
aji-164	273	14	v.(2020).macrophagic	v.(2020).macrophagic	NOUN
aji-164	273	15	myofasciitis	myofasciitis	NOUN
aji-164	273	16	:	:	PUNCT
aji-164	273	17	a	a	DET
aji-164	273	18	typical	typical	ADJ
aji-164	273	19	presentation	presentation	NOUN
aji-164	273	20	for	for	ADP
aji-164	273	21	a	a	DET
aji-164	273	22	rare	rare	ADJ
aji-164	273	23	disease	disease	NOUN
aji-164	273	24	with	with	ADP
aji-164	273	25	challenging	challenging	ADJ
aji-164	273	26	approach	approach	NOUN
aji-164	273	27	.	.	PUNCT
aji-164	274	1	rheumatologia	rheumatologia	ADJ
aji-164	274	2	,	,	PUNCT
aji-164	274	3	58(3),167	58(3),167	NUM
aji-164	274	4	-	-	SYM
aji-164	274	5	172	172	NUM
aji-164	274	6	.	.	PUNCT
aji-164	274	7	dittmann	dittmann	PROPN
aji-164	274	8	,	,	PUNCT
aji-164	274	9	s.	s.	PROPN
aji-164	274	10	(	(	PUNCT
aji-164	274	11	2009	2009	NUM
aji-164	274	12	)	)	PUNCT
aji-164	274	13	.	.	PUNCT
aji-164	275	1	macrophagic	macrophagic	PROPN
aji-164	275	2	myofasciitis	myofasciitis	PROPN
aji-164	275	3	clinical	clinical	ADJ
aji-164	275	4	signs	sign	NOUN
aji-164	275	5	in	in	ADP
aji-164	275	6	human	human	ADJ
aji-164	275	7	and	and	CCONJ
aji-164	275	8	animals	animal	NOUN
aji-164	275	9	associated	associate	VERB
aji-164	275	10	with	with	ADP
aji-164	275	11	minerals	mineral	NOUN
aji-164	275	12	,	,	PUNCT
aji-164	275	13	trace	trace	NOUN
aji-164	275	14	element	element	NOUN
aji-164	275	15	and	and	CCONJ
aji-164	275	16	rare	rare	ADJ
aji-164	275	17	earth	earth	NOUN
aji-164	275	18	elements	element	NOUN
aji-164	275	19	,	,	PUNCT
aji-164	275	20	2022	2022	NUM
aji-164	275	21	.	.	PUNCT
aji-164	276	1	fan	fan	PROPN
aji-164	276	2	,	,	PUNCT
aji-164	276	3	j.	j.	PROPN
aji-164	276	4	,	,	PUNCT
aji-164	276	5	jin	jin	PROPN
aji-164	276	6	,	,	PUNCT
aji-164	276	7	s.	s.	PROPN
aji-164	276	8	,	,	PUNCT
aji-164	276	9	gilmartin	gilmartin	PROPN
aji-164	276	10	,	,	PUNCT
aji-164	276	11	l.	l.	PROPN
aji-164	276	12	,	,	PUNCT
aji-164	276	13	et	et	PROPN
aji-164	276	14	al	al	PROPN
aji-164	276	15	.	.	PROPN
aji-164	276	16	(	(	PUNCT
aji-164	276	17	2022	2022	NUM
aji-164	276	18	)	)	PUNCT
aji-164	276	19	.	.	PUNCT
aji-164	277	1	advances	advance	NOUN
aji-164	277	2	in	in	ADP
aji-164	277	3	infectious	infectious	ADJ
aji-164	277	4	disease	disease	NOUN
aji-164	277	5	vaccines	vaccine	NOUN
aji-164	277	6	adjuvants	adjuvant	NOUN
aji-164	277	7	.	.	PUNCT
aji-164	278	1	vaccines	vaccine	NOUN
aji-164	278	2	,	,	PUNCT
aji-164	278	3	10	10	NUM
aji-164	278	4	,	,	PUNCT
aji-164	278	5	1120	1120	NUM
aji-164	278	6	.	.	PUNCT
aji-164	279	1	gherardi	gherardi	NOUN
aji-164	279	2	,	,	PUNCT
aji-164	279	3	r.	r.	PROPN
aji-164	279	4	k.	k.	PROPN
aji-164	279	5	(	(	PUNCT
aji-164	279	6	2011	2011	NUM
aji-164	279	7	)	)	PUNCT
aji-164	279	8	.	.	PUNCT
aji-164	280	1	macrophagic	macrophagic	PROPN
aji-164	280	2	myofasciitis	myofasciitis	PROPN
aji-164	280	3	assess	assess	VERB
aji-164	280	4	long	long	ADJ
aji-164	280	5	term	term	NOUN
aji-164	280	6	persistence	persistence	NOUN
aji-164	280	7	of	of	ADP
aji-164	280	8	vaccine	vaccine	NOUN
aji-164	280	9	derive	derive	VERB
aji-164	280	10	aluminum	aluminum	NOUN
aji-164	280	11	hydroxide	hydroxide	NOUN
aji-164	280	12	in	in	ADP
aji-164	280	13	muscle	muscle	NOUN
aji-164	280	14	.	.	PUNCT
aji-164	281	1	brain	brain	NOUN
aji-164	281	2	,	,	PUNCT
aji-164	281	3	124(9	124(9	NUM
aji-164	281	4	)	)	PUNCT
aji-164	281	5	,	,	PUNCT
aji-164	281	6	1821–1831	1821–1831	NUM
aji-164	281	7	.	.	PUNCT
aji-164	282	1	gherardi	gherardi	PROPN
aji-164	282	2	,	,	PUNCT
aji-164	282	3	r.	r.	PROPN
aji-164	282	4	k.	k.	PROPN
aji-164	282	5	,	,	PUNCT
aji-164	282	6	&	&	CCONJ
aji-164	282	7	authier	authier	NOUN
aji-164	282	8	,	,	PUNCT
aji-164	282	9	f.-j	f.-j	PROPN
aji-164	282	10	.	.	PUNCT
aji-164	283	1	(	(	PUNCT
aji-164	283	2	2003	2003	NUM
aji-164	283	3	)	)	PUNCT
aji-164	283	4	.	.	PUNCT
aji-164	284	1	aluminum	aluminum	NOUN
aji-164	284	2	inclusion	inclusion	NOUN
aji-164	284	3	mmf	mmf	NOUN
aji-164	284	4	:	:	PUNCT
aji-164	284	5	recently	recently	ADV
aji-164	284	6	identified	identify	VERB
aji-164	284	7	condition	condition	NOUN
aji-164	284	8	.	.	PUNCT
aji-164	285	1	immunology	immunology	NOUN
aji-164	285	2	allergy	allergy	NOUN
aji-164	285	3	clininic	clininic	NOUN
aji-164	285	4	.	.	PUNCT
aji-164	286	1	gherardi	gherardi	PROPN
aji-164	286	2	,	,	PUNCT
aji-164	286	3	r.	r.	PROPN
aji-164	286	4	k.	k.	PROPN
aji-164	286	5	,	,	PUNCT
aji-164	286	6	&	&	CCONJ
aji-164	286	7	authier	authier	NOUN
aji-164	286	8	,	,	PUNCT
aji-164	286	9	f.-j	f.-j	PROPN
aji-164	286	10	.	.	PUNCT
aji-164	287	1	(	(	PUNCT
aji-164	287	2	2012	2012	NUM
aji-164	287	3	)	)	PUNCT
aji-164	287	4	.	.	PUNCT
aji-164	288	1	macrophagic	macrophagic	PROPN
aji-164	288	2	myofasciitis	myofasciitis	PROPN
aji-164	288	3	characteristic	characteristic	NOUN
aji-164	288	4	and	and	CCONJ
aji-164	288	5	pathophysiology	pathophysiology	NOUN
aji-164	288	6	.	.	PUNCT
aji-164	289	1	lupus	lupus	NOUN
aji-164	289	2	,	,	PUNCT
aji-164	289	3	21(2	21(2	NUM
aji-164	289	4	)	)	PUNCT
aji-164	289	5	,	,	PUNCT
aji-164	289	6	184	184	NUM
aji-164	289	7	–	–	SYM
aji-164	289	8	189	189	NUM
aji-164	289	9	.	.	PUNCT
aji-164	290	1	gherardi	gherardi	PROPN
aji-164	290	2	,	,	PUNCT
aji-164	290	3	r.	r.	PROPN
aji-164	290	4	k.	k.	PROPN
aji-164	290	5	,	,	PUNCT
aji-164	290	6	crepeaux	crepeaux	PROPN
aji-164	290	7	,	,	PUNCT
aji-164	290	8	g.	g.	PROPN
aji-164	290	9	,	,	PUNCT
aji-164	290	10	&	&	CCONJ
aji-164	290	11	authier	authier	PROPN
aji-164	290	12	,	,	PUNCT
aji-164	290	13	f.	f.	PROPN
aji-164	290	14	(	(	PUNCT
aji-164	290	15	2019	2019	NUM
aji-164	290	16	)	)	PUNCT
aji-164	290	17	.	.	PUNCT
aji-164	291	1	myalgia	myalgia	PROPN
aji-164	291	2	,	,	PUNCT
aji-164	291	3	chronic	chronic	ADJ
aji-164	291	4	fatigue	fatigue	NOUN
aji-164	291	5	syndrome	syndrome	NOUN
aji-164	291	6	following	follow	VERB
aji-164	291	7	immunization	immunization	NOUN
aji-164	291	8	:	:	PUNCT
aji-164	291	9	macrophagic	macrophagic	PROPN
aji-164	291	10	myofasciitis	myofasciitis	PROPN
aji-164	291	11	in	in	ADP
aji-164	291	12	man	man	NOUN
aji-164	291	13	and	and	CCONJ
aji-164	291	14	animals	animal	NOUN
aji-164	291	15	.	.	PUNCT
aji-164	292	1	studies	study	NOUN
aji-164	292	2	support	support	VERB
aji-164	292	3	linkage	linkage	NOUN
aji-164	292	4	to	to	ADP
aji-164	292	5	aluminum	aluminum	NOUN
aji-164	292	6	adjuvant	adjuvant	ADJ
aji-164	292	7	persistence	persistence	NOUN
aji-164	292	8	and	and	CCONJ
aji-164	292	9	diffusion	diffusion	NOUN
aji-164	292	10	into	into	ADP
aji-164	292	11	immune	immune	ADJ
aji-164	292	12	system	system	NOUN
aji-164	292	13	.	.	PUNCT
aji-164	293	1	autoimmunity	autoimmunity	NOUN
aji-164	293	2	review	review	NOUN
aji-164	293	3	,	,	PUNCT
aji-164	293	4	18	18	NUM
aji-164	293	5	,	,	PUNCT
aji-164	293	6	691	691	NUM
aji-164	293	7	–	–	PUNCT
aji-164	293	8	705	705	NUM
aji-164	293	9	.	.	PUNCT
aji-164	294	1	gibson	gibson	PROPN
aji-164	294	2	,	,	PUNCT
aji-164	294	3	c.	c.	PROPN
aji-164	294	4	m.	m.	NOUN
aji-164	294	5	(	(	PUNCT
aji-164	294	6	2024	2024	NUM
aji-164	294	7	)	)	PUNCT
aji-164	294	8	.	.	PUNCT
aji-164	295	1	macrophagic	macrophagic	PROPN
aji-164	295	2	myofasciitis	myofasciitis	PROPN
aji-164	295	3	.	.	PUNCT
aji-164	296	1	wikidoc	wikidoc	ADJ
aji-164	296	2	.	.	PUNCT
aji-164	297	1	hogen	hogen	PROPN
aji-164	297	2	-	-	PUNCT
aji-164	297	3	esch	esch	PROPN
aji-164	297	4	,	,	PUNCT
aji-164	297	5	h.	h.	PROPN
aji-164	297	6	(	(	PUNCT
aji-164	297	7	2013	2013	NUM
aji-164	297	8	)	)	PUNCT
aji-164	297	9	.	.	PUNCT
aji-164	298	1	mechanism	mechanism	NOUN
aji-164	298	2	of	of	ADP
aji-164	298	3	immunpotentiation	immunpotentiation	NOUN
aji-164	298	4	and	and	CCONJ
aji-164	298	5	safety	safety	NOUN
aji-164	298	6	of	of	ADP
aji-164	298	7	aluminum	aluminum	NOUN
aji-164	298	8	adjuvant	adjuvant	NOUN
aji-164	298	9	.	.	PUNCT
aji-164	299	1	frontiers	frontier	NOUN
aji-164	299	2	of	of	ADP
aji-164	299	3	immunology	immunology	NOUN
aji-164	299	4	,	,	PUNCT
aji-164	299	5	3	3	NUM
aji-164	299	6	.	.	PUNCT
aji-164	300	1	https://doi.org/10.3389/fimmu.2012.00406	https://doi.org/10.3389/fimmu.2012.00406	PROPN
aji-164	300	2	israeli	israeli	PROPN
aji-164	300	3	,	,	PUNCT
aji-164	300	4	e.	e.	PROPN
aji-164	300	5	,	,	PUNCT
aji-164	300	6	agmon	agmon	PROPN
aji-164	300	7	-	-	PUNCT
aji-164	300	8	levin	levin	PROPN
aji-164	300	9	,	,	PUNCT
aji-164	300	10	n.	n.	NOUN
aji-164	300	11	,	,	PUNCT
aji-164	300	12	blank	blank	ADJ
aji-164	300	13	,	,	PUNCT
aji-164	300	14	m.	m.	NOUN
aji-164	300	15	,	,	PUNCT
aji-164	300	16	&	&	CCONJ
aji-164	300	17	sheonfeld	sheonfeld	PROPN
aji-164	300	18	,	,	PUNCT
aji-164	300	19	y.	y.	PROPN
aji-164	300	20	(	(	PUNCT
aji-164	300	21	2011	2011	NUM
aji-164	300	22	)	)	PUNCT
aji-164	300	23	.	.	PUNCT
aji-164	301	1	macrophagic	macrophagic	PROPN
aji-164	301	2	myofasciitis	myofasciiti	VERB
aji-164	301	3	a	a	DET
aji-164	301	4	vaccine	vaccine	NOUN
aji-164	301	5	alum	alum	ADJ
aji-164	301	6	autoimmune	autoimmune	ADJ
aji-164	301	7	related	relate	VERB
aji-164	301	8	diseases	disease	NOUN
aji-164	301	9	.	.	PUNCT
aji-164	302	1	clinical	clinical	ADJ
aji-164	302	2	review	review	NOUN
aji-164	302	3	of	of	ADP
aji-164	302	4	immunology	immunology	NOUN
aji-164	302	5	,	,	PUNCT
aji-164	302	6	41(2	41(2	NUM
aji-164	302	7	)	)	PUNCT
aji-164	302	8	,	,	PUNCT
aji-164	302	9	163	163	NUM
aji-164	302	10	.	.	PUNCT
aji-164	303	1	https://doi.org/10.3390/vaccines12101183	https://doi.org/10.3390/vaccines12101183	NOUN
aji-164	303	2	https://doi.org/10.2174/0929867311320990253	https://doi.org/10.2174/0929867311320990253	PROPN
aji-164	303	3	https://doi.org/10.2174/0929867311320990253	https://doi.org/10.2174/0929867311320990253	VERB
aji-164	303	4	shnawa	shnawa	PROPN
aji-164	303	5	;	;	PUNCT
aji-164	304	1	asian	asian	PROPN
aji-164	304	2	j.	j.	PROPN
aji-164	304	3	immunol	immunol	PROPN
aji-164	304	4	.	.	PROPN
aji-164	304	5	,	,	PUNCT
aji-164	304	6	vol	vol	NOUN
aji-164	304	7	.	.	PROPN
aji-164	304	8	8	8	NUM
aji-164	304	9	,	,	PUNCT
aji-164	304	10	no	no	INTJ
aji-164	304	11	.	.	NOUN
aji-164	304	12	1	1	NUM
aji-164	304	13	,	,	PUNCT
aji-164	304	14	pp	pp	ADJ
aji-164	304	15	.	.	PUNCT
aji-164	305	1	97	97	NUM
aji-164	305	2	-	-	SYM
aji-164	305	3	103	103	NUM
aji-164	305	4	,	,	PUNCT
aji-164	305	5	2025	2025	NUM
aji-164	305	6	;	;	PUNCT
aji-164	305	7	article	article	NOUN
aji-164	305	8	no.aji.134974	no.aji.134974	VERB
aji-164	305	9	103	103	NUM
aji-164	305	10	kim	kim	PROPN
aji-164	305	11	,	,	PUNCT
aji-164	305	12	h.	h.	PROPN
aji-164	305	13	,	,	PUNCT
aji-164	305	14	lim	lim	PROPN
aji-164	305	15	,	,	PUNCT
aji-164	305	16	y.	y.	PROPN
aji-164	305	17	,	,	PUNCT
aji-164	305	18	kang	kang	PROPN
aji-164	305	19	,	,	PUNCT
aji-164	305	20	j.	j.	PROPN
aji-164	305	21	,	,	PUNCT
aji-164	305	22	et	et	PROPN
aji-164	305	23	al	al	PROPN
aji-164	305	24	.	.	PROPN
aji-164	306	1	(	(	PUNCT
aji-164	306	2	2020	2020	NUM
aji-164	306	3	)	)	PUNCT
aji-164	306	4	.	.	PUNCT
aji-164	307	1	macrophagic	macrophagic	PROPN
aji-164	307	2	myofasciitis	myofasciitis	PROPN
aji-164	307	3	pseudolymph	pseudolymph	PROPN
aji-164	307	4	node	node	NOUN
aji-164	307	5	caused	cause	VERB
aji-164	307	6	by	by	ADP
aji-164	307	7	aluminum	aluminum	NOUN
aji-164	307	8	adjuvant	adjuvant	NOUN
aji-164	307	9	.	.	PUNCT
aji-164	308	1	science	science	NOUN
aji-164	308	2	reports	report	NOUN
aji-164	308	3	,	,	PUNCT
aji-164	308	4	10	10	NUM
aji-164	308	5	,	,	PUNCT
aji-164	308	6	11834	11834	NUM
aji-164	308	7	.	.	PUNCT
aji-164	309	1	li	li	PROPN
aji-164	309	2	,	,	PUNCT
aji-164	309	3	y.	y.	PROPN
aji-164	309	4	r.	r.	PROPN
aji-164	309	5	,	,	PUNCT
aji-164	309	6	zhao	zhao	PROPN
aji-164	309	7	,	,	PUNCT
aji-164	309	8	s.	s.	PROPN
aji-164	309	9	d.	d.	PROPN
aji-164	309	10	,	,	PUNCT
aji-164	309	11	branield	branield	PROPN
aji-164	309	12	,	,	PUNCT
aji-164	309	13	j.	j.	PROPN
aji-164	309	14	p.	p.	PROPN
aji-164	309	15	,	,	PUNCT
aji-164	309	16	et	et	PROPN
aji-164	309	17	al	al	PROPN
aji-164	309	18	.	.	PUNCT
aji-164	309	19	(	(	PUNCT
aji-164	309	20	2015	2015	NUM
aji-164	309	21	)	)	PUNCT
aji-164	309	22	.	.	PUNCT
aji-164	310	1	genetic	genetic	ADJ
aji-164	310	2	sharing	sharing	NOUN
aji-164	310	3	and	and	CCONJ
aji-164	310	4	heritability	heritability	NOUN
aji-164	310	5	of	of	ADP
aji-164	310	6	pediatric	pediatric	ADJ
aji-164	310	7	age	age	NOUN
aji-164	310	8	onset	onset	NOUN
aji-164	310	9	of	of	ADP
aji-164	310	10	autoimmune	autoimmune	ADJ
aji-164	310	11	disease	disease	NOUN
aji-164	310	12	.	.	PUNCT
aji-164	311	1	nature	nature	NOUN
aji-164	311	2	communication	communication	NOUN
aji-164	311	3	,	,	PUNCT
aji-164	311	4	61	61	NUM
aji-164	311	5	,	,	PUNCT
aji-164	311	6	1–10	1–10	NOUN
aji-164	311	7	.	.	PUNCT
aji-164	312	1	masson	masson	PROPN
aji-164	312	2	,	,	PUNCT
aji-164	312	3	j.-d	j.-d	PROPN
aji-164	312	4	.	.	PROPN
aji-164	312	5	,	,	PUNCT
aji-164	312	6	badran	badran	ADJ
aji-164	312	7	,	,	PUNCT
aji-164	312	8	g.	g.	PROPN
aji-164	312	9	,	,	PUNCT
aji-164	312	10	gherhardi	gherhardi	PROPN
aji-164	312	11	,	,	PUNCT
aji-164	312	12	r.	r.	PROPN
aji-164	312	13	k.	k.	PROPN
aji-164	312	14	,	,	PUNCT
aji-164	312	15	et	et	PROPN
aji-164	312	16	al	al	PROPN
aji-164	312	17	.	.	PUNCT
aji-164	312	18	(	(	PUNCT
aji-164	312	19	2024	2024	NUM
aji-164	312	20	)	)	PUNCT
aji-164	312	21	.	.	PUNCT
aji-164	313	1	wide	wide	ADV
aji-164	313	2	spread	spread	VERB
aji-164	313	3	myalgia	myalgia	NOUN
aji-164	313	4	and	and	CCONJ
aji-164	313	5	chronic	chronic	ADJ
aji-164	313	6	fatigue	fatigue	NOUN
aji-164	313	7	:	:	PUNCT
aji-164	313	8	phagocytosis	phagocytosis	NOUN
aji-164	313	9	from	from	ADP
aji-164	313	10	macrophagic	macrophagic	ADJ
aji-164	313	11	myofasciitis	myofasciitis	NOUN
aji-164	313	12	patients	patient	NOUN
aji-164	313	13	exposed	expose	VERB
aji-164	313	14	to	to	ADP
aji-164	313	15	aluminum	aluminum	NOUN
aji-164	313	16	oxyhydroxide	oxyhydroxide	ADV
aji-164	313	17	-	-	PUNCT
aji-164	313	18	adjuvanted	adjuvante	VERB
aji-164	313	19	vaccine	vaccine	NOUN
aji-164	313	20	exhibits	exhibit	VERB
aji-164	313	21	specific	specific	ADJ
aji-164	313	22	inflammatory	inflammatory	ADJ
aji-164	313	23	,	,	PUNCT
aji-164	313	24	autophagy	autophagy	ADJ
aji-164	313	25	and	and	CCONJ
aji-164	313	26	mitochondrial	mitochondrial	ADJ
aji-164	313	27	responses	response	NOUN
aji-164	313	28	.	.	PUNCT
aji-164	314	1	toxics	toxic	NOUN
aji-164	314	2	,	,	PUNCT
aji-164	314	3	12	12	NUM
aji-164	314	4	,	,	PUNCT
aji-164	314	5	491	491	NUM
aji-164	314	6	.	.	PUNCT
aji-164	315	1	https://doi.org/10.3390/toxics12070491	https://doi.org/10.3390/toxics12070491	PROPN
aji-164	315	2	papo	papo	PROPN
aji-164	315	3	,	,	PUNCT
aji-164	315	4	t.	t.	PROPN
aji-164	315	5	(	(	PUNCT
aji-164	315	6	2003	2003	NUM
aji-164	315	7	)	)	PUNCT
aji-164	315	8	.	.	PUNCT
aji-164	316	1	macrophagic	macrophagic	PROPN
aji-164	316	2	myofasciitis	myofasciitis	PROPN
aji-164	316	3	focal	focal	ADJ
aji-164	316	4	or	or	CCONJ
aji-164	316	5	systemic	systemic	ADJ
aji-164	316	6	.	.	PUNCT
aji-164	317	1	joint	joint	ADJ
aji-164	317	2	bone	bone	NOUN
aji-164	317	3	spine	spine	NOUN
aji-164	317	4	,	,	PUNCT
aji-164	317	5	70(4	70(4	NUM
aji-164	317	6	)	)	PUNCT
aji-164	317	7	,	,	PUNCT
aji-164	317	8	242	242	NUM
aji-164	317	9	–	–	SYM
aji-164	317	10	245	245	NUM
aji-164	317	11	.	.	PUNCT
aji-164	318	1	park	park	NOUN
aji-164	318	2	,	,	PUNCT
aji-164	318	3	j.-h	j.-h	PROPN
aji-164	318	4	.	.	PUNCT
aji-164	318	5	,	,	PUNCT
aji-164	318	6	na	na	PROPN
aji-164	318	7	,	,	PUNCT
aji-164	318	8	k.-s	k.-s	PROPN
aji-164	318	9	.	.	PROPN
aji-164	318	10	,	,	PUNCT
aji-164	318	11	paik	paik	NOUN
aji-164	318	12	,	,	PUNCT
aji-164	318	13	s.-s	s.-	NOUN
aji-164	318	14	.	.	PUNCT
aji-164	318	15	,	,	PUNCT
aji-164	318	16	&	&	CCONJ
aji-164	318	17	yoo	yoo	PROPN
aji-164	318	18	,	,	PUNCT
aji-164	318	19	d.-h	d.-h	PROPN
aji-164	318	20	.	.	PUNCT
aji-164	319	1	(	(	PUNCT
aji-164	319	2	2005	2005	NUM
aji-164	319	3	)	)	PUNCT
aji-164	319	4	.	.	PUNCT
aji-164	320	1	macrophagic	macrophagic	PROPN
aji-164	320	2	myofasciitis	myofasciitis	PROPN
aji-164	320	3	unrelated	unrelated	ADJ
aji-164	320	4	to	to	ADP
aji-164	320	5	vaccination	vaccination	NOUN
aji-164	320	6	.	.	PUNCT
aji-164	321	1	journal	journal	NOUN
aji-164	321	2	of	of	ADP
aji-164	321	3	rheumatology	rheumatology	NOUN
aji-164	321	4	,	,	PUNCT
aji-164	321	5	24(1	24(1	NUM
aji-164	321	6	)	)	PUNCT
aji-164	321	7	,	,	PUNCT
aji-164	321	8	65–67	65–67	NUM
aji-164	321	9	.	.	PUNCT
aji-164	322	1	perricon	perricon	NOUN
aji-164	322	2	,	,	PUNCT
aji-164	322	3	c.	c.	PROPN
aji-164	322	4	,	,	PUNCT
aji-164	322	5	&	&	CCONJ
aji-164	322	6	sheonfeld	sheonfeld	PROPN
aji-164	322	7	,	,	PUNCT
aji-164	322	8	y.	y.	PROPN
aji-164	322	9	(	(	PUNCT
aji-164	322	10	2019	2019	NUM
aji-164	322	11	)	)	PUNCT
aji-164	322	12	.	.	PUNCT
aji-164	323	1	mosaic	mosaic	ADJ
aji-164	323	2	of	of	ADP
aji-164	323	3	autoimmunity	autoimmunity	NOUN
aji-164	323	4	:	:	PUNCT
aji-164	323	5	the	the	DET
aji-164	323	6	novel	novel	ADJ
aji-164	323	7	factors	factor	NOUN
aji-164	323	8	of	of	ADP
aji-164	323	9	autoimmune	autoimmune	ADJ
aji-164	323	10	diseases	disease	NOUN
aji-164	323	11	.	.	PUNCT
aji-164	324	1	academic	academic	ADJ
aji-164	324	2	press	press	NOUN
aji-164	324	3	.	.	PUNCT
aji-164	325	1	ravindran	ravindran	NOUN
aji-164	325	2	,	,	PUNCT
aji-164	325	3	t.	t.	PROPN
aji-164	325	4	(	(	PUNCT
aji-164	325	5	2024	2024	NUM
aji-164	325	6	)	)	PUNCT
aji-164	325	7	.	.	PUNCT
aji-164	326	1	macrophagic	macrophagic	PROPN
aji-164	326	2	myofaciitis	myofaciitis	NOUN
aji-164	326	3	;	;	PUNCT
aji-164	326	4	causes	cause	NOUN
aji-164	326	5	,	,	PUNCT
aji-164	326	6	symptoms	symptom	NOUN
aji-164	326	7	,	,	PUNCT
aji-164	326	8	and	and	CCONJ
aji-164	326	9	treatment	treatment	NOUN
aji-164	326	10	.	.	PUNCT
aji-164	327	1	cliniq	cliniq	PROPN
aji-164	327	2	:	:	PUNCT
aji-164	327	3	the	the	DET
aji-164	327	4	virtual	virtual	ADJ
aji-164	327	5	hospit	hospit	PROPN
aji-164	327	6	ruiz	ruiz	PROPN
aji-164	327	7	,	,	PUNCT
aji-164	327	8	j.	j.	PROPN
aji-164	327	9	t.	t.	PROPN
aji-164	327	10	,	,	PUNCT
aji-164	327	11	lujan	lujan	PROPN
aji-164	327	12	,	,	PUNCT
aji-164	327	13	l.	l.	PROPN
aji-164	327	14	,	,	PUNCT
aji-164	327	15	blank	blank	NOUN
aji-164	327	16	,	,	PUNCT
aji-164	327	17	m.	m.	NOUN
aji-164	327	18	,	,	PUNCT
aji-164	327	19	&	&	CCONJ
aji-164	327	20	seonfeld	seonfeld	PROPN
aji-164	327	21	,	,	PUNCT
aji-164	327	22	y.	y.	PROPN
aji-164	327	23	(	(	PUNCT
aji-164	327	24	2017	2017	NUM
aji-164	327	25	)	)	PUNCT
aji-164	327	26	.	.	PUNCT
aji-164	328	1	adjuvant	adjuvant	NOUN
aji-164	328	2	and	and	CCONJ
aji-164	328	3	vaccine	vaccine	NOUN
aji-164	328	4	induced	induce	VERB
aji-164	328	5	autoimmunity	autoimmunity	NOUN
aji-164	328	6	,	,	PUNCT
aji-164	328	7	animal	animal	NOUN
aji-164	328	8	models	model	NOUN
aji-164	328	9	.	.	PUNCT
aji-164	329	1	environmental	environmental	ADJ
aji-164	329	2	autoimmunity	autoimmunity	NOUN
aji-164	329	3	,	,	PUNCT
aji-164	329	4	56	56	NUM
aji-164	329	5	,	,	PUNCT
aji-164	329	6	55	55	NUM
aji-164	329	7	–	–	SYM
aji-164	329	8	65	65	NUM
aji-164	329	9	.	.	PUNCT
aji-164	329	10	santos	santos	PROPN
aji-164	329	11	,	,	PUNCT
aji-164	329	12	d.	d.	PROPN
aji-164	329	13	s.	s.	PROPN
aji-164	329	14	,	,	PUNCT
aji-164	329	15	santo	santo	PROPN
aji-164	329	16	,	,	PUNCT
aji-164	329	17	a.	a.	NOUN
aji-164	329	18	,	,	PUNCT
aji-164	329	19	&	&	CCONJ
aji-164	329	20	rebelo	rebelo	PROPN
aji-164	329	21	,	,	PUNCT
aji-164	329	22	c.	c.	NOUN
aji-164	329	23	(	(	PUNCT
aji-164	329	24	2018	2018	NUM
aji-164	329	25	)	)	PUNCT
aji-164	329	26	.	.	PUNCT
aji-164	330	1	macrophagic	macrophagic	PROPN
aji-164	330	2	myofasciitis	myofasciitis	NOUN
aji-164	330	3	:	:	PUNCT
aji-164	330	4	challenging	challenge	VERB
aji-164	330	5	diagnosis	diagnosis	NOUN
aji-164	330	6	.	.	PUNCT
aji-164	331	1	british	british	ADJ
aji-164	331	2	medical	medical	PROPN
aji-164	331	3	journal	journal	PROPN
aji-164	331	4	:	:	PUNCT
aji-164	331	5	case	case	NOUN
aji-164	331	6	reports	report	VERB
aji-164	331	7	.	.	PUNCT
aji-164	332	1	https://doi.org/10.1136/bcr2018	https://doi.org/10.1136/bcr2018	NOUN
aji-164	332	2	sheonfeld	sheonfeld	VERB
aji-164	332	3	,	,	PUNCT
aji-164	332	4	y.	y.	PROPN
aji-164	332	5	,	,	PUNCT
aji-164	332	6	&	&	CCONJ
aji-164	332	7	agmon	agmon	PROPN
aji-164	332	8	-	-	PUNCT
aji-164	332	9	levin	levin	PROPN
aji-164	332	10	,	,	PUNCT
aji-164	332	11	n.	n.	PROPN
aji-164	332	12	(	(	PUNCT
aji-164	332	13	2011	2011	NUM
aji-164	332	14	)	)	PUNCT
aji-164	332	15	.	.	PUNCT
aji-164	333	1	asia	asia	PROPN
aji-164	333	2	–	–	PUNCT
aji-164	333	3	autoimmune	autoimmune	NOUN
aji-164	333	4	-	-	PUNCT
aji-164	333	5	inflammatory	inflammatory	ADJ
aji-164	333	6	syndrome	syndrome	NOUN
aji-164	333	7	induced	induce	VERB
aji-164	333	8	by	by	ADP
aji-164	333	9	adjuvant	adjuvant	ADJ
aji-164	333	10	.	.	PUNCT
aji-164	334	1	journal	journal	PROPN
aji-164	334	2	of	of	ADP
aji-164	334	3	autoimmunity	autoimmunity	NOUN
aji-164	334	4	,	,	PUNCT
aji-164	334	5	36(11	36(11	NUM
aji-164	334	6	)	)	PUNCT
aji-164	334	7	,	,	PUNCT
aji-164	334	8	4–8	4–8	NOUN
aji-164	334	9	.	.	NOUN
aji-164	334	10	shingdi	shingdi	PROPN
aji-164	334	11	,	,	PUNCT
aji-164	334	12	m.	m.	NOUN
aji-164	334	13	,	,	PUNCT
aji-164	334	14	pamplette	pamplette	PROPN
aji-164	334	15	,	,	PUNCT
aji-164	334	16	r.	r.	PROPN
aji-164	334	17	,	,	PUNCT
aji-164	334	18	hughes	hughes	PROPN
aji-164	334	19	,	,	PUNCT
aji-164	334	20	j.	j.	PROPN
aji-164	334	21	,	,	PUNCT
aji-164	334	22	et	et	PROPN
aji-164	334	23	al	al	PROPN
aji-164	334	24	.	.	PUNCT
aji-164	335	1	(	(	PUNCT
aji-164	335	2	2005	2005	NUM
aji-164	335	3	)	)	PUNCT
aji-164	335	4	.	.	PUNCT
aji-164	336	1	macrophagic	macrophagic	PROPN
aji-164	336	2	myofasciitis	myofasciitis	PROPN
aji-164	336	3	associated	associate	VERB
aji-164	336	4	with	with	ADP
aji-164	336	5	vaccine	vaccine	NOUN
aji-164	336	6	derived	derive	VERB
aji-164	336	7	alumium	alumium	NOUN
aji-164	336	8	.	.	PUNCT
aji-164	337	1	medical	medical	ADJ
aji-164	337	2	journal	journal	PROPN
aji-164	337	3	of	of	ADP
aji-164	337	4	australia	australia	PROPN
aji-164	337	5	,	,	PUNCT
aji-164	337	6	163(3	163(3	NUM
aji-164	337	7	)	)	PUNCT
aji-164	337	8	,	,	PUNCT
aji-164	337	9	145	145	NUM
aji-164	337	10	–	–	PUNCT
aji-164	337	11	146	146	NUM
aji-164	337	12	.	.	PUNCT
aji-164	338	1	shivane	shivane	PROPN
aji-164	338	2	,	,	PUNCT
aji-164	338	3	a.	a.	PROPN
aji-164	338	4	,	,	PUNCT
aji-164	338	5	hilton	hilton	PROPN
aji-164	338	6	,	,	PUNCT
aji-164	338	7	d.	d.	PROPN
aji-164	338	8	a.	a.	PROPN
aji-164	338	9	,	,	PUNCT
aji-164	338	10	moat	moat	ADV
aji-164	338	11	,	,	PUNCT
aji-164	338	12	r.	r.	PROPN
aji-164	338	13	m.	m.	PROPN
aji-164	338	14	,	,	PUNCT
aji-164	338	15	et	et	PROPN
aji-164	338	16	al	al	PROPN
aji-164	338	17	.	.	PUNCT
aji-164	338	18	(	(	PUNCT
aji-164	338	19	2012	2012	NUM
aji-164	338	20	)	)	PUNCT
aji-164	338	21	.	.	PUNCT
aji-164	339	1	macrophagic	macrophagic	PROPN
aji-164	339	2	myofasciitis	myofasciitis	PROPN
aji-164	339	3	:	:	PUNCT
aji-164	339	4	a	a	DET
aji-164	339	5	report	report	NOUN
aji-164	339	6	of	of	ADP
aji-164	339	7	second	second	ADJ
aji-164	339	8	case	case	NOUN
aji-164	339	9	from	from	ADP
aji-164	339	10	uk	uk	PROPN
aji-164	339	11	.	.	PROPN
aji-164	339	12	neuropathology	neuropathology	PROPN
aji-164	339	13	applied	apply	VERB
aji-164	339	14	neurology	neurology	NOUN
aji-164	339	15	,	,	PUNCT
aji-164	339	16	38	38	NUM
aji-164	339	17	,	,	PUNCT
aji-164	339	18	711–716	711–716	NUM
aji-164	339	19	.	.	PUNCT
aji-164	340	1	shnawa	shnawa	PROPN
aji-164	340	2	,	,	PUNCT
aji-164	340	3	i.	i.	PROPN
aji-164	340	4	m.	m.	PROPN
aji-164	340	5	s.	s.	PROPN
aji-164	340	6	(	(	PUNCT
aji-164	340	7	2017	2017	NUM
aji-164	340	8	)	)	PUNCT
aji-164	340	9	.	.	PUNCT
aji-164	341	1	vaccine	vaccine	NOUN
aji-164	341	2	allied	ally	VERB
aji-164	341	3	biologics	biologic	NOUN
aji-164	341	4	.	.	PUNCT
aji-164	342	1	international	international	ADJ
aji-164	342	2	journal	journal	NOUN
aji-164	342	3	of	of	ADP
aji-164	342	4	vaccination	vaccination	NOUN
aji-164	342	5	and	and	CCONJ
aji-164	342	6	immunization	immunization	NOUN
aji-164	342	7	,	,	PUNCT
aji-164	342	8	2(2	2(2	NUM
aji-164	342	9	)	)	PUNCT
aji-164	342	10	,	,	PUNCT
aji-164	342	11	13–19	13–19	NUM
aji-164	342	12	.	.	PUNCT
aji-164	343	1	shnawa	shnawa	PROPN
aji-164	343	2	,	,	PUNCT
aji-164	343	3	i.	i.	PROPN
aji-164	343	4	m.	m.	PROPN
aji-164	343	5	s.	s.	PROPN
aji-164	343	6	(	(	PUNCT
aji-164	343	7	2023	2023	NUM
aji-164	343	8	)	)	PUNCT
aji-164	343	9	.	.	PUNCT
aji-164	344	1	vaccine	vaccine	NOUN
aji-164	344	2	and	and	CCONJ
aji-164	344	3	adjuvant	adjuvant	ADJ
aji-164	344	4	mediated	mediate	VERB
aji-164	344	5	autoimmunity	autoimmunity	NOUN
aji-164	344	6	.	.	PUNCT
aji-164	345	1	journal	journal	PROPN
aji-164	345	2	of	of	ADP
aji-164	345	3	pharmaceutical	pharmaceutical	PROPN
aji-164	345	4	research	research	NOUN
aji-164	345	5	international	international	PROPN
aji-164	345	6	,	,	PUNCT
aji-164	345	7	35(24	35(24	NUM
aji-164	345	8	)	)	PUNCT
aji-164	345	9	,	,	PUNCT
aji-164	345	10	42–48	42–48	PROPN
aji-164	345	11	.	.	PUNCT
aji-164	346	1	shnawa	shnawa	PROPN
aji-164	346	2	,	,	PUNCT
aji-164	346	3	i.	i.	PROPN
aji-164	346	4	m.	m.	PROPN
aji-164	346	5	s.	s.	PROPN
aji-164	346	6	,	,	PUNCT
aji-164	346	7	&	&	CCONJ
aji-164	346	8	alkafaji	alkafaji	PROPN
aji-164	346	9	,	,	PUNCT
aji-164	346	10	a.	a.	PROPN
aji-164	346	11	j.	j.	PROPN
aji-164	346	12	(	(	PUNCT
aji-164	346	13	2023	2023	NUM
aji-164	346	14	)	)	PUNCT
aji-164	346	15	.	.	PUNCT
aji-164	347	1	sarscov-2	sarscov-2	NUM
aji-164	347	2	vaccine	vaccine	NOUN
aji-164	347	3	adverse	adverse	ADJ
aji-164	347	4	effects	effect	NOUN
aji-164	347	5	.	.	PUNCT
aji-164	348	1	pharmaceutical	pharmaceutical	ADJ
aji-164	348	2	negative	negative	ADJ
aji-164	348	3	results	result	NOUN
aji-164	348	4	.	.	PUNCT
aji-164	349	1	tervaert	tervaert	PROPN
aji-164	349	2	,	,	PUNCT
aji-164	349	3	j.	j.	PROPN
aji-164	349	4	w.	w.	PROPN
aji-164	349	5	c.	c.	PROPN
aji-164	349	6	,	,	PUNCT
aji-164	349	7	et	et	PROPN
aji-164	349	8	al	al	PROPN
aji-164	349	9	.	.	PROPN
aji-164	349	10	(	(	PUNCT
aji-164	349	11	2023	2023	NUM
aji-164	349	12	)	)	PUNCT
aji-164	349	13	.	.	PUNCT
aji-164	350	1	autoimmune	autoimmune	ADJ
aji-164	350	2	inflammatory	inflammatory	ADJ
aji-164	350	3	syndrome	syndrome	NOUN
aji-164	350	4	induced	induce	VERB
aji-164	350	5	by	by	ADP
aji-164	350	6	adjuvant	adjuvant	ADJ
aji-164	350	7	asia	asia	PROPN
aji-164	350	8	.	.	PUNCT
aji-164	351	1	autoimmunity	autoimmunity	PROPN
aji-164	351	2	review	review	PROPN
aji-164	351	3	,	,	PUNCT
aji-164	351	4	22(6	22(6	NUM
aji-164	351	5	)	)	PUNCT
aji-164	351	6	,	,	PUNCT
aji-164	351	7	103287	103287	NUM
aji-164	351	8	.	.	PUNCT
aji-164	352	1	watad	watad	NOUN
aji-164	352	2	,	,	PUNCT
aji-164	352	3	a.	a.	NOUN
aji-164	352	4	,	,	PUNCT
aji-164	352	5	sarif	sarif	PROPN
aji-164	352	6	,	,	PUNCT
aji-164	352	7	k.	k.	PROPN
aji-164	352	8	,	,	PUNCT
aji-164	352	9	&	&	CCONJ
aji-164	352	10	sheonfeld	sheonfeld	PROPN
aji-164	352	11	,	,	PUNCT
aji-164	352	12	y.	y.	PROPN
aji-164	352	13	(	(	PUNCT
aji-164	352	14	2017	2017	NUM
aji-164	352	15	)	)	PUNCT
aji-164	352	16	.	.	PUNCT
aji-164	353	1	the	the	DET
aji-164	353	2	asia	asia	PROPN
aji-164	353	3	syndrome	syndrome	PROPN
aji-164	353	4	:	:	PUNCT
aji-164	353	5	basic	basic	ADJ
aji-164	353	6	concept	concept	NOUN
aji-164	353	7	.	.	PUNCT
aji-164	354	1	mediterranean	mediterranean	PROPN
aji-164	354	2	journal	journal	PROPN
aji-164	354	3	of	of	ADP
aji-164	354	4	rheumatology	rheumatology	NOUN
aji-164	354	5	,	,	PUNCT
aji-164	354	6	28(2	28(2	NUM
aji-164	354	7	)	)	PUNCT
aji-164	354	8	,	,	PUNCT
aji-164	354	9	64–69	64–69	PROPN
aji-164	354	10	.	.	PUNCT
aji-164	355	1	zherankova	zherankova	PROPN
aji-164	355	2	,	,	PUNCT
aji-164	355	3	v.	v.	ADV
aji-164	355	4	,	,	PUNCT
aji-164	355	5	van	van	PROPN
aji-164	355	6	diemen	dieman	NOUN
aji-164	355	7	,	,	PUNCT
aji-164	355	8	c.	c.	PROPN
aji-164	355	9	c.	c.	PROPN
aji-164	355	10	,	,	PUNCT
aji-164	355	11	&	&	CCONJ
aji-164	355	12	wijmenga	wijmenga	PROPN
aji-164	355	13	,	,	PUNCT
aji-164	355	14	c.	c.	PROPN
aji-164	355	15	(	(	PUNCT
aji-164	355	16	2009	2009	NUM
aji-164	355	17	)	)	PUNCT
aji-164	355	18	.	.	PUNCT
aji-164	356	1	detecting	detect	VERB
aji-164	356	2	shared	share	VERB
aji-164	356	3	pathogenesis	pathogenesis	NOUN
aji-164	356	4	from	from	ADP
aji-164	356	5	shared	share	VERB
aji-164	356	6	genetics	genetic	NOUN
aji-164	356	7	of	of	ADP
aji-164	356	8	immune	immune	ADJ
aji-164	356	9	related	relate	VERB
aji-164	356	10	diseases	disease	NOUN
aji-164	356	11	.	.	PUNCT
aji-164	357	1	nature	nature	NOUN
aji-164	357	2	reviews	review	VERB
aji-164	357	3	genetics	genetic	NOUN
aji-164	357	4	,	,	PUNCT
aji-164	357	5	10	10	NUM
aji-164	357	6	,	,	PUNCT
aji-164	357	7	586	586	NUM
aji-164	357	8	–	–	PUNCT
aji-164	357	9	594	594	NUM
aji-164	357	10	.	.	PUNCT
aji-164	358	1	disclaimer	disclaimer	ADJ
aji-164	358	2	/	/	SYM
aji-164	358	3	publisher	publisher	NOUN
aji-164	358	4	’s	’s	PART
aji-164	358	5	note	note	NOUN
aji-164	358	6	:	:	PUNCT
aji-164	358	7	the	the	DET
aji-164	358	8	statements	statement	NOUN
aji-164	358	9	,	,	PUNCT
aji-164	358	10	opinions	opinion	NOUN
aji-164	358	11	and	and	CCONJ
aji-164	358	12	data	datum	NOUN
aji-164	358	13	contained	contain	VERB
aji-164	358	14	in	in	ADP
aji-164	358	15	all	all	DET
aji-164	358	16	publications	publication	NOUN
aji-164	358	17	are	be	AUX
aji-164	358	18	solely	solely	ADV
aji-164	358	19	those	those	PRON
aji-164	358	20	of	of	ADP
aji-164	358	21	the	the	DET
aji-164	358	22	individual	individual	ADJ
aji-164	358	23	author(s	author(s	PROPN
aji-164	358	24	)	)	PUNCT
aji-164	358	25	and	and	CCONJ
aji-164	358	26	contributor(s	contributor(s	NOUN
aji-164	358	27	)	)	PUNCT
aji-164	358	28	and	and	CCONJ
aji-164	358	29	not	not	PART
aji-164	358	30	of	of	ADP
aji-164	358	31	the	the	DET
aji-164	358	32	publisher	publisher	NOUN
aji-164	358	33	and/or	and/or	CCONJ
aji-164	358	34	the	the	DET
aji-164	358	35	editor(s	editor(s	NOUN
aji-164	358	36	)	)	PUNCT
aji-164	358	37	.	.	PUNCT
aji-164	359	1	this	this	DET
aji-164	359	2	publisher	publisher	NOUN
aji-164	359	3	and/or	and/or	CCONJ
aji-164	359	4	the	the	DET
aji-164	359	5	editor(s	editor(s	NOUN
aji-164	359	6	)	)	PUNCT
aji-164	359	7	disclaim	disclaim	VERB
aji-164	359	8	responsibility	responsibility	NOUN
aji-164	359	9	for	for	ADP
aji-164	359	10	any	any	DET
aji-164	359	11	injury	injury	NOUN
aji-164	359	12	to	to	ADP
aji-164	359	13	people	people	NOUN
aji-164	359	14	or	or	CCONJ
aji-164	359	15	property	property	NOUN
aji-164	359	16	resulting	result	VERB
aji-164	359	17	from	from	ADP
aji-164	359	18	any	any	DET
aji-164	359	19	ideas	idea	NOUN
aji-164	359	20	,	,	PUNCT
aji-164	359	21	methods	method	NOUN
aji-164	359	22	,	,	PUNCT
aji-164	359	23	instructions	instruction	NOUN
aji-164	359	24	or	or	CCONJ
aji-164	359	25	products	product	NOUN
aji-164	359	26	referred	refer	VERB
aji-164	359	27	to	to	ADP
aji-164	359	28	in	in	ADP
aji-164	359	29	the	the	DET
aji-164	359	30	content	content	NOUN
aji-164	359	31	.	.	PUNCT
aji-164	360	1	_	_	PUNCT
aji-164	361	1	_	_	PUNCT
aji-164	362	1	_	_	PUNCT
aji-164	363	1	_	_	PUNCT
aji-164	364	1	_	_	PUNCT
aji-164	365	1	_	_	PUNCT
aji-164	366	1	_	_	PUNCT
aji-164	367	1	_	_	PUNCT
aji-164	368	1	_	_	PUNCT
aji-164	369	1	_	_	PUNCT
aji-164	370	1	_	_	PUNCT
aji-164	371	1	_	_	PUNCT
aji-164	372	1	_	_	PUNCT
aji-164	373	1	_	_	PUNCT
aji-164	374	1	_	_	PUNCT
aji-164	375	1	_	_	PUNCT
aji-164	376	1	_	_	PUNCT
aji-164	377	1	_	_	PUNCT
aji-164	378	1	_	_	PUNCT
aji-164	379	1	_	_	PUNCT
aji-164	380	1	_	_	PUNCT
aji-164	381	1	_	_	PUNCT
aji-164	382	1	_	_	PUNCT
aji-164	383	1	_	_	PUNCT
aji-164	384	1	_	_	PUNCT
aji-164	385	1	_	_	PUNCT
aji-164	386	1	_	_	PUNCT
aji-164	387	1	_	_	PUNCT
aji-164	388	1	_	_	PUNCT
aji-164	389	1	_	_	PUNCT
aji-164	390	1	_	_	PUNCT
aji-164	391	1	_	_	PUNCT
aji-164	392	1	_	_	PUNCT
aji-164	393	1	_	_	PUNCT
aji-164	394	1	_	_	PUNCT
aji-164	395	1	_	_	PUNCT
aji-164	396	1	_	_	PUNCT
aji-164	397	1	_	_	PUNCT
aji-164	398	1	_	_	PUNCT
aji-164	399	1	_	_	PUNCT
aji-164	400	1	_	_	PUNCT
aji-164	401	1	_	_	PUNCT
aji-164	402	1	_	_	PUNCT
aji-164	403	1	_	_	PUNCT
aji-164	404	1	_	_	PUNCT
aji-164	405	1	_	_	PUNCT
aji-164	406	1	_	_	PUNCT
aji-164	407	1	_	_	PUNCT
aji-164	408	1	_	_	PUNCT
aji-164	409	1	_	_	PUNCT
aji-164	410	1	_	_	PUNCT
aji-164	411	1	_	_	PUNCT
aji-164	412	1	_	_	PUNCT
aji-164	413	1	_	_	PUNCT
aji-164	414	1	_	_	PUNCT
aji-164	415	1	_	_	PUNCT
aji-164	416	1	_	_	PUNCT
aji-164	417	1	_	_	PUNCT
aji-164	418	1	_	_	PUNCT
aji-164	419	1	_	_	PUNCT
aji-164	420	1	_	_	PUNCT
aji-164	421	1	_	_	PUNCT
aji-164	422	1	_	_	PUNCT
aji-164	423	1	_	_	PUNCT
aji-164	424	1	_	_	PUNCT
aji-164	425	1	_	_	PUNCT
aji-164	426	1	_	_	PUNCT
aji-164	427	1	_	_	PUNCT
aji-164	428	1	_	_	PUNCT
aji-164	429	1	_	_	PUNCT
aji-164	430	1	_	_	PUNCT
aji-164	431	1	_	_	PUNCT
aji-164	432	1	_	_	PUNCT
aji-164	433	1	_	_	PUNCT
aji-164	434	1	_	_	PUNCT
aji-164	435	1	_	_	PUNCT
aji-164	436	1	_	_	PUNCT
aji-164	437	1	_	_	PUNCT
aji-164	438	1	_	_	PUNCT
aji-164	439	1	_	_	PUNCT
aji-164	440	1	_	_	PUNCT
aji-164	441	1	©	©	PRON
aji-164	441	2	copyright	copyright	NOUN
aji-164	441	3	(	(	PUNCT
aji-164	441	4	2025	2025	NUM
aji-164	441	5	):	):	PUNCT
aji-164	441	6	author(s	author(s	NOUN
aji-164	441	7	)	)	PUNCT
aji-164	441	8	.	.	PUNCT
aji-164	442	1	the	the	DET
aji-164	442	2	licensee	licensee	NOUN
aji-164	442	3	is	be	AUX
aji-164	442	4	the	the	DET
aji-164	442	5	journal	journal	PROPN
aji-164	442	6	publisher	publisher	NOUN
aji-164	442	7	.	.	PUNCT
aji-164	443	1	this	this	PRON
aji-164	443	2	is	be	AUX
aji-164	443	3	an	an	DET
aji-164	443	4	open	open	ADJ
aji-164	443	5	access	access	NOUN
aji-164	443	6	article	article	NOUN
aji-164	443	7	distributed	distribute	VERB
aji-164	443	8	under	under	ADP
aji-164	443	9	the	the	DET
aji-164	443	10	terms	term	NOUN
aji-164	443	11	of	of	ADP
aji-164	443	12	the	the	DET
aji-164	443	13	creative	creative	ADJ
aji-164	443	14	commons	common	NOUN
aji-164	443	15	attribution	attribution	NOUN
aji-164	443	16	license	license	NOUN
aji-164	443	17	(	(	PUNCT
aji-164	443	18	http://creativecommons.org/licenses/by/4.0	http://creativecommons.org/licenses/by/4.0	NOUN
aji-164	443	19	)	)	PUNCT
aji-164	443	20	,	,	PUNCT
aji-164	443	21	which	which	PRON
aji-164	443	22	permits	permit	VERB
aji-164	443	23	unrestricted	unrestricted	ADJ
aji-164	443	24	use	use	NOUN
aji-164	443	25	,	,	PUNCT
aji-164	443	26	distribution	distribution	NOUN
aji-164	443	27	,	,	PUNCT
aji-164	443	28	and	and	CCONJ
aji-164	443	29	reproduction	reproduction	NOUN
aji-164	443	30	in	in	ADP
aji-164	443	31	any	any	DET
aji-164	443	32	medium	medium	NOUN
aji-164	443	33	,	,	PUNCT
aji-164	443	34	provided	provide	VERB
aji-164	443	35	the	the	DET
aji-164	443	36	original	original	ADJ
aji-164	443	37	work	work	NOUN
aji-164	443	38	is	be	AUX
aji-164	443	39	properly	properly	ADV
aji-164	443	40	cited	cite	VERB
aji-164	443	41	.	.	PUNCT
aji-164	444	1	peer	peer	NOUN
aji-164	444	2	-	-	PUNCT
aji-164	444	3	review	review	NOUN
aji-164	444	4	history	history	NOUN
aji-164	444	5	:	:	PUNCT
aji-164	444	6	the	the	DET
aji-164	444	7	peer	peer	NOUN
aji-164	444	8	review	review	NOUN
aji-164	444	9	history	history	NOUN
aji-164	444	10	for	for	ADP
aji-164	444	11	this	this	DET
aji-164	444	12	paper	paper	NOUN
aji-164	444	13	can	can	AUX
aji-164	444	14	be	be	AUX
aji-164	444	15	accessed	access	VERB
aji-164	444	16	here	here	ADV
aji-164	444	17	:	:	PUNCT
aji-164	444	18	https://pr.sdiarticle5.com/review-history/134974	https://pr.sdiarticle5.com/review-history/134974	X
aji-164	444	19	https://pr.sdiarticle5.com/review-history/134974	https://pr.sdiarticle5.com/review-history/134974	PUNCT